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Abstract 
 
Neospora caninum is an obligate intracellular protozoan that in recent years 
has been recognized as a major infectious agent responsible for consecutive 
abortions in cattle leading to high economic losses. Although the gastrointestinal 
tract is the natural route of infection in horizontally transmitted neosporosis, the 
host immune response in the intestinal mucosa following parasite infection is 
largely uncharacterized. Nevertheless, and due to the unique role of the gut 
mucosa in the establishment of host infection, the stimulation of a local immune 
response at this mucosa may be a privileged form for the host to counteract or 
avoid this infection. 
 In this thesis a murine model of intragastrically established neosporosis was 
used to further characterize the host intestinal mucosal immune response 
following N. caninum challenge. The obtained results showed that an early Th1-
type immune response is elicited in the intestinal mucosa and associated lymphoid 
tissue of the infected mice thus confirming that immune cells at this mucosal site 
can actively contribute to host resistance against N. caninum. Taking these results 
into account, an intranasal immunization protocol was developed with the specific 
aim of eliciting a mucosal immune response as a means to confer protection 
against neosporosis established through the gastrointestinal tract. The results 
presented here showed that this immunization strategy successfully induced a 
long-lasting mucosal and systemic parasite-specific immune response that 
conferred protection against N. caninum infection. Yet despite the intracellular 
nature of this parasite, no increased interferon-γ production was observed in the 
immunized mice following infection. In contrast, our results showed that production 
of intestinal parasite-agglutinating IgA was elicited by immunization suggesting 
that it could account for the observed protection. Supporting this hypothesis, it is 
shown here that the developed intranasal immunization protocol can also confer 
protection against N. caninum infection in mice with compromised cell-mediated 
immunity.  
X 
 
Lastly, the immunogenicity of the used immunization strategy was assessed 
in cattle, which mounted a humoral and cellular parasite-specific immune response 
upon the intranasal immunization 
Altogether the studies presented here contributed to the characterization of 
the immune response in the intestinal mucosa of N. caninum infected mice and 
confirmed that a mucosal immunization strategy is be a viable and robust 
alternative to achieve host protection against this intracellular pathogen. 
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Resumo 
 
Neospora caninum é um protozoário intracelular obrigatório que nos últimos 
anos tem sido reconhecido como um importante agente infeccioso responsável 
por abortos consecutivos em gado bovino que se traduzem em elevadas perdas 
económicas. Apesar de o tracto gastrointestinal ser a via de infecção natural do 
parasita na neosporose transmitida de forma horizontal, a resposta imune do 
hospedeiro na mucosa intestinal após a infecção encontra-se ainda pouco 
caracterizada. No entanto, e devido ao papel que mucosa intestinal apresenta no 
estabelecimento da infecção do hospedeiro por N. caninum, a indução de uma 
resposta imunológica nesta mucosa poderá constituir uma forma privilegiada de o 
hospedeiro evitar a infecção por este parasita. 
Nesta tese, usou-se um modelo de neosporose estabelecida pela via 
intragástrica em murganhos para melhor caracterizar a resposta imunológica 
intestinal do hospedeiro desencadeada pela infecção com N. caninum. Neste 
estudo, mostrou-se que é induzida uma resposta imunológica precoce do tipo Th1 
na mucosa intestinal e tecidos linfóides associados nos murganhos infectados, 
confirmando assim que as células imunitárias presentes nesta mucosa contribuem 
activamente para a resistência do hospedeiro face à infecção por N. caninum. 
Tendo em conta estes resultados, foi desenvolvido um protocolo de imunização 
intra-nasal com o objectivo específico de induzir uma resposta imunológica em 
mucosas, como um meio para conferir protecção contra a neosporose 
estabelecida através do trato gastro-intestinal. Os resultados aqui apresentados 
mostram que esta estratégia de vacinação foi bem-sucedida na indução de uma 
resposta imunológica específica, duradoura e protectora do hospedeiro, 
detectável na mucosa intestinal e de modo sistémico. Apesar da natureza 
intracelular deste parasita, não foi observado um aumento na produção de 
interferão-γ nos murganhos imunizados após infecção. No entanto, os resultados 
obtidos mostraram que a IgA intestinal, cuja produção foi induzida pela 
imunização, é capaz de aglutinar o parasita sugerindo que a resposta humoral 
mediada por esta imunoglobulina poderá contribuir para a protecção observada. 
Apoiando essa hipótese, demonstrou-se que a estratégia de imunização utilizada 
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também confere protecção contra a infecção por N. caninum em murganhos que 
apresentam imunidade celular comprometida. 
Por fim, a imunogenicidade do protocolo de imunização utilizado foi 
confirmada em bovinos, mostrando que o mesmo foi capaz de induzir uma 
resposta imune humoral e celular específica contra o parasita nestes animais. 
No seu conjunto, os resultados aqui apresentados contribuíram para a 
caracterização da resposta imune na mucosa intestinal de murganhos infectados 
por N. caninum e demonstraram que uma estratégia de imunização em mucosas 
pode constituir uma alternativa viável e robusta para conferir protecção contra 
este patogénio intracelular. 
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Thesis Outline 
 
 The present thesis is organized in 8 chapters: 
 
 In chapter 1, an overview of the literature relevant for the understanding of 
the thesis objectives and results is presented. In this regard this chapter contains a 
description of N. caninum life cycle and its implications in the context of infection 
and pathogenesis, as well as a comprehensive review of the immune related host 
parasite-relationship and its impact for the development of vaccination strategies 
against this pathogen. Due to the importance of the intestinal mucosa for the 
establishment of natural N. caninum infection, a summary of the major 
components of the host immune response in this mucosa as well as their 
implication for mucosal immunization are also presented. 
 
 In chapter 2, the aims of this dissertation are given. 
 
 The results derived from the experimental work performed in the context of 
this dissertation are presented in chapters 3 to 7. Each chapter follows the usual 
organization of a scientific article, containing an abstract, a brief introduction 
relevant for the presented results, followed by methods and results sections, 
finishing with a discussion of the study.  
 Regarding each results chapter: 
Chapter 3 contains part of the results present in the published article 
entitled: “Mucosal and systemic T cell response in mice intragastrically infected 
with Neospora caninum tachyzoites”, which I co-authored. 
 Chapter 4 is based in the published article entitled: “Protective effect of 
intranasal immunization with Neospora caninum membrane antigens against 
murine neosporosis established through the gastrointestinal tract” of which I am 
the first author. However novel results obtained after its publication that have 
complemented the published work are also presented in this chapter. 
  Chapters 5 to 7 contain unpublished results that further explore the 
protective effect of the intranasal immunization protocol presented in chapter 4 
and assess its immunogenicity in cattle. 
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 Lastly, chapter 8 comprises a general discussion of the work presented in 
this dissertation where the models presented in this thesis are further discussed 
and future perspectives are proposed. 
 
 
 The articles referred above, that constitute the basis of the results 
presented in chapters 3 and 4, are annexed in their published form in the end of 
this dissertation. 
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1.1 Neospora caninum 
 
1.1.1 Phylogeny and identification 
 
Neospora caninum is an obligate intracellular coccidian protozoan 
belonging to the phylum apicomplexa within the sarcocystidae family1,2. This 
phylum is a large and diverse group that encompasses over 5000 different species 
with a wide environmental distribution3,4. The name apicomplexa derives from the 
presence of an evolutionary unique complex structure of organelles located in the 
cell’s apical end, which are essential for host cell invasion by apicomplexa 
members5,6. All the members of this phylum display a characteristic parasitic 
lifestyle with often complex life cycles that alternate between sexual and asexual 
reproduction and usually require the infection of more than one host to complete 
it4,5. The host range presented by the members of this phylum is extremely large 
and varies from aquatic as well as terrestrial invertebrates and vertebrates5. Of 
notice, many of these protozoa are known human pathogens such as Plasmodium 
spp., Toxoplasma gondii and Cryptosporidium spp.4,5,7, all of which present a 
serious concern to public health especially in developing countries. In addition, 
several members of this phylum are also important pathogens of veterinary 
relevance like N. caninum and also T. gondii as well as Babesia, Theileria and 
Eimeria spp.4,5,7 all responsible for high economic losses. Still, it is estimated that 
only a small fraction of the members of this phylum has been discovered3,4 and 
therefore the number of hosts affected by apicomplexa pathogens may be 
presently underestimated.  
 Retrospectively, the first described case of neosporosis (the disease 
caused by N. caninum infection) was reported in Norway, in 1984, in dogs 
suffering from several neuromuscular disorders. In this instance, several parasites 
with apicomplexa morphology could be observed, however their exact species 
could not be determined8. A few years after, in 1988, N. caninum was isolated for 
the first time in a dog presenting clinical signs of neosporosis9 and was 
subsequently described and characterized as a new species in the same year10. 
The relatively recent discovery of this parasite can in part be explained by its 
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almost identical morphological characteristics to those of T. gondii. In fact, it is 
estimated that before 1988 cases of N. caninum infection were largely 
misidentified and attributed to T. gondii since these two parasites are 
indistinguishable under most microscopic observations11. Nevertheless, 
phylogenetic analysis and comparison of the RNA sequences present in the 18S 
ribosomal unit of both coccidians proved that these two parasites are indeed 
separate species that however have only recently diverged12. Still, despite all the 
similarities N. caninum presents a unique set of characteristics such as host 
range, route of transmission and antigenic composition1 that will be further 
elaborated in the following chapters.  
 
1.1.2 Cell structure  
 
The life cycle of N. caninum is characterized by three distinct infectious-
stages: tachyzoite, bradyzoite (organized in tissue cysts) and oocyst, all off each 
are essential to the parasite survival13. Oocysts are ovoid structures with 
approximately 10 to 15 µm and represent the sexual replication stage of the 
parasite. Oocysts are initially formed in an unsporulated state that sporulates in 24 
hours upon release from the host. The sporulated state is usually characterized by 
the presence of two sporocysts each containing 4 sporozoites14,15. However, very 
little is known regarding the resistance of oocysts to environmental conditions 
once outside of the host16 however, and in analogy with T. gondii, they are 
expected to be very resistant13,17.  
Tachyzoites and bradyzoites replicate asexually and are both intracellular 
stages of the parasite. Tachyzoites are the most well characterized life-stage of N. 
caninum since these are easier to maintain in vitro and isolate from infected hosts. 
Morphologically, tachyzoites are lunar shaped or ovoid, depending on the state of 
division, with approximately 6 × 2 µm and represent the acute infection stage of 
the parasite, capable of fast replication13,18. Tachyzoites can infect a wide range of 
nucleated cells such as neurons, schwann cells, astrocytes, monocytes, 
fibroblasts, muscle cells, placental cells and hepatocytes11,19. This parasitic stage 
also presents the complex apical vesicle system characteristic of apicomplexa 
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parasites, composed by micronemes, rhoptries and dense granules. In addition, N. 
caninum tachyzoites also possess a locomotion system powered by an actin-
myosin motor named gliding motility that allows parasite mobility and is essential 
for the process of active invasion of new host cells11,19.  
Bradyzoites are slender shaped with approximately 7 × 2 µm and organized 
themselves into intracellular tissue cysts13,18. Morphologically, bradyzoites closely 
resemble tachyzoites, presenting however fewer vesicles in the apical 
complex11,19. Tissue cysts can contain several dozen bradyzoites surrounded by a 
cyst wall and can be primarily found in the central nervous system and muscle 
cells1,17. In this stage the parasite replicates slowly and is capable of maintaining 
the infection for long periods of time, possibly spawning the entire host’s life13,18. 
Nevertheless, and despite the capacity to evade complete sterilization by the host 
immune response, cysts very rarely lead to clinical manifestations in 
immunocompetent hosts2,11. 
 
1.1.3 Host cell invasion  
 
Due to the intracellular lifestyle of apicomplexa parasites, the invasion of 
new host cells is of paramount importance. In this regard, apicomplexa parasites 
are capable of actively invade new cells by employing generally conserved 
mechanisms among this phylum6,20. Due to this fact, much of the knowledge on 
how these parasites invade new cells is derived from studies using T. gondii as a 
model21. The first steps of invasion are mediated by a low affinity interaction 
between the parasite membrane proteins and host cell membrane that allows the 
initial attachment. Upon this first interaction the parasite reorients itself and 
sequentially releases the apical vesicles contents, which mediate the process of 
active invasion. First, microneme proteins are released which stabilizes parasite 
adhesion. Then rhoptries proteins are ejected, and in conjunction with microneme 
proteins form a tight ring-like junction that coupled with the gliding motility action of 
the parasite allows its entry in the host cell. Once inside, the parasite resides in a 
unique cell compartment designated as the parasitophorus vacuole. At this point 
the remaining rhoptries and dense granule proteins are released, modulating the 
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environment of the vacuole and of the host cell, favoring the parasite survival and 
preventing events such as lysosome fusion5,6,21.  
In the case of N. caninum, it has been shown that the parasite can invade a 
host cell in as little as 5 minutes after the initial attachment22. This initial interaction 
between cells is largely mediated by two major immunodominant proteins in N. 
caninum tachyzoite cell surface, NcSAG1 and NcSRS2, which exhibit high 
homology with previously identified T. gondii proteins also involved in cell 
adhesion23. The importance of these two proteins in parasite survival has been 
demonstrated in vitro where specific antibodies against these proteins were 
capable of reducing N. caninum invasion of new host cells24-26. Nevertheless, 
these initial interactions constitute a very dynamic process and this attachment 
can be disengaged if the host cell is not suitable for parasite infection or growth23. 
 Several proteins from N. caninum micronemes have also been identified, 
once again showing a great degree of homology with T. gondii counterparts. As 
such, N. caninum microneme proteins NcMIC1 to 4 have been implicated in the 
stabilization of the initial interaction between parasite and host cell27-31. Similar to 
the previously mentioned membrane proteins, specific antibodies raised against 
these microneme proteins were also capable of preventing N. caninum host cell 
invasion28,29,32. On the other hand, and in contrast with T. gondii, in vitro assays 
have shown that some of these microneme proteins are released spontaneously 
upon egress from host cell27-30 which can in part explain the rapid loss of infectivity 
observed in N. caninum tachyzoites after as few as 6 hours of extracellular 
maintenance33. Upon stabilization of the parasite-host cell interaction, rhoptries 
proteins in conjunction with the microneme protein NcAMA134 and the parasite 
gliding motility22 mediate N. caninum active invasion process33. Very few proteins 
from rhoptries and dense granules have been identified in N. caninum. Still, the 
rhoptry protein NcROP2 is known to be essential for parasite invasion of host 
cells35 although its precise role in this process is still unknown36. Once inside the 
parasitophorus vacuole the N. caninum tachyzoite and bradyzoite stages divide by 
endodyogeny11. Similarly to T. gondii, N. caninum can modulate the host cell 
environment in order to favor parasite survival. N. caninum tachyzoites were 
recently found to be capable of recruiting mitochondria, the endoplasmic reticulum 
and late endocytic organelles to the vicinity of the parasitophorus vacuole all of 
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which the parasite scavenges for nutrients37. Further modulation of the host cell 
environment by the parasite is characterized by the blocking of apoptosis of the 
host cell favoring N. caninum propagation38. 
 
1.1.4 Host range, life cycle and transmission 
 
Like many members of the phylum apicomplexa, N. caninum has a 
heteroxenous life-cycle and therefore requires both a definitive and an 
intermediate host to complete it (Figure 1-1). Dogs were the first to be identified as 
definitive hosts for the parasite14. More recently other canine species like 
coyotes39, wolfs40 and dingoes41 have also been characterized as definitive hosts. 
On the other hand the parasite can infect a wide range of intermediate hosts, 
usually large herbivores. Due to the characteristics of N. caninum transmission 
and economic impact, cattle is the most widely recognized and important 
intermediate host but the parasite has also been isolated from goats, horses and 
sheep13,42. In addition, N. caninum has also been isolated in wild herbivores such 
as white-tail deer, water buffalos and bisons. However, parasite DNA or specific 
antibodies have been reported in an increasing number of animal species like rats 
and mice, chicken, rabbit, red fox, rhinoceros, pigs and even dolphins13,42. Still, 
despite its close relation with T. gondii, no firm evidence exists that N. caninum 
can infect humans where only low antibody levels have been reported and no DNA 
or viable parasites have ever been detected43-45. Nevertheless experimental 
infection of Rhesus monkeys has been proven possible and reproducing some of 
the characteristics of neosporosis46. 
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Figure 1-1 – N. caninum life cycle. From Goodswen, S et al., Infection, Genetics and 
Evolution, 2013, 13; 133-50 
 
The distinction between definitive and intermediate hosts is tightly related 
with the cycle of sexual and asexual reproduction of the parasite. As such, in the 
definitive host the parasite can replicate both sexually and asexually. It is 
assumed, although it has not been shown, that sexual reproduction occurs in the 
intestinal epithelial cells of the definitive host47. Nevertheless, it is well established 
that the newly formed oocysts are excreted with the host feces14,15,48,49. At least in 
the case of experimentally infected dogs the shedding of oocysts occurs in a 
limited time frame14,15. However relapsing and de novo release of oocysts can 
occur either by reactivation of a latent infection or by re-infection49. Intermediate 
hosts can become infected through the ingestion of pasture and water 
contaminated with oocysts. Although not formally shown, but in analogy with T. 
gondii50, sporozoites are thought to be excystized from the oocysts in the gut of 
the host, after which they can invade the intestinal epithelial cells and differentiate 
in tachyzoites2. Intracellular tachyzoites rapidly proliferate and are released 
following induction of host cell lysis11. This period marks the acute stage of 
infection which roughly accounts for the first 2 weeks following initial parasite 
exposure2. Following this period the host is considered latently infected which 
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coincides with parasite encystation and differentiation into bradyzoites. The 
parasite life cycle is completed with the infection of a new definitive host through 
the ingestion of contaminated tissue from an infected intermediate host51-53. The 
transmission between definitive and intermediate host characterizes the horizontal 
route of transmission of the parasite. Nevertheless, N. caninum can also be 
transmitted vertically (or transplacentally) from dam to fetus during pregnancy. In 
this case, and depending on the timing when infection occurs, two distinct 
scenarios can take place: endogenous transplacental transmission or exogenous 
transplacental transmission54. In the first case the primary infection of the 
progenitor occurs during pregnancy, which leads to parasite dissemination to the 
fetus during the acute stage of infection. In the second case the parasite is 
transmitted to the fetus following the recrudescence of a latent infection acquired 
by the progenitor prior to the pregnancy54. Both scenarios have different impacts in 
the outcome of pregnancy and to the host immune response13,17,47,54,55. 
Transmission of the parasite between definitive and intermediate hosts is 
best characterized in cattle and dogs due to the relevance of these species as  
hosts for N. caninum and due to the associated pathologies of neosporosis13,17,55. 
Vertical transmission is widely considered the most important transmission route 
for the maintenance of N. caninum infection in cattle herds56-59. Several studies 
have shown that the rate of vertical transmission varies between 61 and 95%57,60-
65 which makes N. caninum one of the most successful vertically transmitted 
pathogens in cattle13,42. In addition the parasite can be transmitted over 
consecutive pregnancies increasing its capacity to perpetuate the infection over 
several generations58,66. Nevertheless, and despite the very high rate of vertical 
transmission, it is evident from mathematical models that the maintenance of N. 
caninum infection in a herd cannot be sustained without horizontal transmission 
events67. In fact, experimental infection of cattle with oocysts was proven 
possible68,69 and vertical transmission could also be observed in some 
instances70,71 although endogenous transplacental transmission was not 
registered in following pregnancies71. Further indication of post-natal exposure to 
the parasite in nature is provided by the existence of seropositive calves born from 
seronegative dams72-74 as well as a tendency for increase seropositivity with 
age73,75. In line with these observations, the existence of dogs near cattle livestock 
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farms has been associated with increased seroprevalence64,76-78. In turn, several 
epidemiological studies have also provided evidence that the distribution profile of 
infection in herds is consistent with the existence of a point-source exposure to the 
parasite confirming the existence of horizontal transmission events58,79-81. 
Furthermore, horizontal transmission has been shown to occur regularly in some 
studies62,82,83 reaching a mean annual rate of transmission between 22%62 and 
49%84.  
The ingestion of oocysts is so far the only known mode of horizontal 
transmission in cattle17,18,55, and as such direct transmission of the parasite by 
animal contact has not yet been observed59. While parasite DNA has been 
detected in the milk85 and semen86,87 of infected cattle direct feeding of calves and 
dogs with milk spiked tachyzoites was found to be non-infective51,88 and to date no 
evidence was found of venereal transmitted neosporosis89,90. 
 
1.1.5 Neosporosis – pathogenesis 
 
 Despite N. caninum large range of hosts, neosporosis is a disease 
observed mainly in dogs and particularly in cattle. The pathologies and clinical 
manifestations of neosporosis are for the most part a direct consequence of the 
parasite life-cycle and transmission17,55. As previously mentioned, neosporosis 
was initially described in dogs and the first descriptions of the disease coincide 
with the discovery of the parasite8-10. Clinical signs range from dermatitis, 
neuromuscular disorders and pneumonia18,91,92. However, the most frequent 
clinical manifestations in dogs are the occurrence of abortions or the birth of 
congenitally infected animals93. In fact the most severe cases of neuromuscular 
disorders are observed in congenitally infected puppies usually presenting 
ascending paralysis of the hindlimbs18,91,92. Nevertheless, vertical transmission in 
dogs is highly variable and clinical symptoms in the definitive host seems to be the 
exception rather than the norm13,42.  
 As initially stated, neosporosis is mainly a disease of cattle and most of the 
pathogenesis in these animals is linked to the parasite transmission. Infected 
cattle has been reported worldwide although the prevalence of infection can vary 
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between different countries13,42 and different cattle breeds94,95. Adult, non-pregnant 
N. caninum infected cattle are for the most part asymptomatic, which makes it 
difficult to identify infected animals17,42. However, and as previously mentioned, 
infected animals display a very high rate of vertical transmission which accounts 
for much of the pathology associated with bovine neosporosis. During pregnancy, 
and either as a result of endogenous or exogenous transplacental transmission, 
the parasite can reach and infect the placenta96-98. This process is essential for the 
parasite crossing of the dam/fetus barrier and establishment of an in utero 
infection. In most instances, in utero infection leads to the birth of a congenitally 
infected and asymptomatic calf57,60,61. Nevertheless, a small proportion of 
congenitally infected animals may develop clinical manifestations in the first 
months after birth42,55, usually characterized by several neuromuscular disorders 
and low body weight gain99-101. 
 Although in most cases vertical transmission culminates in the birth of a 
congenitally infected but otherwise healthy calf, parasite infection of the placenta 
and fetus can also result in the most common clinical manifestation of bovine 
neosporosis, which is abortion. In fact, N. caninum was recognized as a major 
pathogen responsible for abortions in cattle very soon after its description102-106 
and isolated from an aborted fetus shortly after107. In recent years, the impact of 
neosporosis associated abortion has been widely recognized since N. caninum is 
regarded as the most common abortive pathogen in cattle13,42. Infected dams have 
a significant increase in abortion risk that is estimated to be between 2 and 7 fold 
higher in some studies58,65,72,108,109, while other studies observed a 12 to 13% 
increase110,111. Abortions caused by N. caninum arise from irreparable damage to 
the placenta or fetal tissue96,112 and may occur year round and in cows of any 
age13,55. Abortions are possible from the third month of gestation until term and 
although the majority of cases are reported between the 4 and 7 months78,102-
104,106,111,113 the outcome of the fetus infection may vary depending on several 
factors such as virulence of the N. caninum strain and time of infection42,112,114. In 
this regard, infection in early gestation can lead to fetus mummification or 
resorption while mid-gestation infections often result in the expulsion of an aborted 
fetus105,106,115 and late-gestation infections generally end in the birth of a 
congenitally infected calf55.  
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 The abortion pattern in N. caninum infected herds can be classified as 
endemic or epidemic. Epidemic outbreaks are by far the most severe events and 
are often named “abortion storms”47. These outbreaks are normally self-contained 
temporary episodes where at least 15% of the herd dams are at risk of aborting 
within 4 weeks47,55. In severe cases it has been reported that up to 57% of 
pregnant cows within a herd can abort during an epidemic outbreak77,80,108,116. 
Several studies have indicated that abortion storms are correlated with horizontal 
transmission events which in part can explain their temporary nature77,80,81. This 
correlation is supported by evidence showing that during epidemic cases dams 
present low avidity parasite-specific IgG responses indicating a recent exposure to 
the parasite62, while the presence of dogs near cattle farms can also be associated 
with the beginning of some outbreak events77,81.  
After an epidemic event the heard can experience endemic cases of 
abortion62,108. These cases are correlated with endogenous vertical transmission 
and can occur unpredictably and persist for several months or years13,42,55. In fact, 
during endemic abortion events an increase in parasite-specific antibodies has 
been reported during pregnancy indicating the recrudescence of a latent 
infection60,117 which also accounts for the high degree of association between 
seropositive dams and abortion cases observed during these events 
59,64,74,76,85,112,119.  
 
1.1.6 Neosporosis - economic impact and control 
 
 Neosporosis is mainly a disease of pregnant cattle and as such most 
economic losses are associated with abortion events in cattle livestock farms. 
Recent projections based in publish data from several countries, estimated that 
globally 46.5 million cows are at risk of aborting as a result of N. caninum infection. 
In this scenario, the estimated mean worldwide economic losses directly linked to 
neosporosis in cattle are of 1.3 billion US dollars but can be as high as 2.4 
billion118. The vast majority of these losses are linked with reproductive failure, 
which results in the loss of the new offspring and the added costs of veterinary 
intervention13,119. Nevertheless, other sources of economic losses such as a 
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reduced milk production120-123 and reduced body weight gain124 in infected animals 
have also been reported although with much less expression.  
 Taking into account these losses, different strategies have been proposed 
to reduce N. caninum economic impact. Some of the proposed measures include: 
test and cull of infected animals, pharmacological treatment, vaccination or simply 
perform no intervention and live with the disease125. More recently an economic 
model has been put forward to estimate the feasibility of these strategies in the 
field126. According to this model and contrary to what could be expected, 
performing no intervention in a herd with very low N. caninum seroprevalence (up 
to 10%) is the soundest option in economic terms. Nevertheless, in the case of an 
epidemic outbreak or if higher seroprevalence is common the losses incurred by 
this course of action quickly rise126. Testing and culling of infected animals has 
been proven very effective at decreasing the herd seroprevalence and reducing 
the cases of abortion127. Nonetheless this is a time consuming measure and 
theoretical models126 as well as field implementations127 showed that the 
investment in this strategy far outweigh the losses associated with neosporosis 
cases. Furthermore, besides testing and culling, additional steps have to be taken 
to limit the interaction between dogs or other wild canids with cattle, in order to 
prevent horizontal transmission and reinfection of the herd, further increasing 
costs118,128. Pharmacological treatment to prevent parasite infection or reactivation 
during pregnancy has also been explored. In fact, several studies have shown that 
neosporosis could be averted in experimentally infected mice using different 
pharmacological compounds129-133. In addition, one of these compounds was 
found to have 90% efficacy in the treatment of experimentally infected cattle 
resulting in the elimination of the parasite134. Nevertheless in all studies drug 
administration was started before or in the moments after infection of the animals 
and as such no data is available regarding the treatment efficacy in chronically 
infected animals which are the most common case in farms. Furthermore and 
taking into account concerns regarding the production of undesirable residues in 
milk and meat for human consumption as well as a break in production during 
treatment of infected animals119,125, pharmacological intervention even with a 90% 
efficacy would not constitute an viable economically option for N. caninum 
control126. Out of all control measures purposed, vaccination (further discussed 
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below) stands as the most cost-effective strategy to control bovine neosporosis126. 
Up until recently the only commercial vaccine against bovine neosporosis, Bovilis® 
Neoguard, was available in a few selected countries. However reports indicated 
that this vaccine could at most confer 50% protection against N. caninum induced 
abortion135,136. Nevertheless, even with a limited efficacy, vaccination was found to 
be the best option to prevent neosporosis associated losses126. In addition, since 
other successful vaccines against parasites, including some N. caninum closely 
related protozoa, are commercially available137-141, vaccination against 
neosporosis should also be feasible. In this regard, and with the recent withdrawal 
from sales of Bovilis® Neoguard, there is a pressing need for the development of 
an effective vaccine that can prevent both primary infection and abortion. 
 
1.2 Neospora caninum host-parasite relationship 
 
1.2.1 Animal models and experimental infection 
 
 Much of the knowledge regarding the host-parasite relationship following N. 
caninum infection has been obtained using murine models. The existence of 
different inbred mouse strains as well as a vast collection of targeted knockout 
mice, added to the high costs of performing experimental infection in cattle, made 
mice a prime species to study N. caninum host-parasite interaction in laboratory 
conditions119. In fact, experimental infection in mice was established as a model 
very shortly after N. caninum description142 and vertical transmission and abortion, 
the most common characteristics of neosporosis, were shown to be reproducible 
in infected pregnant mice119,143-145. Furthermore, different inbred mouse strains 
showed clear differences regarding host susceptibility to the parasite that could be 
linked with the elicited immune response in these strains146.  
N. caninum infection of both definitive and intermediate hosts in the wild is 
initiated with the ingestion of oocysts or tissues cysts. Nevertheless, nearly all 
experimental infections in mice and cattle are performed using tachyzoites and 
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either the intraperitoneal, subcutaneous or intravenous route143. This point can in 
part be explained with the difficulty in obtaining viable oocysts that so far have only 
been isolated from the feces of infected definitive hosts68,69,71. Although some 
protocols for N. caninum cyst differentiation in vitro have been described147,148, 
differentiation into this parasitic stage is achieved by inducing chemical stress in 
parasite cell cultures, which can compromise parasite virulence. Furthermore, 
these protocols are characterized by low cysts yields, which are not compatible 
with large-scale infection studies. In contrast, and as previously mentioned, 
tachyzoite maintenance and isolation from in vitro cell cultures is a well-
established technique commonly used in laboratory conditions that better suit the 
requirements of experimental infection in mice and infection of mice with 
tachyzoites using the intragastric route is also feasible149. Still, despite the fact that 
this model could better mimic the natural route of infection observed in the wild, to 
date very few studies to date have used it to analyze and characterize the host 
immune response following N. caninum challenge149.  
 
1.2.2 N. caninum infection and host immune response 
 
 N. caninum is an obligate intracellular pathogen, and similarly to other 
apicomplexa parasites such as Plasmodium150 and the closely related T. gondii151-
154, a cellular mediated immune response characterized by a T helper 1 (Th1) 
phenotype can be expected as essential for host protection. Indeed interleukin 
(IL)-12 and interferon gamma (IFN-γ), two hallmark cytokines of Th1-type immune 
responses have been shown to have a pivotal role in host resistance against N. 
caninum infection. The host protective role of IFN-γ was initially described in in 
vitro assays were this cytokine was shown to prevent N. caninum intracellular 
proliferation155. Following this initial study, the importance of the IL-12/IFN-γ axis in 
the context of neosporosis was dramatically shown in different mice models where 
depletion of both cytokines with monoclonal antibodies156,157 or genetic 
deficiencies in their production158-160 or its receptors161 render mice lethally 
susceptible to N. caninum infection. Still, and as expected, host protection against 
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N. caninum and the maintenance of the IL-12/IFN-γ axis is dependent on the 
crosstalk and activation of different innate and adaptive immune cells. 
 
1.2.2.1 Innate immunity 
 
Following N. caninum infection, innate immune cells are expected to be 
among the first to encounter and recognize the parasite. Initial recognition of 
pathogens by innate immune cells is generally mediated by pattern recognition 
receptors such as those belonging to the toll-like receptor (TLR) family162-164. TLRs 
recognize a limited number of pathogen associated molecular patterns and in the 
case of N. caninum recognition, signaling trough TLRs has been shown to be 
essential for host survival159. Due to their anatomical positions and role in the 
immune response, dendritic cells (DC) and macrophages are thought to be among 
the first to come in contact and recognize the parasite. In both cell types TLR2 has 
been found to be largely responsible for N. caninum recognition. Engagement of 
this TLR lead to cell activation and maturation while its absence resulted in 
increased parasitic burden following infection165. Upon recognition both cell types 
are known to uptake N. caninum either by phagocytosis or active cell invasion by 
the parasite166,167.  
DC represent a population of professional antigen presenting cells, that 
upon pathogen uptake are capable of migrating to the draining lymph nodes where 
they promote and direct T cell differentiation168,169. In vitro studies using either DC 
cell lines or primary mouse DC cultures have shown that following N. caninum 
recognition these cells become activated and maturate166,167. In agreement with 
these observations, both conventional and plasmacytoid DC populations were 
found activated in the spleen of infected mice as early as 12 hours following N. 
caninum challenge170. In these studies, DC activation was phenotypically 
characterized by an increase expression of major histocompatibility complex class 
(MHC) II, upregulation of co-stimulatory molecules as well as IL-12 
production166,167,170. In accordance with this phenotype, in vitro studies have also 
shown that N. caninum activated DC were capable of inducing T cell differentiation 
into a host protective IFN-γ producing Th1 phenotype167. So far very few studies 
 16 
 
have been performed on bovine DC, however it is known that bovine DC are 
capable of uptaking and processing the parasite leading to cell activation and 
upregulation of MHC II expression171. Still, despite the host protective role of DC, 
these are also thought to contribute to parasite dissemination following infection. 
Supporting this idea, N. caninum infected DC were shown to have increased 
mobility and were able to transverse polarized epithelial cell barriers in vitro172. In 
addition, mice injected with parasite loaded DC displayed increased parasitic 
burdens when compared with direct inoculation of tachyzoites172. Furthermore, DC 
can directly sustain parasite survival in the host since N. caninum proliferation has 
been reported in this cell type166,167. 
Macrophages although activated following N. caninum recognition display a 
reduced capacity to up-regulate the expression of co-stimulatory molecules as well 
as a reduce production of IL-12 in comparison with DC167. Contrastingly, murine 
macrophages infected with N. caninum were show to be unable to drive T cell 
differentiation167. However, N. caninum stimulated bovine macrophages were 
found to induce the production of IFN-γ and IL-17 in bovine T cells173. Although 
parasite proliferation has also been observed in this cell population167, IFN-γ 
activated macrophages as well as murine174 and bovine175 microglial cells, a 
population of resident macrophage-like cells in the central nervous system, were 
shown to be capable of controlling intracellular tachyzoites158. More recently 
macrophages were found essential for mice resistance against N. caninum 
infection176, stressing the importance of this cell population in the control of 
parasite dissemination.  
Due to their capacity to produce IFN-γ and lyse infected cells natural killer 
(NK) cells177 can also be expected to contribute to the early immune response 
against N. caninum. In this regard, in vitro IL-2 stimulated bovine NK cells were 
shown to produce IFN-γ following contact with N. caninum-infected host cells or 
directly with N. caninum tachyzoites178. In vivo studies in cattle have also confirm 
the host protective role of NK cells and showed that these contribute to the early 
production of IFN-γ following parasite infection179.  
 
 17 
 
1.2.2.2 Adaptive immunity 
 
 As mentioned above, cell-mediated immunity is essential for host protection 
against N. caninum infection. This has been noticed since depletion of CD4+ and 
CD8+ T cells was shown to render mice lethally susceptible to N. caninum 
challenge180. This study also established the predominant role of CD4+ T cells in 
host protection against neosporosis, since the depletion of this population resulted 
in a more severe outcome than when CD8+ T cells alone were depleted180. Early 
reports on the role of CD4+ T cells in bovine neosporosis indicate that this cell 
population was capable of recognizing several N. caninum antigens in infected 
animals181 with concomitant proliferation and IFN-γ production in both 
pregnant182,183 and non-pregnant cattle181,184,185. Furthermore, in cattle orally 
infected with N. caninum oocysts a similar activation of CD4+ T cells was also 
described, indicating that the observed immune response is independent of the 
route of infection or parasite stage used68. Consistent with the predominant 
protective role of CD4+ T cells in mice, CD4+ T cells were shown to be the major 
producers of IFN-γ179 in experimentally infected calves and this cell population was 
also found to be cytotoxic and capable of lysing N. caninum infected bovine cells 
through a preforin/granzyme pathway186. 
 Regarding the role of CD8+ T cells in neosporosis, and despite the 
indication that this cell population had a smaller contribution to mice resistance 
against N. caninum challenge, MHC I-deficient mice, lacking CD8+ T cells, were 
shown to be lethally susceptible to N. caninum infection160. More recently, IFN-γ 
production rather than the cytotoxic capacity of CD8+ T cells was shown to 
mediate the host protective effect of these cells in murine acute neosporosis187. 
Although essential for host protection against N. caninum infection, both CD4+ and 
CD8+ T cells can also contribute to host pathology following N. caninum challenge 
since adoptive transfer of N. caninum-primed CD4+ and CD8+ T cells increased 
immunopathology in recipient naïve mice following N. caninum infection188. 
 Although N. caninum is an obligate intracellular pathogen, B cell-deficient 
mice were found to be lethally susceptible to infection189. In fact, this cell 
population was found to be activated very early after N. caninum challenge and 
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subsequently proliferate190. Some of the effector functions of antibodies that can 
explain the importance of B cells in the context of N. caninum infection are their 
possible capacity to prevent infection of host cells and opsonophagocytosis of the 
parasite as well as the initiation of antibody-mediated cell cytotoxicity191. In fact, 
several studies have shown that antibodies directed against membrane proteins 
as well as some proteins of the apical vesicles of N. caninum were capable of 
blocking host cell infection24-26,28,29,32,192. Nevertheless, in vivo host protection 
mediated by antibodies against N. caninum has never been demonstrated.  
 
1.2.2.3 Pregnancy and immunity 
 
 During pregnancy the immune system of the progenitor is faced with a 
unique challenge - allowing fetal development without rejection of what is 
essentially a semi-allograft. In order to cope with this situation an extensive 
modulation of the mother immune response, especially in the maternal-fetal 
interface, is initiated193-195. This modulation most notably leads to an alteration of 
the Th1/Th2 balance. In this sense, it is well established that during pregnancy cell 
mediated immunity, that could damage the placenta and fetus, is down regulated 
in favor of humoral, T regulatory and Th2-type immune responses193,194. In this 
regard, characteristic Th2 cytokines such as IL-4 and IL-5 as well as the anti-
inflammatory cytokines IL-10 and transforming growth factor β (TGF-β), are known 
to be upregulated in the placenta and surrounding tissues196. In sharp contrast Th1 
cytokines, especially IFN-γ and tumor necrosis factor α (TNF-α) are known to be 
detrimental to pregnancy and, in the most severe cases, over-production of these 
cytokines can lead to abortion197. 
  Regarding N. caninum infection, it is expected that an alteration in the host-
parasite relationship during pregnancy, due to a modulation of the dam immune 
response, can in part explain the high rate of vertical transmission and abortion 
caused by N. caninum198. It is still not well established if abortions induced by 
neosporosis are a consequence of a robust Th1 immune response against the 
parasite recrudescence or primary infection during pregnancy or the result of 
parasite proliferation or rather a combination of both198. In addition, conflicting 
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results also exist regarding the dam and fetus protective immune response against 
N. caninum during pregnancy. In naturally infected calves, recrudescence of the 
parasite has been registered at mid-gestation followed by an increase in IFN-γ 
production98. However, and in contrast with the known damaging effects of IFN-γ 
during pregnancy, one study pointed the fact that dams that had reduced IFN-γ 
production following parasite recrudescence were 15.6 times more likely to 
abort199. Still, and in line with the pregnancy-mediated modulation of the host 
immune response, in a pregnant mouse model of neosporosis a reduction in the 
levels IL-12 and IFN-γ concomitant with a higher production of IL-4 has been 
reported200,201. Regarding the occurrence of abortions, studies in both cattle and 
mice showed that the timing of infection during pregnancy could be directly related 
with the outcome and pathology198,202,203. Experimental infection of dams in either 
early, mid, or late-gestation period was found to be accompanied by an increase in 
parasite-specific IFN-γ production by peripheral blood mononuclear cells182,204-210. 
Still, despite this similarity, several studies have reported that experimental 
infection during early-gestation in both cattle and mice led to a very high rate of 
abortion96,112,207,209. The comparison between cytokines produced in the placenta 
and surrounding tissues after N. caninum infection in the early and late gestational 
periods also showed that although the profile of cytokine production was similar, a 
higher production of pro-inflammatory cytokines could be observed in the early-
gestation challenge207,211. 
 Although most cases of N. caninum induced abortion in the wild are 
reported between 4 and 7 moths of gestation, experimental infection of cattle at 
mid and late-gestation seldom result in abortion, although vertical transmission 
has been extensively reported112,182,206,208,210,212. Fetal immunocompetence in 
cattle has been described from day 120 of gestation onwards213 and in accordance 
in these data, some studies have shown the existence of a parasite-specific 
immune response with IFN-γ production in fetus of dams infected at mid and late-
gestation182,205,206,208. This fetal immune response is thought to be a contributing 
factor for the reduce abortion rate observed at these time-points198.  
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1.3 Immunization strategies against Neospora caninum  
 
 Vaccination is regarded as the best strategy to manage and possibly 
prevent cattle neosporosis126. It is generally assumed that an ideal vaccine against 
this protozoan should prevent parasite recrudescence and dissemination during 
pregnancy, thus preventing vertical transmission, and or prevent the host primary 
infection altogether33,143. Taking into consideration the parasite natural route of 
infection, an ideal immunization protocol should elicit both systemic and mucosal 
parasite-specific immunity33. Since other vaccines for closely related apicomplexa 
protozoa are commercially available137,138,141, there is a consensus on the 
feasibility to develop an effect vaccine against N. caninum119. Further indication 
that a successful immunization protocol against neosporosis can be achieved 
comes from field observations were infected cattle display a progressive reduction 
in the abortion risk over consecutive pregnancies indicating that some degree of 
protection can be acquired63,109,214. In addition, other studies pointed out that 
naturally infected cattle, although prone to vertically transmit the parasite, display a 
reduced risk of abortion during an outbreak event80 or when experimentally 
infected during early-gestation215. Furthermore, modulation of the host immune 
response prior to pregnancy was also found to be a determining factor in the 
prevention of vertical transmission. Neutralization of IL-4 coupled with N. caninum-
specific priming of the host immune response prior to pregnancy was shown to 
prevent vertical transmission in mice while similar modulation of IL-4 production 
during pregnancy was not successful216. 
Taking into account these observations, several strategies have been 
pursued with the aim of developing an effective immunization protocol against 
bovine neosporosis143,217.  
 
1.3.1 Live and attenuated vaccines 
 
The use of live parasites as a means of conferring protection against 
neosporosis stems directly from the observation that naturally infected animals 
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display an increased degree of protection regarding fetal loss. In agreement with 
these observations, infection with a small inoculum of live and virulent tachyzoites 
was found to protect mice against a lethal challenge with N. caninum218,219 and to 
prevent vertical transmission in cattle infected at mid-gestation185. Still, the use of 
live and virulent strains in these studies, although effective at proving the concept, 
would never be desirable for a live immunization strategy due to the virulence 
status of the used parasites. As such, several natural and laboratory induced 
attenuated strains of N. caninum have been screened, both in mouse and cattle 
models, for their possible host protective value. In the case of laboratory induced 
parasite attenuation using gamma radiation, results in murine models are 
controversial. While one study indicated that previous exposure to these 
attenuated tachyzoites could confer protection against a lethal challenge220, 
another study using mice reported an increased susceptibility to N. caninum 
infection190. In the case of naturally attenuated strains, these are in most cases 
isolated from congenitally infected non-symptomatic calves and have generally 
been proven safe in cattle since animals infected with these strains are rarely 
reported to present abortions or vertical transmission events as a consequence of 
this initial exposure114,221,222. Mice223-225 and cattle221,222,226,227 immunization with 
attenuated strains of the parasite prior to pregnancy have proved that this strategy 
was very successful at preventing both fetal loss and vertical transmission 
following infection with virulent strains even when this was performed in the early-
gestation period. Still, immunization with an attenuated strain in chronically 
infected cows was only partially successful in reducing abortion228, indicating that 
the modulation of host immune response through immunization is most successful 
when performed prior to parasite exposure.  
Although highly effective in mice and cattle, naturally attenuated strains 
have considerable drawbacks that have prevented their introduction as a viable 
commercial vaccine against cattle neosporosis. Although proven safe in several 
studies, the use of live pathogens for immunization purposes raises multiple 
concerns such as the possibility of cross contamination with other pathogens as 
well as the reversion to more virulent status which could compromise host 
protection119,143,217. In economic terms, live vaccination also presents a daunting 
logistic challenge due to their reduced self-life time that severely hampers storage 
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and distribution119,221. Nevertheless, immunization with live attenuated strains has 
been successfully implemented against other relevant veterinary apicomplexa 
parasites like the approved vaccines against T. gondii229 and Babesia bovis141. In 
this regard, and since no other vaccine against neosporosis is now commercially 
available, live vaccination has been gaining support from many researchers which 
propose this strategy as short-term measure to control bovine neosporosis230. 
  
1.3.2 Whole parasite lysates vaccines 
 
In order to overcome the limitations and concerns regarding live 
vaccination, many studies evaluated the use whole N. caninum lysates as a 
means of inducing a host protective immune response against neosporosis. Initial 
studies reported a high degree of protection conferred by this formulation in a 
pregnant mouse model of infection where vertical transmission was found to be 
averted in immunized mice231,232. These initial results ultimately led to the creation 
and introduction of the only ever commercial available vaccine against bovine 
neosporosis, Bovilis® Neoguard, which used whole parasite lysates and havlogen 
adjuvant. However, the effectiveness of this vaccine has always been 
controversial and different field studies revealed that this immunization could only 
confer at best 50% protection against N. caninum induced abortion135, while in 
some cases immunized dams presented even higher rates of vertical 
transmission136. These generalized doubts about this vaccine effectiveness 
ultimately led to its recent withdrawal from the market128,217.  
 Following the initial successful report of protection against vertical 
transmission achieved in mice by using N. caninum lysates232, the efficacy of this 
formulation with different adjuvants was assessed in both mice and cattle. Still, the 
effectiveness of whole parasite lysates in vaccine formulation remains 
controversial. While in some instances host protection has been reported25,233-236, 
in other cases no significant reduction in parasite burden, or vertical transmission 
was achieved226,227,237-239. Furthermore, immunization with parasite lysates was 
also found to be capable of exacerbating pathology in immunized mice following 
infection rendering these highly susceptible to N. caninum challenge190,240,241. The 
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increased pathology observed in these studies might be related to the complex 
antigenic composition of parasite lysates, and also stresses the fact that adjuvant 
selection can be of paramount importance to achieve host protection. This last 
point has been clearly shown in mice immunized with parasite lysates without any 
adjuvant which greatly exacerbated mice susceptibility to N. caninum infection218 
indicating that this antigenic formulation can also induce a host non-protective 
immune response that cloud account for the lack of protection observed in some 
studies33.  
 
1.3.3 Parasite subunit vaccines 
 
 The majority of studies published to date aiming at developing an effective 
immunization protocol against neosporosis have focused on the use of single 
parasite recombinant proteins33,119,143,217. The use of selected proteins or antigens 
for immunization offers several advantages over the previous discussed 
alternatives, since these formulations are in most cases considered safe and have 
a high stability and shelf-life33,119. Most proteins used in these studies, such as N. 
caninum surface proteins NcSAG1 and NcSRS2, were selected for their 
immunodominant status or their importance in key steps in the parasite life cycle, 
such as adhesion and invasion of host cells33,217. Different studies indicate that 
immunization with recombinant NcSAG125,242 or recombinant NcSRS225,243-246 
conferred protection to mice upon N. caninum challenge. Still, in most instances, 
the achieved protection was characterized by a reduction in parasitic burdens and 
not clearance of the parasite. This characteristic might account for the relatively 
modest results obtained in pregnant mouse models where upon infection only 
small reductions in vertical transmission and fetal loss were observed25,243. 
Nevertheless, and despite the pivotal role of these proteins in N. caninum 
survival23, the protective effect conferred by these two cell surface proteins is still 
disputable since a few studies found no increased protection in infected 
immunized mice despite the induction of an antigen-specific immune 
response242,247. These results once again indicate that adjuvant selection can be a 
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determining factor to achieve protection even when targeting essential proteins for 
parasite survival.  
 Besides NcSAG1 and NcSRS2, several apical vesicle proteins have also 
been screened for their possible host protective effect. Although microneme 
proteins NcMIC1, NcMIC3 and NcMIC4 were shown to be involved in parasite 
adhesion to host cells28-30, the protection conferred by immunization with these 
recombinant proteins is once again controversial. While NcMIC3 immunized mice 
were found to have a small parasite burden reduction248, a recent study did not 
observed any significant protection when using this recombinant protein242. 
However, clear differences between the two studies exist regarding the protocol 
for recombinant protein production that can account for the different outcomes. In 
the case of NcMIC1 immunized mice, these were reported to have a reduction in 
parasitic burdens following infection249, however and in sharp contrast, 
immunization with recombinant NcMIC4 was largely unsuccessful and even 
precipitated lethal pathology in immunized mice32. Immunization with the 
microneme protein NcAMA1 also presented promising results in mice since it was 
successful, to some extent, at preventing parasite colonization as well as fetal 
loss250. On the other hand, several reports in murine models demonstrated the 
host protective effect rhoptry protein NcROP2 combined with different adjuvants 
and with other microneme proteins, although once again the observed protection 
was only characterized by parasitic burden reduction35,251-253. The dense granule 
protein NcGRA7254 was also shown to confer some level of protection against N. 
caninum in both mice and cattle255,256. However, NcGRA7 altogether with the 
exclusively bradyzoite stage antigen NcSAG4 were found to be non-protective in 
pregnant and only slightly protective in non-pregnant mouse models257. In addition, 
cattle immunization with recombinant NcGRA7 and NcSAG1 conferred no 
protection against vertical transmission when experimental infection was 
performed at early gestation258. Other studies have also screen bradyzoite 
exclusive antigens in the formulation of immunization protocols, but only partial 
protection was afforded by most of the used proteins259, while in one study a 
mixture of bradyzoite and tachyzoite proteins was again found to be completely 
non-protective260.  
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In most studies a mixed Th1/Th2 immune response was elicited following 
immunization with tachyzoite surface or apical vesicles proteins35,242,245,250,251,257. 
Nevertheless, and despite the ample evidence that a Th1 type immune response 
is essential for host survival, a Th2 biased immune response was also found to be 
host protective, in some instances leading to parasitic burden reduction 
243,252,253,261,262. In one particular case, immunization with a NcROP2 and NcMIC1 
and 3 chimeric antigen was capable of achieving host protection with the 
stimulation of a Th2-type immune response253, while the same antigen used with a 
Th1 stimulating adjuvant, although successful at inducing a Th1-biased parasite-
specific immune response, was found to be non-protective263. Interestingly, and 
despite in this case a host protective Th2 immune response was reported, this 
chimeric protein was unable to confer protection against vertical transmission and 
fetal loss in pregnant mice model264. 
 Besides the selection of suitable antigens and adjuvant when developing an 
effective immunization strategy, a recent set of reports also showed that the route 
of immunization used could be a determining factor in vaccine effectiveness 
against N. caninum. In this sense NcPDI, a tachyzoite cell surface disulfide 
isomerase protein192, was found to have host protective capabilities only when 
administered intranasally in contrast with the induction of a non-protective host 
immune response when administered intraperitoneally even with different 
adjuvants252,261. Nevertheless, the observed protection in intranasal (i.n.) 
immunization was only translated into a reduction of parasitic burdens, and 
although once again a host protective Th2 immune response was elicited in non-
pregnant mice, i.n. immunization with NcPDI was found to be non-protective in a 
pregnant mice model where it elicited a Th1-type immune response262. 
Nonetheless, these studies were the first to employ mucosal immunization as a 
means to confer protection against N. caninum. Despite the fact that natural 
infection with N. caninum occurs through the gastrointestinal mucosa and thus an 
ideal immunization protocol against this pathogen should induce both mucosal and 
systemic immunity, the stimulation of a parasite-specific mucosal immune 
response as a means to confer protection against N. caninum has never been 
attempted. 
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1.4 Intestinal mucosal immunity 
 
Mucosa associated lymphoid tissue 
 
The host mucosal surfaces collectively account for the majority of the 
surface area in contact with the outside environment. In fact, the intestinal mucosa 
alone presents a surface area greater than that of the skin and as such it is no 
surprise that besides harboring a vast collection of symbiotic commensal microbes 
that constitute the gastrointestinal microbiota, this mucosa is one of the most 
common entry sites for several pathogens265-267. In this scenario, the intestinal 
mucosa poses a significant challenge for the host immune system since it needs 
to maintain a mucosal homeostasis allowing the presence of a large collection of 
commensal residents while simultaneously respond to and prevent pathogen 
invasion267,268. As such, the immune system maintains at the intestinal mucosa a 
considerable amount of the host total lymphocyte population organized in 
lymphoid structures collectively known as the gut associated lymphoid tissue 
(GALT) that can be spatially separated into two main locations - inductive and 
effector sites, differentiated by their anatomical and functional proprieties267-270 
 
1.4.1 GALT inductive and effector sites 
 
Most GALT inductive sites have histological and cellular characteristics 
similar to those observed in other secondary lymphoid organs266,269-271. However, 
these inductive sites characteristically lack an efferent lymphatic system, meaning 
that presented antigens are sampled directly from the intestinal luminal 
space266,269,270. For this reason, intestinal draining mesenteric lymph nodes (MLN), 
although considered a draining site for antigen experienced presenting cells from 
the intestinal mucosa, are not considered part of the GALT269,270. Antigen sampling 
from the intestinal lumen, characteristic of GALT inductive sites, is made possible 
due to the existence of a specialized follicle-associated epithelium over lining 
these structures. This epithelium contains several adaptations that foster antigen 
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sampling such as the existence of a thinner mucus layer that allows direct contact 
with luminal contents269,272,273 as well as the presence of antigen sampling cells 
known as M cells269,273. These cells present a phagocytic-like capacity that allow 
them to sample large macromolecules or microorganisms through the epithelium 
allowing antigen uptake by mononuclear phagocytes such as DC and their traffic 
GALT inductive sites273.  
Distinct lymphoid structures that make up the GALT inductive sites can be 
identified along the intestinal mucosa such as Peyer’s patches (PP), isolated 
lymphoid follicles and cryptopatches267,269,271. PP are the best characterized GALT 
structures and constitute a primary site for the induction of mucosal immune 
response267,270. PP are especially effective at inducing the activation and 
differentiation of IgA-producing B cells. As such, these sites constantly present 
several germinal centers267 and although their formation is initiated in fetal life, the 
contact with intestine commensals has been shown to be essential for the 
development and normal activity of these structures274.  
Both isolated lymphoid follicles and cryptopatches are smaller lymphoid 
structures that can be found scattered throughout the intestinal mucosa267,269,275. 
While the precise role of these structures is still debatable, isolated lymphoid 
follicles display a cellular composition similar to that of PP while cryptopatches are 
enriched in T cells and antigen presenting cells and are almost devoid of B 
cells267,269. Isolated lymphoid follicles formation is exclusively dependent on the 
colonization of the intestinal mucosa by commensals and germ free mice have 
been shown to lack these structures267,274. Cryptopatches can be found in some of 
the epithelium crypts formed by the villus organization and are considered 
precursors of isolated lymphoid follicles following that can arise following gut 
colonization267,274. 
Upon activation and differentiation in the inductive sites, lymphocytes 
migrate to the effector sites in the mucosal epithelium and the epithelium lamina 
propria269,270. While the epithelium contains almost exclusively T cells, generally 
known as intraepithelial lymphocytes (IEL), the lamina propria (LP) is home to very 
a large number of antibody producing B and plasma cells as well as T cells and 
mononuclear phagocytes269. Although considered effector sites where immune 
cells can encounter invading pathogens, terminal differentiation of lymphocytes, 
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such as B cell differentiation into plasma cells, occurs in the LP267,270. In addition, 
and as explained in the following chapters, absence of GALT inductive sites in 
mice does not result in the complete absence of antibody producing plasma cells 
in the intestinal LP, which also indicates that this effector site can support the 
initiation of antigen-specific immune responses to some extent276. 
 
1.4.2 GALT mononuclear phagocytes and antigen trafficking 
 
Macrophages and DC constitute the main populations of mononuclear 
phagocytic cells in the intestinal mucosa and can be found scattered throughout 
the mucosa epithelium and adjacent LP as well as in the GALT inductive sites277. 
While replenishment of both cell types in the intestinal mucosa is assured by 
common bone marrow progenitors277-279, mucosal DC and macrophages were 
shown to arise from different precursors280 and fulfill different roles in the tissue. 
Much due to the expression of several common phenotypic markers, the 
characterization and distinction of GALT DC and macrophages was until recently 
highly difficult which sometimes led to misleading characterization of some of their 
cellular functions277-279.  
Resident intestinal macrophages constitute the majority of mononuclear 
phagocytes present in GALT effector sites277. Even though the exact role fulfilled 
by these cells is still debatable, possible functions include clearance of invading 
pathogens, tissue repair and remodeling, and modulation of mucosal immune 
responses through cytokine production277,279. Besides their capacity to uptake 
antigens trough M cell transport, intestine mucosal macrophages have been 
shown in vitro and in vivo to have the capacity to directly sample antigens from the 
gut lumen281,282. However, the implications of antigen uptake by macrophages are 
still poorly understood since these were shown to be weak inducers of T cell 
activation and were not found to migrate to GALT inductive sites or MLN following 
antigen uptake283. One possible role attributed to this antigen capture capacity 
could be the transfer of processed antigens to DC277. 
DC in the intestinal mucosa are mainly responsible for antigen trafficking to 
inductive sites and initiation of the adaptive immune response277-279. DC can also 
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uptake antigens from M cells in the intestinal epithelium279, and similar to intestinal 
macrophages, extend cellular projections through epithelial enterocytes and 
sample antigens or pathogens directly from the gut lumen284 (Figure 1-2). Antigen 
loaded DC preferentially migrate to GALT inductive sites and MLN in a mechanism 
dependent on the chemokine receptor CCR7283,285,286. In the inductive sites, DC 
were shown to be proficient in lymphocyte activation and responsible for inducing 
the expression of chemokine receptor CCR9 and the integrin α4β7 expression 
285,287, both essential for cellular trafficking and homing of activated lymphocytes to 
the intestinal mucosa288,289. Although GALT DC are known to be capable of 
supporting the differentiation of Th1290 and Th17291 T cell phenotypes in vitro, 
these cells are also key regulators of oral tolerance286 through the production of 
TGF-β that stimulate the differentiation and maintenance of T regulatory (Treg) 
cells292. Both the induction of GALT homing markers in activated lymphocytes as 
well as the biased induction of Treg cell differentiation and oral tolerance to 
sampled antigens by DC is known to be largely dependent on the production of 
retinoic acid from dietary vitamin A288,292. In this regard, Vitamin A has been shown 
to induce in DC the expression of the enzymatic machinery necessary for retinoic 
acid synthesis287 which in turn can also account for the major role of DC in antigen 
trafficking and initiation of immune responses in the GALT279. 
 
1.4.3 GALT effector sites 
 
1.4.3.1 Intestinal intraepithelial lymphocytes 
 
As a GALT effector site, the intestinal epithelium harbors a highly 
heterogeneous and unique population of resident T cells with different phenotypes 
and functions generally named IEL268,293-296. These lymphocytes are scattered 
throughout the epithelial barrier at a rate of around 1 IEL per 5 epithelial cells, 
making them one of the largest immune cell populations in intestinal mucosa293,296. 
The IEL repertoire and functions are highly influenced by the interactions with the 
nearby intestinal flora and its absence is known to lead to significant alterations in 
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the IEL population294. These cells fulfill several roles in the intestinal epithelium but 
are mainly involved in tissue remodeling and healing as well as in the rapid control 
and clearance of invading pathogens295-297. In these sense, and in order to allow a 
swift response IEL usually present several characteristics of both innate and 
adaptive immune cells, and are normally divided into two main populations294-296. 
 Induced IEL (iIEL), are mainly constituted by conventional CD8+ and a small 
population of CD4+ T cells of thymic origin294-296 and as such display a repertoire 
similar to other GALT and circulating T cells298. Although these cells can migrate 
from the thymus directly to GALT effector sites where they become antigen 
experienced299, the vast majority of these IEL are activated in GALT inductive 
sites294 from where they acquire their intestinal mucosa homing phenotype288,289. 
Once in the epithelium, IEL are known to be permanent resident cells that do not 
normally recirculate300,301 and present a characteristic resident memory phenotype 
294-296. As such, these cells are not known to proliferate in situ but present however 
higher cytotoxic and cytokine production capabilities302. In this regard, iIEL are 
known to produce several pro-inflammatory cytokines, including IFN-γ, that are 
essential for pathogen clearance294,295. In fact, this cell population was found to be 
capable of conferring long-lasting protection against invading pathogens as shown 
in the case of the apicomplexa parasite T. gondii303. 
 Natural IEL (nIEL) are comprised of TCRγδ and unconventional TCRαβ+ 
CD8αα+ T cell populations294-296. These unconventional T cells are mainly of 
thymic origin, acquiring in their differentiation process the intestinal homing 
molecules and the activation profile characteristic of this population294,296. Although 
also considered resident memory cells, nIEL lack the expression of several 
activation and memory markers commonly observed in iIEL294-296. Even though the 
majority of these cells are of thymic origin, several reports indicate that low 
numbers of nIEL can also be found in athymic mice indicating the existence of an 
extra-thymic differentiation route that can possible occur in cryptopatches294,296. 
nIEL, especially TCRγδ-expressing T cells are highly involved in tissue remodeling 
and homeostasis293,294,297. In this regard, TCRγδ-deficient mice have been shown 
to present an altered epithelial morphology304, characterized by deficiencies in 
epithelial tight junction formation305. Still, these TCRγδ+ T cells are also capable of 
actively participate in the immune response against invading pathogens294,297 and 
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incidentally, TCRγδ+ IEL response has also been shown to synergically contribute 
to protection against T. gondii infection coffered by iIEL303. 
 
1.4.3.2 Intestinal lamina propria and B cell activation 
 
 As previously described, the intestinal LP, which underlines and supports 
the epithelial barrier constitutes, the second and largest GALT effector site268-270. 
As expected, the LP harbors a multitude of resident immune cells such as several 
mononuclear phagocytic cells with some intervening T cells and a large population 
of B cells and immunoglobulin producing plasma cells269. In fact, due to the role of 
antibody producing cells in the maintenance of mucosal homeostasis and 
protection against invading pathogens, immunoglobulin production and trafficking 
across the mucosal epithelium is considered a hallmark of mucosal immunity306,307. 
Due to its characteristics and adaptations, IgA is the predominant immunoglobulin 
isotype present in mucosal secretions and overall the most abundantly produced 
antibody isotype in the body308-310. B cell activation with concomitant class-switch 
recombination to IgA occurs preferentially in the GALT inductive sites as well as in 
the MLN306,309,310 as a consequence of the unique cytokine milieu and cellular 
composition found in these locations267. As expected, the majority of mucosal IgA-
producing cells arise from a T cell dependent activation process306,309 however, T 
cell independent activation of B cells with IgA class-switching has also been 
shown to occur in the intestinal mucosa311.  
 T cell dependent IgA production occurs mainly in PP and MLN where B cell 
activation, class-switching and somatic hypermutation takes place in organized 
lymphoid structures known as germinal centers309,312 (Figure 1-2). This pathway 
involves the activation of CD4+ T cells by antigen presenting DC originating from 
the intestinal mucosa306,308,309 that favors Treg cell differentiation, as previously 
remarked, through the production of TGF-β and retinoic acid292. Treg cells in PP, 
and in contrast with other lymphoid organs, have been shown to efficiently 
differentiate into T follicular helper cells313 which are essential for T cell dependent 
B cell activation. The prime role of Treg cells in T cell dependent IgA production 
can also be explained by their production of TGF-β314, whose activity and 
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production has been shown essential for IgA class-switching in B cells315. T cell 
depended IgA production culminates in the synthesis of high antigen affinity IgA by 
B cells306,309,316 that has been shown to be fundamental for maintenance of 
intestinal homeostasis. In this regard, lack of somatic hypermutation associated 
with T dependent B cell activation in mice, resulted in a deregulation of the 
intestinal microbiota with expansion of several bacterial types that led to an 
increase bacterial translocation across the mucosa317. 
 Mice deficient in T cells311,318 or lacking GALT inductive sites291 retain a 
significant amount of IgA producing cells in the intestinal LP which indicates the 
existence of a T cell independent IgA production pathway that appears to be 
dependent on signals provided by the intestinal microbiota311,318: Regardless of the 
site where T cell independent activation of B cells occurs, DC are known to be 
essential for this process306,308-310. In these regard, both PP319,320 and LP DC291 
have been shown to be capable of directly present antigen to B cells and induced 
IgA class-switching in a process dependent on TLR signaling, retinoic acid 
synthesis and TGF-β production291,318. Additionally, both DC and intestinal 
epithelial cells are known to produce the B cell activating factor and the A 
proliferation-inducing ligand that further stimulates and promotes T cell 
independent IgA class-switching318,321. As expected, IgA produced from T cell 
independent activation, also known as natural IgA, presents a low affinity to target 
antigens306,316 but nevertheless can efficiently recognize and coat intestinal 
microbiota residents322, indicating a role in the modulation of the intestinal flora 
and in gut homeostasis310,323. 
 In both T cell dependent or independent B cell activation, DC, through 
retinoic acid production, are known to be responsible for the induction of intestine 
homing markers in newly differentiated IgA producing cells320. Once in the LP, B 
cells terminally differentiate into IgA producing plasma cells306,309 (Figure 1-2). 
Although this process is not fully understood, it is believed that this differentiation 
is dependent on signals provided by both DC and macrophages as well as signals 
derived from intestinal epithelial cells306,307. Once terminally differentiated, IgA 
producing plasma cells in the intestine LP were shown to be long lived324, but 
nevertheless their maintenance is highly dependent on survival signals provided 
by Treg cells314. Even though IgA plasma cells are long-lived, memory IgA 
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responses at mucosal sites present a relatively rapid turnover. In this regard, a 
study has shown that upon arrival, new IgA producing cells displace resident 
plasma cells in the LP in a competition process324. Although this process can lead 
to the relatively rapid loss of IgA producing cells against certain antigens, it is 
believed that this strategy allows for a dynamic rearrangement of the IgA 
repertoire that can better adapt to changes in the intestinal flora allowing a 
stronger response against the most prevalent mucosal antigens324. Nevertheless, 
and particularly in the context of immunization, IgA+ memory cells are thought to 
be maintained in the GALT in spite of the reduction of IgA production in the LP 
overtime325. In this regard, and although the number of IgA producing cells 
decreased overtime in the LP following oral immunization with cholera toxin, mice 
still presented memory IgA producing antigen-specific cells in MLN one year after 
infection326 and following toxin re-exposure a rapid expansion and detection of 
antigen-specific IgA in the LP could be observed327, indicating that long-term 
mucosal immune memory can be achieved. 
 
Figure 1-2 – Schematic representation of antigen sampling by GALT DC and lymphocyte 
activation in GALT inductive sites. Following activation terminal differentiation and IgA 
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production by B cells occurs in the intestinal lamina propria. From Cerutti, A, Science, 
2010, 328; 1646-7 
 
1.4.3.3 IgA secretion and effector functions 
 
 Trafficking and secretion of immunoglobulin across the mucosal epithelium 
is a multistep process involving plasma cells and epithelial cells266,307-309. Although 
IgA is the most abundant antibody produced and secreted at mucosal sites308-310, 
IgM can also by trafficked across mucosal barriers although much less 
efficiently266. Upon production, monomeric IgA is dimerized in the LP through the 
interaction with a small polypeptide produced by plasma cells named joining chain. 
Upon dimerization, joining chain-containing antibodies can bind to the poly-Ig 
receptor present in the basal membrane of epithelial cells and bound antibodies 
are then trafficked across the epithelial cell cytoplasm in a process known as 
transcytosis. The resulting secreted IgA retains a small peptide fragment of the 
poly-Ig receptor designated secretory component that covalently binds to the IgA 
polypeptide chain, thereby stabilizing its conformation while at the same time 
conferring resistance to enzymatic degradation and also allowing IgA retention in 
the mucus layer266,307-309.  
 Once in the mucosal lumen, secreted IgA functions revolve around the 
maintenance of mucosal homeostasis and prevention of pathogen crossing of the 
mucosal barrier in combination with other mucosal defenses267,309,310,323. One of 
the most well characterized mechanisms of protection mediated by secreted IgA is 
the process of immune exclusion. In this mechanism, due to the dimeric 
conformation of IgA and to the mucus anchorage capacity provided by the 
secretory component, bound antigens are efficiently agglutinated and entrapped in 
the mucus layer, preventing their direct contact with epithelial cells266,307,309,323. In 
addition, IgA is essential for the neutralization of several enteric toxins, such as 
cholera toxin, by their entrapment in the mucus layer and prevention of their 
activity266,307,323. The transcytosis export process also allows IgA to traffic 
intracellular pathogens and toxin present inside intestinal epithelial cells or in the 
LP, back to the mucosal lumen266,307,323. Furthermore, IgA can also facilitate the 
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antigen uptake by M cells through a process not yet fully understood that favors 
antigen sampling and initiation of immune response against enteric 
antigens273,309,310,323.  
Although the effector mechanisms of IgA mediated protection have been 
well characterized in past decades the appearance of mice deficient in IgA 
production or secretion led to some conflicting results regarding the importance of 
this immunoglobulin in host protection. Nevertheless, IgA secretion has been 
shown to be important in the regulation of the intestinal microbiota since its 
absence can be correlated with an expansion of several bacteria328,329 while 
transfer of IgA producing cells was capable of restoring mucosal homeostasis329. 
IgA also regulates bacterial translocation across the epithelium and in its absence 
an increased trafficking of bacteria to the MLN has been reported319. In addition, 
protection against enteric toxins such as cholera toxin has also been shown to be 
highly dependent on IgA production330,331. Furthermore, following previous 
exposure to pathogens or immunization, the production of antigen-specific IgA has 
been shown to be capable of preventing pathogen crossing of the epithelial 
barrier, further indicating the possible host protective role of IgA in immunization 
protocols332,333. Nevertheless, in basal conditions, mice lacking either IgA 
production or its secretions do not normally present a very severe phenotype334,335. 
This point can in part be explained by the existence of several compensatory 
mucosal defense mechanisms308, since IgA-deficient mice present increase IgM 
production and transcytosis in the intestine, which can account for the attenuation 
of the mice phenotype334. In addition, lack of IgA was shown to have no impact in 
the clearance of some mucosal invading pathogens336 even when infection was 
preceded by pathogen-specific immunization331 
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1.5 Mucosal immunization 
 
In the last century vaccination has proven itself as one of the great 
successes of preventive medicine becoming an invaluable means of controlling 
and reducing the incidence of several infectious diseases337,338. Among the 
different immunization types and formulations, most of the approved vaccines 
used in both human and veterinary medicine are administered through parenteral 
routes337,339-341. In general, these vaccines induce a primarily humoral systemic 
immune response that has proven nonetheless highly successful at conferring 
protection especially against blood borne pathogens and toxins340-347. 
Nevertheless and as previously mentioned, host mucosal tissue account for the 
majority of the surface area in contact with the outside environment and constitute 
the most common entry site for several pathogens265-267. In this regard, induction 
of pathogen-specific immune response at mucosal sites could prove a determining 
factor to achieve protection against disease causing mucosal pathogens325,338-
340,342,343,345 or even prevent pathogen crossing of the mucosal barriers325,340,342,346. 
As such and since mucosal sites present a highly developed and dedicated 
mucosal associated lymphoid tissue (MALT)267-270, mucosal immunization can 
constitute a valuable strategy to induce pathogen-specific mucosal immune 
responses325,342,346. In comparison with parenteral administered vaccines, mucosal 
immunization strategies present several advantages such as the capacity to 
induce both mucosal and systemic humoral and cellular immune 
responses325,344,346,348, easy and painless administration leading to better 
vaccination acceptance by the public, reduced risk of cross contamination, 
absence of invasive procedures and site reactions, reduced costs of purification 
and no need for highly trained medical and veterinary staff, as well as easier 
distribution and administration to large scale populations325,337,339,340,342,343,346,349. 
Still, despite the advantages of mucosal vaccination, this strategy has seen limited 
implementation in both human and veterinary medicine, although the knowledge 
achieved in recent decades in the field of mucosal immunity has increase the 
interest in this strategy340,344,349. 
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1.5.1 Intestinal mucosa and mucosal immunization sites 
 
Depending on the target mucosa and due to the unique characteristics of 
the different mucosal sites, the designing of a successful mucosal immunization 
protocol heavily relies in the selection of the most advantageous mucosal 
route339,341. Due to the large number of pathogens that invade the host through the 
intestinal mucosa265-267, the induction of pathogen-specific immune responses at 
this site has been one of the main goals of mucosal immunization337,341. As such, 
oral administration has been one of the best studied routes for mucosal 
immunization and has proven that stimulation of the GALT and induction of both 
mucosal and systemic immune response against target antigens is possible325. 
Nevertheless, and despite in general a stronger mucosal response is elicited in the 
MALT site of vaccine exposure325,339, oral immunization has also faced several 
obstacles that contributed to its limited employment325,337,346. Due to the natural 
physical and chemical barriers of the gastrointestinal tract, oral delivered antigens 
are subject to the same unspecific host protective mechanism that target invading 
microorganisms. As such, oral delivered antigens and adjuvants usually display 
low bioavailability and are subject to high levels of degradation as the result of the 
high pH variations, high proteolytic activity and entrapment in the mucus 
layer325,337,346. This point is especially important in ruminants where the more 
complex gastrointestinal system and increased digestion times makes it harder for 
oral administered vaccine formulations to reach GALT inductive sites350.  
The identification and organization of the MALT in inductive and effector 
sites where activated cells could recirculate and populate different mucosal 
effector sites, created the early concept of a common mucosal immune system. 
Based in on this concept, stimulation of different MALT inductive sites through 
immunization or direct pathogen encounter could lead to the induction of antigen-
specific immune responses at distant mucosal surfaces344,346,348,349. In this regard, 
and due to the limitations presented by oral immunization, the nasal mucosa has 
also been explored as an alternative for the induction of mucosal immune 
responses325,341,346. The GALT and the nasal associated lymphoid tissue (NALT) 
share similar characteristics regarding lymphoid tissue organization, specialized 
epithelium adaptations that allows direct antigen uptake, as well as a similar 
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immune cell population composition344,346,348. Furthermore, and in analogy with the 
oral route, the nasal mucosa also constitutes an easily accessible site for mucosal 
immunization that in contrast with the gastrointestinal tract presents increase 
permeability and absorption rates coupled with limited enzymatic activity, which 
reduces antigen and adjuvant degradation and increases overall bioavailability346. 
As such, several experimental studies have demonstrated in mouse models that 
protection against several pathogens could be achieved following i.n. 
immunization and confirmed the capacity of this route to induce both mucosal and 
systemic pathogen-specific immune responses351-359. i.n. immunization has also 
been experimentally explored as a vaccination strategy in several veterinary 
relevant ruminant species360-367. In fact, a commercial i.n. vaccine against bovine 
respiratory syncytial virus in cattle using attenuated virus is already available in the 
United States (InforceTM3, Zoetis) and in Europe (RispovalTM, Zoetis).However, 
this vaccination employs live attenuated pathogens which raises concerns of 
pathogen reversion to a more virulent state. Nevertheless, experimental i.n. 
immunization in ruminants using sub-unit vaccines has shown that this strategy is 
capable of inducing pathogen-specific mucosal and systemic immune responses 
characterized by IgA production at mucosal sites, proving the feasibility of using 
this route in veterinary medicine362-364,366,367.  
More recent data in the study of mucosal immunity suggested the existence 
of a compartmentalization in different mucosal sites which can compromise the 
idea of a common mucosal immune system and the possibility of the induction of 
mucosal immune responses through immunization in distant mucosal 
sites339,341,368. Incidentally, some authors indicate that nasal immunization, 
although capable of inducing both mucosal and systemic immune responses to 
target antigens, induces somewhat weak responses in the intestinal 
mucosa265,325,344,369. This fact is linked to the apparent different requirements of 
cell surface integrins and chemokine receptors for cellular trafficking into the upper 
respiratory tract and the intestinal mucosa370. Still, several experimental i.n. 
immunization studies have reported conflicting results regarding the description of 
a stricter compartmentalization of mucosal sites and the apparent dichotomy 
between the nasal and intestinal mucosa. In this regard, characterization of cell 
trafficking following i.n. immunization revealed that antigen-specific lymphocytes 
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can not only be found in NALT effector sites, as well as in the respective draining 
cervical and mediastinal lymph nodes371, but also in MLN, spleen and intestinal 
lamina propria372. In addition, activated lymphocytes, and not antigen-loaded DC 
originating from the nasal mucosa, were shown to migrate to the MLN and 
intestinal mucosa following i.n. immunization in a process dependent on the 
expression of the α4β7 integrin373. Antigen-specific proliferating T cells in the 
cervical lymph nodes can upregulate the integrin α4β7372 and their later 
dissemination to MLN was demonstrated to be dependent on this expression373. 
The expression of α4β7 has also been implicated in the retention of lymphocytes 
in the cervical lymph nodes, which can account for the interconnection with 
intestinal mucosal sites374. A recent study has also shown that following i.n. 
immunization, lung DC were capable of inducing in activated lymphocytes the 
expression of α4β7 and CCR9 in a process dependent on DC production of TGF-β 
and the local metabolization of vitamin A into retinoic acid, both of which were 
essential for lymphocyte migration to the intestinal lamina propria375. Furthermore 
experimental i.n. immunization with SAG1 protein of T. gondii revealed that 
antigen-specific cells could indeed be found in the MLN, and in IEL compartment 
following immunization and that transfer of these populations to naïve mice could 
mediate protection against a T. gondii challenge376. A similar i.n. immunization 
protocol also indicated that antigen-specific IgA response against T. gondii SAG1 
could be induced in the intestinal mucosa following i.n. immunization351,359, even 
though mice can traffic circulating IgA to the gut lumen through the bile via poly-Ig 
receptor expression on hepatocytes266. Surprisingly, one study has even reported 
increased protection against helicobacter infection following i.n. immunization in 
comparison with oral immunization, challenging the idea that i.n. immunization 
induces weaker responses in the gastrointestinal tract353. More recently, reports on 
ruminants have also shown that following i.n. immunization antigen-specific IgA 
response could be detected in the animal’s feces363. A similar gastrointestinal 
mucosal immune response activation following i.n. immunization was also 
observed in sheep immunized against serine/threonine phosphatase 2A present in 
several pathogenic nematode species, which resulted in a reduced presence of 
viable worms in abomasal contents and reduced shedding of parasitic eggs in the 
feces365, indicating that a similar mechanism of cellular trafficking to the 
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gastrointestinal mucosa following i.n. immunization should also exist in ruminant 
species. 
 
1.5.2 Mucosal adjuvants 
 
 One of the limitations for the large scale introduction of mucosal vaccination 
is the absence of suitable and licensed mucosal adjuvants337,342,346,348,377. In fact 
aluminum hydroxide salts, the most widely used adjuvant in human vaccination347, 
has very little to no adjuvant capacity when used mucosal immunization342. In this 
regard, an ideal mucosal adjuvant should be capable of promoting antigen uptake 
by mucosal immune cells, present high stability and resistance to pH variations 
and enzymatic degradation and possess a strong immunostimulatory activity 
capable of inducing the activation of both B and T lymphocytes, although without 
causing unwanted immunopathology or inducing tolerance338,342. To date the most 
powerful and well-studied mucosal adjuvants are the bacterial cholera and heat 
labile toxins338,342,377. Although these two bacterial products present very high 
enteric toxicity, especially in humans, their specific catalytic activity also accounts 
for their strong mucosal adjuvant capacity338,342,377. Both cholera and heat labile 
toxin are known to be proficient inducers of mucosal IgA responses but 
nevertheless can stimulate strong cell-mediated immune responses although 
generally biased towards a Th2 phenotype325,343,378. However, and due to its high 
toxicity, non-toxic derivatives from these two toxins, usually lacking the catalytic 
domain, have been evaluated for their mucosal adjuvant capacity. These 
derivatives did not induced significant toxic effects, but presented a considerably 
reduced adjuvant capacity which limits their use in mucosal immunization 
protocols342. 
Due to the role of pattern recognition receptors in the activation of innate 
immune cells, TLR agonists have also been explored as possible adjuvants for 
mucosal immunization325,338,342,344,346,347,377. In this regard, both macrophages and 
DC as well as other non-related immune cells in mucosal sites express several 
TLR, making them a valued target for mucosal immune response stimulation379. 
TLR9 is an intracellular pattern recognition receptor that is expressed in multiple 
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immune cells including conventional and plasmacytoid DC, monocytes, NK cells 
and B cells and is capable of recognize unmethylated cytosine phosphate guanine 
DNA sequences (CpG)347,380,381. The use of CpG in mucosal immunization has 
revealed that these sequences possess a strong mucosal immunomodulatory 
capacity and limited cytotoxic effects380,382. Of notice, mucosally administered CpG 
is capable of inducing strong IgA based mucosal responses as well as Th1-type 
immune responses which makes it an interesting alternative to conventional toxin-
based adjuvants325,342,346,347,380,381. Experimentally i.n. immunization with CpG has 
been shown to induce Th1-type responses against bacterial and protozoan 
antigens352-357. Interestingly, and since CpG administration alone is known to affect 
the immune response for a considerable time length381, i.n. immunization with 
Yersinia pestis peptides and CpG adjuvant were capable of inducing a long-lasting 
production of IgA in the intestinal mucosa indicating that the rapid kinetics of IgA 
responses can be modulated through mucosal immunization356. i.n. immunization 
with CpG and T. gondii sonicates could also induce intestinal IgA production and a 
systemic Th1-type immune response that were capable of conferring protection 
against the parasite357. Still, despite the advantages and promising results 
obtained in experimental mouse models, the experimental use of CpG in the 
development of veterinary related vaccines has been limited. This fact can in part 
be explained by lack of optimized CpG sequences for some veterinary relevant 
species. However, and taking into account the promising results obtained in 
experimental mice models, the use of CpG as a mucosal adjuvant in veterinary 
medicine may nonetheless contribute for the development of successful mucosal 
immunization protocols. 
  
 42 
 
References 
 
1 Dubey JP, Barr BC, Barta JR, Bjerkås I, Björkman C, Blagburn BL, et al. 2002. 
Redescription of Neospora caninum and its differentiation from related coccidia. 
International Journal for Parasitology. 32(8):929-46. 
2 Goodswen SJ, Kennedy PJ, Ellis JT. 2013. A review of the infection, genetics, and 
evolution of Neospora caninum: from the past to the present. Infect Genet Evol. 
13:133-50. 
3 Levine ND. 1988. Progress in taxonomy of the Apicomplexan protozoa. J 
Protozool. 35(4):518-20. 
4 Morrison DA. 2009. Evolution of the Apicomplexa: where are we now? Trends in 
Parasitology. 25(8):375-82. 
5 Gubbels M-JJ, Duraisingh MT. 2012. Evolution of apicomplexan secretory 
organelles. International Journal for Parasitology. 42(12):1071-81. 
6 Shen B, Sibley LD. 2012. The moving junction, a key portal to host cell invasion by 
apicomplexan parasites. Current opinion in microbiology. 15(4):449-55. 
7 Arisue N, Hashimoto T. 2015. Phylogeny and evolution of apicoplasts and 
apicomplexan parasites. Parasitology international. 64(3):254-9. 
8 Bjerkas I, Mohn SF, Presthus J. 1984. Unidentified cyst-forming sporozoon 
causing encephalomyelitis and myositis in dogs. Z Parasitenkd. 70(2):271-4. 
9 Dubey JP, Hattel AL, Lindsay DS, Topper MJ. 1988. Neonatal Neospora caninum 
infection in dogs: isolation of the causative agent and experimental transmission. J 
Am Vet Med Assoc. 193(10):1259-63. 
10 Dubey JP, Carpenter JL, Speer CA, Topper MJ, Uggla A. 1988. Newly recognized 
fatal protozoan disease of dogs. J Am Vet Med Assoc. 192(9):1269-85. 
11 Dubey JP, Lindsay DS. 1996. A review of Neospora caninum and neosporosis. 
Veterinary Parasitology. 67(1):1-59. 
12 John E, Kim L, Peter RB, Paul JB, Karen AN, Alan MJ. 1994. The phylogeny of 
Neospora caninum. Molecular and Biochemical Parasitology. 64(2):303311. 
13 Dubey JP, Schares G, Ortega-Mora LM. 2007. Epidemiology and control of 
neosporosis and Neospora caninum. Clin Microbiol Rev. 20(2):323-67. 
14 McAllister MM, Dubey JP, Lindsay DS, Jolley WR, Wills RA, McGuire AM. 1998. 
Dogs are definitive hosts of Neospora caninum. Int J Parasitol. 28(9):1473-8. 
15 Lindsay DS, Dubey JP, Duncan RB. 1999. Confirmation that the dog is a definitive 
host for Neospora caninum. Veterinary Parasitology. 82(4):327-33. 
16 Alves Neto AF, Bandini LA, Nishi SM, Soares RM, Driemeier D, Antoniassi NA, et 
al. 2011. Viability of sporulated oocysts of Neospora caninum after exposure to 
different physical and chemical treatments. The Journal of parasitology. 97(1):135-
9. 
17 Almería S, López-Gatius F. 2013. Bovine neosporosis: clinical and practical 
aspects. Research in Veterinary Science. 95(2):303-9. 
18 Dubey JP, Dubey J. 2003. Review of Neospora caninum and neosporosis in 
animals. The Korean journal of parasitology. 41(1):1-16. 
 43 
 
19 Hemphill A. 1999. The host-parasite relationship in neosporosis. Advances in 
parasitology. 43:47-104. 
20 Boucher LE, Bosch J. 2015. The apicomplexan glideosome and adhesins - 
Structures and function. Journal of structural biology. 190(4):93-114. 
21 Carruthers V, Boothroyd JC. 2007. Pulling together: an integrated model of 
Toxoplasma cell invasion. Current opinion in microbiology. 10(1):83-9. 
22 Hemphill A, Gottstein B, Kaufmann H. 1996. Adhesion and invasion of bovine 
endothelial cells by Neospora caninum. Parasitology. 112(Pt 2):183-97. 
23 Howe DK, Crawford AC, Lindsay D, Sibley LD. 1998. The p29 and p35 
immunodominant antigens of Neospora caninum tachyzoites are homologous to 
the family of surface antigens of Toxoplasma gondii. Infect Immun. 66(11):5322-8. 
24 Nishikawa Y, Xuan X, Nagasawa H, Igarashi I, Fujisaki K, Otsuka H, et al. 2000. 
Monoclonal antibody inhibition of Neospora caninum tachyzoite invasion into host 
cells. International Journal for Parasitology. 30(1):51-8. 
25 Cho J-HH, Chung W-SS, Song K-JJ, Na B-KK, Kang S-WW, Song C-YY, et al. 
2005. Protective efficacy of vaccination with Neospora caninum multiple 
recombinant antigens against experimental Neospora caninum infection. The 
Korean journal of parasitology. 43(1):19-25. 
26 Haldorson GJ, Stanton JB, Mathison BA, Suarez CE, Baszler TV. 2006. Neospora 
caninum: antibodies directed against tachyzoite surface protein NcSRS2 inhibit 
parasite attachment and invasion of placental trophoblasts in vitro. Exp Parasitol. 
112(3):172-8. 
27 Lovett JL, Howe DK, Sibley LD. 2000. Molecular characterization of a 
thrombospondin-related anonymous protein homologue in Neospora caninum. 
Molecular and Biochemical Parasitology. 107(1):33-43. 
28 Naguleswaran A, Cannas A, Keller N, Vonlaufen N, Schares G, Conraths FJ, et al. 
2001. Neospora caninum microneme protein NcMIC3: secretion, subcellular 
localization, and functional involvement in host cell interaction. Infection and 
Immunity. 69(10):6483-94. 
29 Keller N, Naguleswaran A, Cannas A. 2002. Identification of a Neospora caninum 
microneme protein (NcMIC1) which interacts with sulfated host cell surface 
glycosaminoglycans. Infect Immun. 70(6):3187-98. 
30 Keller N, Riesen M, Naguleswaran A, Vonlaufen N, Stettler R, Leepin A, et al. 
2004. Identification and characterization of a Neospora caninum microneme-
associated protein (NcMIC4) that exhibits unique lactose-binding properties. 
Infection and Immunity. 72(8):4791-800. 
31 Sonda S, Fuchs N, Gottstein B, Hemphill A. 2000. Molecular characterization of a 
novel microneme antigen in Neospora caninum. Molecular and Biochemical 
Parasitology. 108(1):39-51. 
32 Srinivasan S, Mueller J, Suana A, Hemphill A. 2007. Vaccination with microneme 
protein NcMIC4 increases mortality in mice inoculated with Neospora caninum. 
The Journal of parasitology. 93(5):1046-55. 
33 Hemphill A, Debache K, Monney T, Schorer M, Guionaud C, Alaeddine F, et al. 
2013. Proteins mediating the Neospora caninum-host cell interaction as targets for 
vaccination. Frontiers in bioscience (Elite edition). 5:23-36. 
34 Zhang H, Compaore MK, Lee EG, Liao M, Zhang G, Sugimoto C, et al. 2007. 
Apical membrane antigen 1 is a cross-reactive antigen between Neospora 
 44 
 
caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell 
invasion by both parasites. Mol Biochem Parasitol. 151(2):205-12. 
35 Debache K, Alaeddine F, Guionaud C, Monney T, Muller J, Strohbusch M, et al. 
2009. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 
and NcMIC3 reduces cerebral infection and vertical transmission in mice 
experimentally infected with Neospora caninum tachyzoites. Int J Parasitol. 
39(12):1373-84. 
36 Alaeddine F, Hemphill A, Debache K, Guionaud C. 2013. Molecular cloning and 
characterization of NcROP2Fam-1, a member of the ROP2 family of rhoptry 
proteins in Neospora caninum that is targeted by antibodies neutralizing host cell 
invasion in vitro. Parasitology. 140(8):1033-50. 
37 Nolan SJ, Romano JD, Luechtefeld T, Coppens I. 2015. Neospora caninum 
recruits host cell structures to its parasitophorous vacuole and salvages lipids from 
organelles. Eukaryotic cell. 14(5):454-73. 
38 Herman RK, Molestina RE, Sinai AP, Howe DK. 2007. The apicomplexan 
pathogen Neospora caninum inhibits host cell apoptosis in the absence of 
discernible NF-kappa B activation. Infection and Immunity. 75(9):4255-62. 
39 Gondim LF, McAllister MM, Pitt WC, Zemlicka DE. 2004. Coyotes (Canis latrans) 
are definitive hosts of Neospora caninum. Int J Parasitol. 34(2):159-61. 
40 Dubey JP, Jenkins MC, Rajendran C, Miska K, Ferreira LR, Martins J, et al. 2011. 
Gray wolf (Canis lupus) is a natural definitive host for Neospora caninum. Vet 
Parasitol. 181(2-4):382-7. 
41 King JS, Šlapeta J, Jenkins DJ, Al-Qassab SE. 2010. Australian dingoes are 
definitive hosts of Neospora caninum. Int J Parasitol. 40(8):945-50 
42 Dubey JP, Schares G. 2011. Neosporosis in animals--the last five years. Vet 
Parasitol. 180(1-2):90-108. 
43 McCann CM, Vyse AJ, Salmon RL, Thomas D, Williams DJ, McGarry JW, et al. 
2008. Lack of serologic evidence of Neospora caninum in humans, England. 
Emerging infectious diseases. 14(6):978-80. 
44 Petersen E, Lebech M, Jensen L, Lind P, Rask M, Bagger P, et al. 1999. 
Neospora caninum infection and repeated abortions in humans. Emerging 
infectious diseases. 5(2):278-80. 
45 Tranas J, Heinzen RA, Weiss LM, McAllister MM. 1999. Serological evidence of 
human infection with the protozoan Neospora caninum. Clinical and diagnostic 
laboratory immunology. 6(5):765-7. 
46 Barr BC, Conrad PA, Sverlow KW, Tarantal AF, Hendrickx AG. 1994. 
Experimental fetal and transplacental Neospora infection in the nonhuman 
primate. Lab Invest. 71(2):236-42. 
47 Williams DJ, Hartley CS, Björkman C, Trees AJ. 2009. Endogenous and 
exogenous transplacental transmission of Neospora caninum - how the route of 
transmission impacts on epidemiology and control of disease. Parasitology. 
136(14):1895-900. 
48 Basso W, Venturini L, Venturini M, Hill D, Kwok O, Shen S, et al. 2001. First 
Isolation of Neospora caninum From the Feces of a Naturally Infected Dog. 
Journal of Parasitology. 87(3):612-8 
49 McGarry JW, Stockton CM, Williams DJ, Trees AJ. 2003. Protracted shedding of 
oocysts of Neospora caninum by a naturally infected foxhound. The Journal of 
parasitology. 89(3):628-30. 
 45 
 
50 Buxton D. 1998. Protozoan infections (Toxoplasma gondii, Neospora caninum and 
Sarcocystis spp.) in sheep and goats: recent advances. Veterinary research. 29(3-
4):289-310. 
51 Dijkstra T, Eysker M, Schares G, Conraths FJ. 2001. Dogs shed 
Neosporacaninum oocysts after ingestion of naturally infected bovine placenta but 
not after ingestion of colostrum spiked with Neospora caninum tachyzoites. Int J 
Parasitol. 31(8):747-52. 
52 Bandini LA, Neto AF, Pena HF, Cavalcante GT, Schares G, Nishi SM, et al. 2011. 
Experimental infection of dogs (Canis familiaris) with sporulated oocysts of 
Neospora caninum. Veterinary Parasitology. 176(2-3):151-6. 
53 Cavalcante GT, Monteiro RM, Soares RM, Nishi SM, Alves Neto AF, Esmerini PO, 
et al. 2011. Shedding of Neospora caninum oocysts by dogs fed different tissues 
from naturally infected cattle. Veterinary Parasitology. 179(1-3):220-3. 
54 Trees AJ, Williams DJL. 2005. Endogenous and exogenous transplacental 
infection in Neospora caninum and Toxoplasma gondii. Trends in Parasitology. 
21(12):558-61. 
55 Dubey JP, Buxton D, Wouda W. 2006. Pathogenesis of bovine neosporosis. 
Journal of Comparative Pathology. 134(4):267-89. 
56 Bjorkman C, Johansson O, Stenlund S, Holmdahl OJ, Uggla A. 1996. Neospora 
species infection in a herd of dairy cattle. J Am Vet Med Assoc. 208(9):1441-4. 
57 Schares G, Peters M, Wurm R, Bärwald A. 1998. The efficiency of vertical 
transmission of Neospora caninum in dairy cattle analysed by serological 
techniques. Vet Parasitol. 80(2):87-98. 
58 Wouda W, Moen AR, Schukken YH. 1998. Abortion risk in progeny of cows after a 
Neospora caninum epidemic. Theriogenology. 49(7):1311-6. 
59 Anderson ML, Reynolds JP, Rowe JD, Sverlow KW, Packham AE, Barr BC, et al. 
1997. Evidence of vertical transmission of Neospora sp infection in dairy cattle. J 
Am Vet Med Assoc. 210(8):1169-72. 
60 Pare J, Thurmond MC, Hietala SK. 1996. Congenital Neospora caninum infection 
in dairy cattle and associated calfhood mortality. Can J Vet Res. 60(2):133-9. 
61 Davison HC, French NP, Trees AJ. 1999. Herd-specific and age-specific 
seroprevalence of Neospora caninum in 14 British dairy herds. The Veterinary 
record. 144(20):547-50. 
62 Björkman C, McAllister MM, Frössling J. 2003. Application of the Neospora 
caninum IgG avidity ELISA in assessment of chronic reproductive losses after an 
outbreak of neosporosis in a herd of beef cattle. J Vet Diagn Invest. 15(1):3-7. 
63 Dijkstra T, Barkema HW, Eysker M, Beiboer ML. 2003. Evaluation of a single 
serological screening of dairy herds for Neospora caninum antibodies. Vet 
Parasitol. 110(2-4):161-9. 
64 Bartels CJ, Huinink I, Beiboer ML, van Schaik G, Wouda W, Dijkstra T, et al. 2007. 
Quantification of vertical and horizontal transmission of Neospora caninum 
infection in Dutch dairy herds. Veterinary Parasitology. 148(2):83-92. 
65 Mazuz ML, Fish L, Reznikov D, Wolkomirsky R, Leibovitz B, Savitzky I, et al. 2014. 
Neosporosis in naturally infected pregnant dairy cattle. Veterinary Parasitology. 
205(1):85-91. 
 46 
 
66 Fioretti PD, Pasquali P, Diaferia M. 2003. Neospora caninum infection and 
congenital transmission: serological and parasitological study of cows up to the 
fourth gestation. J Vet Med B Infect Dis Vet Public Health. 50(8):399-404. 
67 French NP, Clancy D, Davison HC, Trees AJ. 1999. Mathematical models of 
Neospora caninum infection in dairy cattle: transmission and options for control. 
International Journal for Parasitology. 29(10):1691-704. 
68 Marez DT, Liddell S, Dubey JP, Jenkins MC. 1999. Oral infection of calves with 
Neospora caninum oocysts from dogs: humoral and cellular immune responses. 
Int J Parasitol. 29(10):1647-57. 
69 Trees AJ, McAllister MM, Guy CS, McGarry JW. 2002. Neospora caninum: oocyst 
challenge of pregnant cows. Vet Parasitol 109(1-2):147-54. 
70 Gondim LFP, McAllister MM. 2004. Transplacental transmission and abortion in 
cows administered Neospora caninum oocysts. J Parasitol. 90(6):1394-400. 
71 McCann CM, McAllister MM, Gondim LFP. 2007. Neospora caninum in cattle: 
experimental infection with oocysts can result in exogenous transplacental 
infection, but not endogenous transplacental infection in the subsequent 
pregnancy. Int J Parasitol. 37(14):1631-9. 
72 Thurmond MC, Hietala SK. 1997. Herd-based diagnosis of Neospora caninum-
induced endemic and epidemic abortion in cows and evidence for congenital and 
postnatal transmission. J Vet Diagn Invest. 9(1):44-9. 
73 Dyer RM, Jenkins MC, Kwok OCH, Douglas LW. 2000. Serologic survey of 
Neospora caninum infection in a closed dairy cattle herd in Maryland: risk of 
serologic reactivity by production groups. Vet Parasitol. 90(3):171-81. 
74 Dijkstra T, Barkema HW, Eysker M, Wouda W. 2001. Evidence of post-natal 
transmission of Neospora caninum in Dutch dairy herds. International Journal for 
Parasitology. 31(2):209-15. 
75 Eiras C, Arnaiz I, Alvarez-García G, Ortega-Mora LM, Sanjuánl ML, Yus E, et al. 
2011. Neospora caninum seroprevalence in dairy and beef cattle from the 
northwest region of Spain, Galicia. Preventive veterinary medicine. 98(2-3):128-32. 
76 Wouda W, Dijkstra T, Kramer AMH. 1999. Seroepidemiological evidence for a 
relationship between Neospora caninum infections in dogs and cattle. Int J 
Parasitol. 29(10):1677-82. 
77 Bartels CJM, Wouda W, Schukken YH. 1999. Risk factors for Neospora caninum-
associated abortion storms in dairy herds in The Netherlands (1995 to 1997). 
Theriogenology. 52(2):247-57. 
78 Moore DP, Campero CM, Odeón AC, Posso MA. 2002. Seroepidemiology of beef 
and dairy herds and fetal study of Neospora caninum in Argentina. Vet Parasitol. 
107(4):303-16. 
79 McAllister MM, Huffman EM, Hietala SK. 1996. Evidence suggesting a point 
source exposure in an outbreak of bovine abortion due to neosporosis. J Vet 
Diagn Invest. 8(3):355-7. 
80 McAllister MM, Bjorkman C, Anderson-Sprecher R, Rogers DG. 2000. Evidence of 
point-source exposure to Neospora caninum and protective immunity in a herd of 
beef cows. J Am Vet Med Assoc. 217(6):881-7. 
81 Dijkstra T, Barkema HW, Hesselink JW, Wouda W. 2002. Point source exposure 
of cattle to Neospora caninum consistent with periods of common housing and 
feeding and related to the introduction of a dog. Veterinary Parasitology. 
105(2):89-98. 
 47 
 
82 Dijkstra TH, Barkema HW, Björkman C, Wouda W. 2002. A high rate of 
seroconversion for Neospora caninum in a dairy herd without an obvious 
increased incidence of abortions. Veterinary Parasitology. 109(3-4):203-11. 
83 Cardoso JM, Amaku M, Araujo AJ, Gennari SM. 2012. A longitudinal study of 
Neospora caninum infection on three dairy farms in Brazil. Vet Parasitol. 187(3-
4):553-7. 
84 Moré G, Bacigalupe D, Basso W, Rambeaud M, Beltrame F, Ramirez B, et al. 
2009. Frequency of horizontal and vertical transmission for Sarcocystis cruzi and 
Neospora caninum in dairy cattle. Veterinary Parasitology. 160(1):51-4. 
85 Moskwa B, Pastusiak K, Bien J, Cabaj W. 2007. The first detection of Neospora 
caninum DNA in the colostrum of infected cows. Parasitology Research. 
100(3):633-6. 
86 Ortega-Mora LM, Ferre I, del-Pozo I. 2003. Detection of Neospora caninum in 
semen of bulls. Vet Parasitol 117(4):301-8. 
87 Ferre I, Serrano-Martínez E, Martínez A, Osoro K. 2008. Effects of re-infection with 
Neospora caninum in bulls on parasite detection in semen and blood and 
immunological responses. Theriogenology. 69(7):905-11. 
88 Davison HC, Guy CS, McGarry JW, Guy F, Williams DJ, Kelly DF, et al. 2001. 
Experimental studies on the transmission of Neospora caninum between cattle. 
Research in Veterinary Science. 70(2):163-8. 
89 Osoro K, Ortega-Mora LM, Martínez A, Serrano-Martínez E, Ferre I. 2009. Natural 
breeding with bulls experimentally infected with Neospora caninum failed to induce 
seroconversion in dams. Theriogenology. 71(4):639-42. 
90 Canada N, Meireles CS, Ferreira P, Correia da Costa JM, Rocha A. 2006. Artificial 
insemination of cows with semen in vitro contaminated with Neospora caninum 
tachyzoites failed to induce neosporosis. Vet Parasitol. 139(1-3):109-14. 
91 Barber JS, Trees AJ. 1996. Clinical aspects of 27 cases of neosporosis in dogs. 
The Veterinary record. 139(18):439-43. 
92 Reichel MP, Ellis JT, Dubey JP. 2007. Neosporosis and hammondiosis in dogs. 
The Journal of small animal practice. 48(6):308-12. 
93 Dubey JP, Koestner A, Piper RC. 1990. Repeated transplacental transmission of 
Neospora caninum in dogs. J Am Vet Med Assoc. 197(7):857-60. 
94 Armengol R, Pabón M, Santolaria P, Cabezón O, Adelantado C, Yániz J, et al. 
2007. Low seroprevalence of Neospora caninum infection associated with the 
limousin breed in cow-calf herds in Andorra, Europe. The Journal of parasitology. 
93(5):1029-32. 
95 Duong MC, Alenius S, Huong LTT, Björkman C. 2008. Prevalence of Neospora 
caninum and bovine viral diarrhoea virus in dairy cows in Southern Vietnam. 
Veterinary journal (London, England : 1997). 175(3):390-4. 
96 Macaldowie C, Maley SW, Wright S, Bartley P, Esteban-Redondo I, Buxton D, et 
al. 2004. Placental pathology associated with fetal death in cattle inoculated with 
Neospora caninum by two different routes in early pregnancy. Journal of 
Comparative Pathology. 131(2-3):142-56. 
97 Maley SW, Buxton D, Rae AG, Wright SE, Schock A, Bartley PM, et al. 2003. The 
pathogenesis of neosporosis in pregnant cattle: inoculation at mid-gestation. 
Journal of Comparative Pathology. 129(2-3):186-95. 
 48 
 
98 Rosbottom A, Gibney H, Kaiser P, Hartley C, Smith RF, Robinson R, et al. 2011. 
Up regulation of the maternal immune response in the placenta of cattle naturally 
infected with Neospora caninum. PLoS One. 6(1): e15799 
99 Barr BC, Conrad PA, Dubey JP. 1991. Neospora-like encephalomyelitis in a calf: 
pathology, ultrastructure, and immunoreactivity. J Vet Diagn Invest. 3(1):39-46. 
100 Bryan LA, Gajadhar AA, Dubey JP. 1994. Bovine neonatal encephalomyelitis 
associated with a Neospora sp. protozoan. Can Vet J. 35(2):111-3. 
101 Barr BC, Conrad PA, Breitmeyer R, Sverlow K, Anderson ML, Reynolds J, et al. 
1993. Congenital Neospora infection in calves born from cows that had previously 
aborted Neospora-infected fetuses: four cases (1990-1992). J Am Vet Med Assoc. 
202(1):113-7. 
102 Anderson ML, Blanchard PC, Barr BC, Dubey JP, Hoffman RL, Conrad PA. 1991. 
Neospora-like protozoan infection as a major cause of abortion in California dairy 
cattle. J Am Vet Med Assoc. 198(2):241-4. 
103 Barr BC, Anderson ML, Dubey JP, Conrad PA. 1991. Neospora-like protozoal 
infections associated with bovine abortions. Veterinary pathology. 28(2):110-6. 
104 Dubey JP, Miller S, Lindsay DS, Topper MJ. 1990. Neospora caninum-associated 
myocarditis and encephalitis in an aborted calf. J Vet Diagn Invest. 2(1):66-9. 
105 Shivaprasad HL, Ely R, Dubey JP. 1989. A Neospora-like protozoon found in an 
aborted bovine placenta. Veterinary Parasitology. 34(1-2):145-8. 
106 Thilsted JP, Dubey JP. 1989. Neosporosis-like abortions in a herd of dairy cattle. J 
Vet Diagn Invest. 1(3):205-9. 
107 Conrad PA, Barr BC, Sverlow KW, Anderson M, Daft B, Kinde H, et al. 1993. In 
vitro isolation and characterization of a Neospora sp. from aborted bovine 
foetuses. Parasitology. 106(Pt 3):239-49. 
108 Moen AR, Wouda W, Mul MF, Graat EA, van Werven T. 1998. Increased risk of 
abortion following Neospora caninum abortion outbreaks: a retrospective and 
prospective cohort study in four dairy herds. Theriogenology. 49(7):1301-9. 
109 Thurmond MC, Hietala SK. 1997. Effect of congenitally acquired Neospora 
caninum infection on risk of abortion and subsequent abortions in dairy cattle. Am 
J Vet Res. 58(12):1381-5. 
110 Perez E, Gonzalez O, Dolz G, Morales J. 1998. First report of bovine neosporosis 
in dairy cattle in Costa Rica. Vet Rec. 142(19):520-1. 
111 Hall CA, Reichel MP, Ellis JT. 2005. Neospora abortions in dairy cattle: diagnosis, 
mode of transmission and control. Vet Parasitol. 128(3-4):231-41. 
112 Gibney EH, Kipar A, Rosbottom A, Guy CS, Smith RF, Hetzel U, et al. 2008. The 
extent of parasite-associated necrosis in the placenta and foetal tissues of cattle 
following Neospora caninum infection in early and late gestation correlates with 
foetal death. International Journal for Parasitology. 38(5):579-88. 
113 Sager H, Fischer I, Furrer K, Strasser M, Waldvogel A, Boerlin P, et al. 2001. A 
Swiss case–control study to assess Neospora caninum-associated bovine 
abortions by PCR, histopathology and serology. Veterinary Parasitology. 102(1):1-
15. 
114 Rojo-Montejo S, Collantes-Fernández E, Blanco-Murcia J, Rodríguez-Bertos A, 
Risco-Castillo V, Ortega-Mora LM. 2009. Experimental infection with a low 
virulence isolate of Neospora caninum at 70 days gestation in cattle did not result 
in foetopathy. Veterinary research. 40(5):49. 
 49 
 
115 Ghanem ME, Suzuki T, Akita M, Nishibori M. 2009. Neospora caninum and 
complex vertebral malformation as possible causes of bovine fetal mummification. 
The Canadian veterinary journal La revue vétérinaire canadienne. 50(4):389-92. 
116 Thornton RN, Gajadhar A, Evans J. 1994. Neospora abortion epidemic in a dairy 
herd. New Zealand Veterinary Journal. 42(5):190-1. 
117 Guy CS, Williams DJL, Kelly DF, McGarry JW, Guy F, Bjorkman C, et al. 2001. 
Neospora caninum in persistently infected, pregnant cows: spontaneous 
transplacental infection is associated with an acute increase in maternal antibody. 
Vet Rec. 149(15):443-9. 
118 Reichel MP, Alejandra Ayanegui-Alcerreca M, Gondim LF, Ellis JT. 2013. What is 
the global economic impact of Neospora caninum in cattle - the billion dollar 
question. Int J Parasitol. 43(2):133-42. 
119 Reichel MP, Ellis JT. 2009. Neospora caninum--how close are we to development 
of an efficacious vaccine that prevents abortion in cattle? Int J Parasitol. 
39(11):1173-87. 
120 Hernandez J, Risco C, Donovan A. 2001. Association between exposure to 
Neospora caninum and milk production in dairy cows. Journal of the American 
Veterinary Medical Association. 219(5):632-5. 
121 Hobson JC, Duffield TF, Kelton D, Lissemore K, Hietala SK, Leslie KE, et al. 2002. 
Neospora caninum serostatus and milk production of Holstein cattle. Journal of the 
American Veterinary Medical Association. 221(8):1160-4. 
122 Romero JJ, Breda VS, Vargas B, Dolz G. 2005. Effect of neosporosis on 
productive and reproductive performance of dairy cattle in Costa Rica. 
Theriogenology. 64(9):1928-39. 
123 O' Doherty E, Sayers R, O' Grady L, Shalloo L. 2015. Effect of exposure to 
Neospora caninum, Salmonella, and Leptospira interrogans serovar Hardjo on the 
economic performance of Irish dairy herds. Journal of dairy science. 98(4):2789-
800. 
124 Barling KS, McNeill JW, Thompson JA. 2000. Association of serologic status for 
Neospora caninum with postweaning weight gain and carcass measurements in 
beef calves. J Am Vet Med Assoc. 217(9):1356-60. 
125 Reichel MP, Ellis JT. 2002. Control options for Neospora caninum infections in 
cattle—current state of knowledge. New Zealand Veterinary Journal. 50(3):86-92. 
126 Reichel MP, Ellis JT. 2006. If control of Neospora caninum infection is technically 
feasible does it make economic sense? Vet Parasitol. 142(1-2):23-34. 
127 Larson RL, Hardin DK, Pierce VL. 2004. Economic considerations for diagnostic 
and control options for Neospora caninum-induced abortions in endemically 
infected herds of beef cattle. J Am Vet Med Assoc. 224(10):1597-604. 
128 Reichel MP, McAllister MM, Pomroy WE, Campero C, Ortega-Mora LM, Ellis JT. 
2014. Control options for Neospora caninum--is there anything new or are we 
going backwards? Parasitology. 141(11):1455-70. 
129 Gottstein B, Eperon S, Dai WJ, Cannas A, Hemphill A, Greif G. 2001. Efficacy of 
toltrazuril and ponazuril against experimental Neospora caninum infection in mice. 
Parasitol Res. 87(1):43-8. 
130 Debache K, Hemphill A. 2012. Effects of miltefosine treatment in fibroblast cell 
cultures and in mice experimentally infected with Neospora caninum tachyzoites. 
Parasitology. 139(7):934-44. 
 50 
 
131 Mazuz ML, Haynes R, Shkap V, Fish L, Wollkomirsky R, Leibovich B, et al. 2012. 
Neospora caninum: in vivo and in vitro treatment with artemisone. Veterinary 
Parasitology. 187(1):99-104. 
132 Ojo KK, Reid MC, Siddaramaiah KL, Müller J. 2014. Neospora caninum calcium-
dependent protein kinase 1 is an effective drug target for neosporosis therapy. 
PLoS One. 9(3):e92929. 
133 Müller J, Aguado-Martinez A, Manser V, Balmer V, Winzer P, Ritler D, et al. 2015. 
Buparvaquone is active against Neospora caninum in vitro and in experimentally 
infected mice. International journal for parasitology Drugs and drug resistance. 
5(1):16-25. 
134 Kritzner S, Sager H, Blum J, Krebber R, Greif G, Gottstein B. 2002. An explorative 
study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves 
experimentally infected with Neospora caninum. Ann Clin Microbiol Antimicrob. 
1:4. 
135 Romero JJ, Perez E, Frankena K. 2004. Effect of a killed whole Neospora caninum 
tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under 
field conditions. Vet Parasitol. 123(3-4):149-59. 
136 Weston JF, Heuer C, Williamson NB. 2012. Efficacy of a Neospora caninum killed 
tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle. 
Prev Vet Med. 103(2-3):136-44. 
137 Buxton D, Innes EA. 1995. A commercial vaccine for ovine toxoplasmosis. 
Parasitology. 110(Suppl):11-6. 
138 Wallach M. 1997. The importance of transmission-blocking immunity in the control 
of infections by apicomplexan parasites. Int J Parasitol. 27(10):1159-67. 
139 Olson ME, Ceri H, Morck DW. 2000. Giardia vaccination. Parasitol Today. 
16(5):213-7. 
140 Borja-Cabrera GP, Correia Pontes NN, da Silva VO, Paraguai de Souza E, Santos 
WR, Gomes EM, et al. 2002. Long lasting protection against canine kala-azar 
using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo 
do Amarante, RN). Vaccine. 20(27-28):3277-84. 
141 Bock R, Jackson L, de Vos A, Jorgensen W. 2004. Babesiosis of cattle. 
Parasitology. 129(Suppl):247-69. 
142 Lindsay DS, Dubey JP. 1989. Neospora caninum (Protozoa: apicomplexa) 
infections in mice. J Parasitol. 75(5):772-9. 
143 Monney T, Hemphill A. 2014. Vaccines against neosporosis: what can we learn 
from the past studies? Experimental Parasitology. 140:52-70. 
144 Long MT, Baszler TV. 1996. Fetal loss in BALB/C mice infected with Neospora 
caninum. J Parasitol. 82(4):608-11. 
145 Lindsay DS, Lenz SD, Cole RA, Dubey JP, Blagburn BL. 1995. Mouse model for 
central nervous system Neospora caninum infections. J Parasitol. 81(2):313-5. 
146 Long MT, Baszler TV, Mathison BA. 1998. Comparison of intracerebral parasite 
load, lesion development, and systemic cytokines in mouse strains infected with 
Neospora caninum. J Parasitol. 84(2):316-20. 
147 Vonlaufen N, Müller N, Keller N, Naguleswaran A, Bohne W, McAllister MM, et al. 
2002. Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite 
stage conversion in murine epidermal keratinocyte cell cultures. International 
Journal for Parasitology. 32(10):1253-65. 
 51 
 
148 Vonlaufen N, Guetg N, Naguleswaran A, Müller N, Björkman C, Schares G, et al. 
2004. In vitro induction of Neospora caninum bradyzoites in vero cells reveals 
differential antigen expression, localization, and host-cell recognition of tachyzoites 
and bradyzoites. Infection and Immunity. 72(1):576-83. 
149 Teixeira L, Botelho AS, Batista AR, Meireles CS, Ribeiro A, Domingues HS, et al. 
2007. Analysis of the immune response to Neospora caninum in a model of 
intragastric infection in mice. Parasite Immunol. 29(1):23-36. 
150 Su Z, Stevenson MM. 2000. Central role of endogenous gamma interferon in 
protective immunity against blood-stage Plasmodium chabaudi AS infection. 
Infection and Immunity. 68(8):4399-406. 
151 Norose K, Mun HS, Aosai F, Chen M, Hata H, Tagawa Y, et al. 2001. Organ 
infectivity of Toxoplasma gondii in interferon-gamma knockout mice. The Journal 
of parasitology. 87(2):447-52. 
152 Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, et al. 
1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 
responses to Toxoplasma gondii while failing to control acute infection. J Immunol. 
157(9):4045-54. 
153 Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, et al. 
1994. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and 
resistance during acute infection with Toxoplasma gondii. J Immunol. 153(6):2533-
43. 
154 Yap G, Pesin M, Sher A. 2000. Cutting edge: IL-12 is required for the maintenance 
of IFN-gamma production in T cells mediating chronic resistance to the 
intracellular pathogen, Toxoplasma gondii. Journal of immunology (Baltimore, Md : 
1950). 165(2):628-31. 
155 Innes EA, Panton WR, Marks J, Trees AJ, Holmdahl J, Buxton D. 1995. Interferon 
gamma inhibits the intracellular multiplication of Neospora caninum, as shown by 
incorporation of 3H uracil. Journal of Comparative Pathology. 113(1):95-100. 
156 Khan IA, Schwartzman JD, Fonseka S, Kasper LH. 1997. Neospora caninum: role 
for immune cytokines in host immunity. Exp Parasitol. 85(1):24-34. 
157 Baszler TV, Long MT, McElwain TF. 1999. Interferon-γ and interleukin-12 mediate 
protection to acute Neospora caninum infection in BALB/c mice. Int J Parasitol. 
29(10):1635-46. 
158 Nishikawa Y, Tragoolpua K, Inoue N, Makala L, Nagasawa H, Otsuka H, et al. 
2001. In the absence of endogenous gamma interferon, mice acutely infected with 
Neospora caninum succumb to a lethal immune response characterized by 
inactivation of peritoneal macrophages. Clin Diagn Lab Immunol. 8(4):811-6. 
159 Mineo TW, Benevides L, Silva NM, Silva JS. 2009. Myeloid differentiation factor 88 
is required for resistance to Neospora caninum infection. Vet Res. 40(4):32. 
160 Ritter DM, Kerlin R, Sibert G, Brake D. 2002. Immune factors influencing the 
course of infection with Neospora caninum in the murine host. The Journal of 
parasitology. 88(2):271-80. 
161 Botelho AS, Teixeira L, Correia-da-Costa JM, Faustino AM, Castro AG, Vilanova 
M. 2007. Neospora caninum: high susceptibility to the parasite in C57BL/10ScCr 
mice. Exp Parasitol. 115(1):68-75. 
162 Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate 
immunity. Cell. 124(4):783-801. 
 52 
 
163 Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. 
Biochem Biophys Res Commun. 388(4):621-5. 
164 Kumar H, Kawai T, Akira S. 2009. Pathogen recognition in the innate immune 
response. Biochem J. 420(1):1-16. 
165 Mineo TW, Oliveira CJ, Gutierrez FR, Silva JSS. 2010. Recognition by Toll-like 
receptor 2 induces antigen-presenting cell activation and Th1 programming during 
infection by Neospora caninum. Immunology and Cell Biology. 88(8):825-33. 
166 Strohbusch M, Müller N, Hemphill A, Margos M, Grandgirard D, Leib S, et al. 2009. 
Neospora caninum and bone marrow-derived dendritic cells: parasite survival, 
proliferation, and induction of cytokine expression. Parasite Immunology. 
31(7):366-72. 
167 Dion S, Germon S, Guiton R, Ducournau C, Dimier-Poisson I. 2011. Functional 
activation of T cells by dendritic cells and macrophages exposed to the 
intracellular parasite Neospora caninum. International Journal for Parasitology. 
41(6):685-95. 
168 Merad M, Sathe P, Helft J, Miller J, Mortha A. 2013. The dendritic cell lineage: 
ontogeny and function of dendritic cells and their subsets in the steady state and 
the inflamed setting. Annu Rev Immunol. 31:563-604. 
169 Schraml BU, Reis e Sousa C. 2015. Defining dendritic cells. Curr Opin Immunol. 
32:13-20. 
170 Teixeira L, Botelho AS, Mesquita SD, Correia A, Cerca F, Costa R, et al. 2010. 
Plasmacytoid and conventional dendritic cells are early producers of IL-12 in 
Neospora caninum-infected mice. Immunol Cell Biol. 88(1):79-86. 
171 Grandi G, Genchi C, Bazzocchi C, Mortarino M, Borghetti P, De Angelis E, et al. 
2008. Generation and infection of bovine PBMC-derived dendritic cells with 
Neospora caninum. Veterinary research communications. 32(Suppl):1-9. 
172 Collantes-Fernandez E, Arrighi RB, Alvarez-García G, Weidner JM, Regidor-
Cerrillo J, Boothroyd JC, et al. 2012. Infected dendritic cells facilitate systemic 
dissemination and transplacental passage of the obligate intracellular parasite 
Neospora caninum in mice. PLoS One. 7(3): e32123. 
173 Flynn RJ, Marshall ES. 2011. Parasite limiting macrophages promote IL-17 
secretion in naive bovine CD4⁺ T-cells during Neospora caninum infection. 
Veterinary immunology and immunopathology. 144(3-4):423-9. 
174 Jesus EE, Pinheiro AM, Santos AB, Freire SM, Tardy MB, El-Bachá RS, et al. 
2013. Effects of IFN-γ, TNF-α, IL-10 and TGF-β on Neospora caninum infection in 
rat glial cells. Experimental Parasitology. 133(3):269-74. 
175 Yamane I, Kitani H, Kokuho T, Shibahara T, Haritani M, Hamaoka T, et al. 2000. 
The inhibitory effect of interferon gamma and tumor necrosis factor alpha on 
intracellular multiplication of Neospora caninum in primary bovine brain cells. The 
Journal of veterinary medical science / the Japanese Society of Veterinary 
Science. 62(3):347-51. 
176 Abe C, Tanaka S, Ihara F, Nishikawa Y. 2014. Macrophage depletion prior to 
Neospora caninum infection results in severe neosporosis in mice. Clinical and 
vaccine immunology : CVI. 21(8):1185-8. 
177 Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. 2008. Functions of natural 
killer cells. Nat Immunol. 9(5):503-10. 
 53 
 
178 Boysen P, Klevar S, Olsen I, Storset AK. 2006. The Protozoan Neospora caninum 
Directly Triggers Bovine NK Cells To Produce Gamma Interferon and To Kill 
Infected Fibroblasts. Infection and Immunity. 74(2):953960. 
179 Klevar S, Kulberg S, Boysen P, Storset AK. 2007. Natural killer cells act as early 
responders in an experimental infection with Neospora caninum in calves. Int J 
Parasitol 37(3-4):329-39. 
180 Tanaka T, Hamada T, Inoue N, Nagasawa H, Fujisaki K, Suzuki N, et al. 2000. 
The role of CD4(+) or CD8(+) T cells in the protective immune response of BALB/c 
mice to Neospora caninum infection. Vet Parasitol. 90(3):183-91. 
181 Marks J, Lunden A, Harkins D, Innes E. 1998. Identification of Neospora antigens 
recognized by CD4+ T cells and immune sera from experimentally infected cattle. 
Parasite Immunol. 20(7):303-9. 
182 Andrianarivo A, Barr B, Anderson M, Rowe J, Packham A, Sverlow K, et al. 2001. 
Immune responses in pregnant cattle and bovine fetuses following experimental 
infection with Neospora caninum. Parasitology Research. 87(10):817-25. 
183 Rosbottom A, Guy CS, Gibney EH, Smith RF, Valarcher JF, Taylor G, et al. 2007. 
Peripheral immune responses in pregnant cattle following Neospora caninum 
infection. Parasite Immunology. 29(4):219-28. 
184 Lundén A, Marks J, Maley SW, Innes EA. 1998. Cellular immune responses in 
cattle experimentally infected with Neospora caninum. Parasite Immunology. 
20(11):519-26. 
185 Innes EA, Wright SE, Maley S, Rae A, Schock A, Kirvar E, et al. 2001. Protection 
against vertical transmission in bovine neosporosis. International Journal for 
Parasitology. 31(13):1523-34. 
186 Staska LM, McGuire TC, Davies CJ, Lewin HA, Baszler TV. 2003. Neospora 
caninum-infected cattle develop parasite-specific CD4+ cytotoxic T lymphocytes. 
Infection and Immunity. 71(6):3272-9. 
187 Correia A, Ferreirinha P, Botelho S, Belinha A, Leitao C, Caramalho I, et al. 2015. 
Predominant role of interferon-gamma in the host protective effect of CD8(+) T 
cells against Neospora caninum infection. Sci Rep. 5:14913. 
188 Spencer JA, Higginbotham MJ, Young-White RR, Guarino AJ, Blagburn BL. 2005. 
Neospora caninum: adoptive transfer of immune lymphocytes precipitates disease 
in BALB/c mice. Veterinary immunology and immunopathology. 106(3-4):329-33. 
189 Eperon S, Bronnimann K, Hemphill A, Gottstein B. 1999. Susceptibility of B-cell 
deficient C57BL/6 (microMT) mice to Neospora caninum infection. Parasite 
Immunol. 21(5):225-36. 
190 Teixeira L, Marques A, Meireles CS, Seabra AR, Rodrigues D, Madureira P, et al. 
2005. Characterization of the B-cell immune response elicited in BALB/c mice 
challenged with Neospora caninum tachyzoites. Immunology. 116(1):38-52. 
191 Nicole J, Stefan SW, Annette O. 2011. Antibody-Fc receptor interactions in 
protection against intracellular pathogens. European journal of immunology. 
41(4):889-97. 
192 Naguleswaran A, Alaeddine F, Guionaud C, Vonlaufen N, Sonda S, Jenoe P, et al. 
2005. Neospora caninum protein disulfide isomerase is involved in tachyzoite-host 
cell interaction. International Journal for Parasitology. 35(13):1459-72. 
193 Raghupathy R. 1997. Th 1-type immunity is incompatible with successful 
pregnancy. Immunology Today. 18(10):478-82. 
 54 
 
194 Szekeres-Bartho J. 2002. Immunological relationship between the mother and the 
fetus. International reviews of immunology. 21(6):471-95. 
195 Mor G, Cardenas I. 2010. The immune system in pregnancy: a unique complexity. 
American journal of reproductive immunology (New York, NY : 1989). 63(6):425-
33. 
196 Piccinni M-PP. 2003. Role of immune cells in pregnancy. Autoimmunity. 36(1):1-4. 
197 Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG. 1990. Control 
of fetal survival in CBA× DBA/2 mice by lymphokine therapy. Journal of 
reproduction and fertility. 89(2):447-58. 
198 Innes EA. 2007. The host-parasite relationship in pregnant cattle infected with 
Neospora caninum. Parasitology. 134(Pt 13):1903-10. 
199 Lopez-Gatius F, Almeria S, Donofrio G, Nogareda C. 2007. Protection against 
abortion linked to gamma interferon production in pregnant dairy cows naturally 
infected with Neospora caninum. Theriogenology. 68(7):1067-73. 
200 Quinn HE, Miller CM, Ellis JT. 2004. The cell-mediated immune response to 
Neospora caninum during pregnancy in the mouse is associated with a bias 
towards production of interleukin-4. International Journal for Parasitology. 
34(6):723-32. 
201 Kano R, Masukata Y, Omata Y, Kobayashi Y, Maeda R, Saito A. 2005. 
Relationship between type 1/type 2 immune responses and occurrence of vertical 
transmission in BALB/c mice infected with Neospora caninum. Veterinary 
Parasitology. 129(1-2):159-64. 
202 López-Pérez IC, Risco-Castillo V, Collantes-Fernández E, Ortega-Mora LM. 2006. 
Comparative effect of Neospora caninum infection in BALB/c mice at three 
different gestation periods. The Journal of parasitology. 92(6):1286-91. 
203 López-Pérez IC, Collantes-Fernández E, Aguado-Martínez A, Rodríguez-Bertos A, 
Ortega-Mora LM. 2008. Influence of Neospora caninum infection in BALB/c mice 
during pregnancy in post-natal development. Veterinary Parasitology. 155(3-
4):175-83. 
204 Williams DJ, Guy CS, McGarry JW, Guy F, Tasker L, Smith RF, et al. 2000. 
Neospora caninum-associated abortion in cattle: the time of experimentally-
induced parasitaemia during gestation determines foetal survival. Parasitology. 
121 ( Pt 4):347-58. 
205 Almeria S, De Marez T, Dawson H, Araujo R, Dubey JP, Gasbarre LC. 2003. 
Cytokine gene expression in dams and foetuses after experimental Neospora 
caninum infection of heifers at 110 days of gestation. Parasite Immunology. 
25(7):383-92. 
206 Bartley PM, Kirvar E, Wright S, Swales C, Esteban-Redondo I, Buxton D, et al. 
2004. Maternal and fetal immune responses of cattle inoculated with Neospora 
caninum at mid-gestation. Journal of Comparative Pathology. 130(2-3):81-91. 
207 Rosbottom A, Gibney EH, Guy CS, Kipar A, Smith RF, Kaiser P, et al. 2008. 
Upregulation of cytokines is detected in the placentas of cattle infected with 
Neospora caninum and is more marked early in gestation when fetal death is 
observed. Infect Immun. 76(6):2352-61. 
208 Almería S, Araujo R, Tuo W, López-Gatius F, Dubey JP, Gasbarre LC. 2010. Fetal 
death in cows experimentally infected with Neospora caninum at 110 days of 
gestation. Veterinary Parasitology. 169(3-4):304-11. 
 55 
 
209 Bartley PM, Wright SE, Maley SW, Macaldowie CN, Nath M, Hamilton CM, et al. 
2012. Maternal and foetal immune responses of cattle following an experimental 
challenge with Neospora caninum at day 70 of gestation. Veterinary research. 
43:38. 
210 Bartley PM, Katzer F, Rocchi MS, Maley SW, Benavides J, Nath M, et al. 2013. 
Development of maternal and foetal immune responses in cattle following 
experimental challenge with Neospora caninum at day 210 of gestation. Veterinary 
research. 44:91. 
211 Cantón GJJ, Katzer F, Maley SW, Bartley PM, Benavides-Silván J, Palarea-
Albaladejo J, et al. 2014. Cytokine expression in the placenta of pregnant cattle 
after inoculation with Neospora caninum. Veterinary immunology and 
immunopathology. 161(1-2):77-89. 
212 Benavides J, Katzer F, Maley SW, Bartley PM, Cantón G, Palarea-Albaladejo J, et 
al. 2012. High rate of transplacental infection and transmission of Neospora 
caninum following experimental challenge of cattle at day 210 of gestation. 
Veterinary research. 43:83. 
213 Jensen J, Rubino M, Yang WC, Cooley AJ. 1988. Ontogeny of mitogen responsive 
lymphocytes in the bovine fetus. Dev Comp Immunol. 12(3):685-92. 
214 Romero JJ, Perez E, Dolz G, Frankena K. 2002. Factors associated with 
Neospora caninum serostatus in cattle of 20 specialised Costa Rican dairy herds. 
Preventive veterinary medicine. 53(4):263-73. 
215 Williams DJL, Guy CS, Smith RF, Guy F. 2003. First demonstration of protective 
immunity against foetopathy in cattle with latent Neospora caninum infection. Int J 
Parasitol. 33(10):1059-65. 
216 Long MT, Baszler TV. 2000. Neutralization of maternal IL-4 modulates congenital 
protozoal transmission: comparison of innate versus acquired immune responses. 
J Immunol. 164(9):4768-74. 
217 Monney T, Debache K, Hemphill A. 2011. Vaccines against a major cause of 
abortion in cattle, Neospora caninum infection. Animals. 1(3):306-25. 
218 Lunden A, Wright S, Allen JE, Buxton D. 2002. Immunisation of mice against 
neosporosis. Int J Parasitol. 32(7):867-76. 
219 Bartley PM, Wright S, Chianini F, Buxton D, Innes EA. 2008. Inoculation of Balb/c 
mice with live attenuated tachyzoites protects against a lethal challenge of 
Neospora caninum. Parasitology. 135(Pt 1):13-21. 
220 Ramamoorthy S, Lindsay DS, Schurig GG, Boyle SM, Duncan RB, Vemulapalli R, 
et al. 2006. Vaccination with gamma-irradiated Neospora caninum tachyzoites 
protects mice against acute challenge with N. caninum. J Eukaryot Microbiol. 
53(2):151-6. 
221 Weber FH, Jackson JA, Sobecki B, Choromanski L, Olsen M, Meinert T, et al. 
2013. On the efficacy and safety of vaccination with live tachyzoites of Neospora 
caninum for prevention of neospora-associated fetal loss in cattle. Clinical and 
vaccine immunology : CVI. 20(1):99-105. 
222 Rojo-Montejo S, Collantes-Fernández E, Pérez-Zaballos F, Rodríguez-Marcos S, 
Blanco-Murcia J, Rodríguez-Bertos A, et al. 2013. Effect of vaccination of cattle 
with the low virulence Nc-Spain 1H isolate of Neospora caninum against a 
heterologous challenge in early and mid-gestation. Vet Res. 44:106. 
 56 
 
223 Ellis J, Miller C, Quinn H, Ryce C, Reichel MP. 2008. Evaluation of recombinant 
proteins of Neospora caninum as vaccine candidates (in a mouse model). 
Vaccine. 26(47):5989-96. 
224 Rojo-Montejo S, Collantes-Fernández E, López-Pérez I, Risco-Castillo V, 
Prenafeta A, Ortega-Mora LM. 2012. Evaluation of the protection conferred by a 
naturally attenuated Neospora caninum isolate against congenital and cerebral 
neosporosis in mice. Veterinary research. 43:62. 
225 Miller C, Quinn H, Ryce C, Reichel MP, Ellis JT. 2005. Reduction in transplacental 
transmission of Neospora caninum in outbred mice by vaccination. Int J Parasitol. 
35(7):821-8. 
226 Williams DJ, Guy CS, Smith RF, Ellis J, Bjorkman C, Reichel MP, et al. 2007. 
Immunization of cattle with live tachyzoites of Neospora caninum confers 
protection against fetal death. Infect Immun. 75(3):1343-8. 
227 Hecker YP, Moore DP, Quattrocchi V, Regidor-Cerrillo J, Verna A, Leunda MR, et 
al. 2013. Immune response and protection provided by live tachyzoites and native 
antigens from the NC-6 Argentina strain of Neospora caninum in pregnant heifers. 
Veterinary Parasitology. 197(3-4):436-46. 
228 Mazuz ML, Fish L, Wolkomirsky R, Leibovich B, Reznikov D, Savitsky I, et al. 
2015. The effect of a live Neospora caninum tachyzoite vaccine in naturally 
infected pregnant dairy cows. Preventive veterinary medicine. 120(2):232-5. 
229 Buxton D. 1993. Toxoplasmosis: the first commercial vaccine. Parasitology Today. 
9(9):335-7. 
230 Reichel MP, Moore DP, Hemphill A, Ortega-Mora LM, Dubey JP, Ellis JT. 2015. A 
live vaccine against Neospora caninum abortions in cattle. Vaccine. 33(11):1299-
301. 
231 Andrianarivo AG, Choromanski L, McDonough SP, Packham AE, Conrad PA. 
1999. Immunogenicity of a killed whole Neospora caninum tachyzoite preparation 
formulated with different adjuvants. International Journal for Parasitology. 
29(10):1613-25. 
232 Liddell S, Jenkins MC, Collica CM, Dubey JP. 1999. Prevention of vertical transfer 
of Neospora caninum in BALB/c mice by vaccination. J Parasitol. 85(6):1072-5. 
233 Mansilla FC, Franco-Mahecha OL, Lavoria MÁÁ, Moore DPP, Giraldez ANN, 
Iglesias ME, et al. 2012. The immune enhancement of a novel soy lecithin/β-
glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in 
mice. Vaccine. 30(6):1124-31. 
234 Debache K, Hemphill A. 2012. Intra-cisternal vaccination induces high-level 
protection against Neospora caninum infection in mice. Vaccine. 30(28):4209-15. 
235 Rojo-Montejo S, Collantes-Fernández E, Regidor-Cerrillo J, Rodríguez-Bertos A, 
Prenafeta A, Gomez-Bautista M, et al. 2011. Influence of adjuvant and antigen 
dose on protection induced by an inactivated whole vaccine against Neospora 
caninum infection in mice. Veterinary Parasitology. 175(3-4):220-9. 
236 Ribeiro DP, Freitas MM, Cardoso MR, Pajuaba AC, Silva NM, Mineo TW, et al. 
2009. CpG-ODN combined with Neospora caninum lysate, but not with excreted-
secreted antigen, enhances protection against infection in mice. Vaccine. 
27(19):2570-9. 
237 Moore DP, Echaide I, Verna AE, Leunda MR, Cano A, Pereyra S, et al. 2011. 
Immune response to Neospora caninum native antigens formulated with immune 
stimulating complexes in calves. Veterinary Parasitology. 175(3-4):245-51. 
 57 
 
238 Andrianarivo AGG, Anderson ML, Rowe JD, Gardner IA, Reynolds JP, 
Choromanski L, et al. 2005. Immune responses during pregnancy in heifers 
naturally infected with Neospora caninum with and without immunization. 
Parasitology Research. 96(1):24-31. 
239 Andrianarivo AG, Rowe JD, Barr BC, Anderson ML, Packham AE, Sverlow KW, et 
al. 2000. A POLYGEN-adjuvanted killed Neospora caninum tachyzoite preparation 
failed to prevent foetal infection in pregnant cattle following i.v./i.m. experimental 
tachyzoite challenge. Int J Parasitol. 30(9):985-90. 
240 Rojo-Montejo S, Collantes-Fernández E, Rodríguez-Marcos S, Pérez-Zaballos F, 
López-Pérez I, Prenafeta A, et al. 2011. Comparative efficacy of immunization with 
inactivated whole tachyzoites versus a tachyzoite-bradyzoite mixture against 
neosporosis in mice. Parasitology. 138(11):1372-83. 
241 Baszler TV, McElwain TF, Mathison BA. 2000. Immunization of BALB/c mice with 
killed Neospora caninum tachyzoite antigen induces a type 2 immune response 
and exacerbates encephalitis and neurological disease. Clin Diagn Lab Immunol. 
7(6):893-8. 
242 Yoshimoto M, Otsuki T, Itagaki K, Kato T, Kohsaka T, Matsumoto Y, et al. 2015. 
Evaluation of recombinant Neospora caninum antigens purified from silkworm 
larvae for the protection of N. caninum infection in mice. Journal of bioscience and 
bioengineering. 120(6):715-9 
243 Haldorson GJ, Mathison BA, Wenberg K, Conrad PA, Dubey JP, Trees AJ, et al. 
2005. Immunization with native surface protein NcSRS2 induces a Th2 immune 
response and reduces congenital Neospora caninum transmission in mice. 
International Journal for Parasitology. 35(13):1407-15. 
244 Pinitkiatisakul S, Mattsson JG, Wikman M, Friedman M, Bengtsson KL, Stahl S, et 
al. 2005. Immunisation of mice against neosporosis with recombinant NcSRS2 
iscoms. Vet Parasitol. 129(1-2):25-34. 
245 Pinitkiatisakul S, Friedman M, Wikman M, Mattsson JG. 2007. Immunogenicity and 
protective effect against murine cerebral neosporosis of recombinant NcSRS2 in 
different iscom formulations. Vaccine. 25(18):3658-68. 
246 Tuo W, Zhao Y, Zhu D, Jenkins MC. 2011. Immunization of female BALB/c mice 
with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and 
prevents against challenge infection by Neospora caninum. Vaccine. 29(13):2392-
9. 
247 Cannas A, Naguleswaran A, Muller N, Eperon S, Gottstein B, Hemphill A. 2003. 
Vaccination of mice against experimental Neospora caninum infection using 
NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. 
Parasitology. 126(Pt 4):303-12. 
248 Cannas A, Naguleswaran A, Muller N, Gottstein B, Hemphill A. 2003. Reduced 
cerebral infection of Neospora caninum-infected mice after vaccination with 
recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol. 89(1):44-
50. 
249 Alaeddine F, Keller N, Leepin A, Hemphill A. 2005. Reduced infection and 
protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated 
with recombinant microneme antigen NcMIC1. J Parasitol. 91(3):657-65. 
250 Zhang H, Nishikawa Y, Yamagishi J, Zhou J, Ikehara Y, Kojima N, et al. 2010. 
Neospora caninum: application of apical membrane antigen 1 encapsulated in the 
oligomannose-coated liposomes for reduction of offspring mortality from infection 
in BALB/c mice. Experimental Parasitology. 125(2):130-6. 
 58 
 
251 Debache K, Guionaud C, Alaeddine F, Mevissen M, Hemphill A. 2008. Vaccination 
of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection 
in mice infected with Neospora caninum tachyzoites. Int J Parasitol. 38(12):1455-
63. 
252 Debache K, Guionaud C, Alaeddine F, Hemphill A. 2010. Intraperitoneal and intra-
nasal vaccination of mice with three distinct recombinant Neospora caninum 
antigens results in differential effects with regard to protection against 
experimental challenge with Neospora caninum tachyzoites. Parasitology. 
137(2):229-40. 
253 Thierry M, David R, Michelle S, Karim D, Denis G, Stephen LL, et al. 2011. 
RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects 
against acute neosporosis and limits cerebral parasite load in the mouse model for 
Neospora caninum infection. Vaccine. 29(40):6967-75. 
254 Alvarez-Garcia G, Pitarch A, Zaballos A, Fernandez-Garcia A, Gil C, Gomez-
Bautista M, et al. 2007. The NcGRA7 gene encodes the immunodominant 17 kDa 
antigen of Neospora caninum. Parasitology. 134(Pt 1):41-50. 
255 Nishikawa Y, Zhang H, Ikehara Y, Kojima N, Xuan X, Yokoyama N. 2009. 
Immunization with oligomannose-coated liposome-entrapped dense granule 
protein 7 protects dams and offspring from Neospora caninum infection in mice. 
Clinical and Vaccine Immunology. 16(6):792-7. 
256 Nishimura M, Kohara J, Kuroda Y, Hiasa J, Tanaka S, Muroi Y, et al. 2013. 
Oligomannose-coated liposome-entrapped dense granule protein 7 induces 
protective immune response to Neospora caninum in cattle. Vaccine. 31(35):3528-
35. 
257 Aguado-Martínez A, Alvarez-García G, Fernández-García A, Risco-Castillo V, 
Marugán-Hernández V, Ortega-Mora LM. 2009. Failure of a vaccine using 
immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis 
in mice. Vaccine. 27(52):7331-8. 
258 Hecker YP, Cóceres V, Wilkowsky SE, Jaramillo Ortiz JMM, Morrell EL, Verna AE, 
et al. 2014. A Neospora caninum vaccine using recombinant proteins fails to 
prevent foetal infection in pregnant cattle after experimental intravenous challenge. 
Veterinary immunology and immunopathology. 162(3-4):142-53. 
259 Uchida M, Nagashima K, Akatsuka Y, Murakami T, Ito A, Imai S, et al. 2013. 
Comparative study of protective activities of Neospora caninum bradyzoite 
antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute 
parasitic infection. Parasitology Research. 112(2):655-63. 
260 Jiménez-Ruiz E, Alvarez-García G, Aguado-Martínez A, Salman H, Irache JM, 
Marugán-Hernández V, et al. 2012. Low efficacy of NcGRA7, NcSAG4, NcBSR4 
and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum 
infection in mice. Vaccine. 30(33):4983-92. 
261 Debache K, Kropf C, Schutz CA, Harwood LJ, Kauper P, Monney T, et al. 2011. 
Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against 
challenge infection with Neospora caninum tachyzoites. Parasite Immunol. 
33(2):81-94. 
262 Debache K, Hemphill A. 2013. Differential effects of intranasal vaccination with 
recombinant NcPDI in different mouse models of Neospora caninum infection. 
Parasite Immunol. 35(1):11-20. 
 59 
 
263 Monney T, Grandgirard D, Leib SL, Hemphill A. 2013. Use of a Th1 Stimulator 
Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant 
Mouse Model. Pathogens (Basel, Switzerland). 2(2):193-208. 
264 Monney T, Debache K, Grandgirard D, Leib SL, Hemphill A. 2012. Vaccination 
with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective 
Th2-type immune response in the pregnant mouse model for N. caninum infection. 
Vaccine. 30(46):6588-94. 
265 Brandtzaeg P. 2007. Induction of secretory immunity and memory at mucosal 
surfaces. Vaccine. 25(30):5467-84. 
266 Brandtzaeg P. 2009. Mucosal immunity: induction, dissemination, and effector 
functions. Scandinavian journal of immunology. 70(6):505-15. 
267 Suzuki K, Kawamoto S, Maruya M, Fagarasan S. 2010. GALT: organization and 
dynamics leading to IgA synthesis. Advances in immunology. 107:153-85. 
268 Moens E, Veldhoen M. 2012. Epithelial barrier biology: good fences make good 
neighbours. Immunology. 135(1):1-8. 
269 Cesta MF. 2006. Normal structure, function, and histology of mucosa-associated 
lymphoid tissue. Toxicologic pathology. 34(5):599-608. 
270 Brandtzaeg P, Kiyono H, Pabst R, Russell MW. 2008. Terminology: nomenclature 
of mucosa-associated lymphoid tissue. Mucosal immunology. 1(1):31-7. 
271 Serge AvdP, Reina EM. 2010. New insights into the development of lymphoid 
tissues. Nature Reviews Immunology. 10(9):664-74. 
272 Linden SK, Sutton P, Karlsson NG, Korolik V. 2008. Mucins in the mucosal barrier 
to infection. Mucosal Immunol. 1(3):183-97. 
273 Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. 2013. Microfold (M) 
cells: important immunosurveillance posts in the intestinal epithelium. Mucosal 
immunology. 6(4):666-77. 
274 Maynard CL, Elson CO, Hatton RD, Weaver CT. 2012. Reciprocal interactions of 
the intestinal microbiota and immune system. Nature. 489(7415):231-41. 
275 Lügering A, Kucharzik T. 2006. Induction of intestinal lymphoid tissue: the role of 
cryptopatches. Annals of the New York Academy of Sciences. 1072:210-7. 
276 Satoshi U, Kosuke F, Myoung Ho J, Bo-Gie Y, Yun-Jae J, Mika N, et al. 2008. 
Regulation of humoral and cellular gut immunity by lamina propria dendritic cells 
expressing Toll-like receptor 5. Nature immunology. 9(7):769-76. 
277 Gross M, Salame T-MM, Jung S. 2015. Guardians of the Gut - Murine Intestinal 
Macrophages and Dendritic Cells. Frontiers in immunology. 6:254. 
278 Persson EK, Jaensson E, Agace WW. 2010. The diverse ontogeny and function of 
murine small intestinal dendritic cell/macrophage subsets. Immunobiology. 215(9-
10):692-7. 
279 Bekiaris V, Persson EK, Agace WW. 2014. Intestinal dendritic cells in the 
regulation of mucosal immunity. Immunological reviews. 260(1):86-101. 
280 Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, et al. 2009. 
Intestinal lamina propria dendritic cell subsets have different origin and functions. 
Immunity. 31(3):502-12. 
281 Rescigno M, Urbano M, Valzasina B, Francolini M. 2001. Dendritic cells express 
tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. 
Nat Immunol. 2(4):361-7. 
 60 
 
282 Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, et al. 2005. 
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial 
clearance. Science (New York, NY). 307(5707):254-8. 
283 Schulz O, Jaensson E, Persson EK, Liu X. 2009. Intestinal CD103+, but not 
CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic 
cell functions. J Exp Med. 206(13):3101-14. 
284 Farache J, Koren I, Milo I, Gurevich I, Kim KW. 2013. Luminal bacteria recruit 
CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens 
for presentation. Immunity. 38(3):581-95. 
285 Johansson-Lindbom B, Svensson M, Pabst O, Palmqvist C, Marquez G, Förster R, 
et al. 2005. Functional specialization of gut CD103+ dendritic cells in the regulation 
of tissue-selective T cell homing. The Journal of experimental medicine. 
202(8):1063-73. 
286 Worbs T, Bode U, Yan S, Hoffmann MW. 2006. Oral tolerance originates in the 
intestinal immune system and relies on antigen carriage by dendritic cells. J Exp 
Med. 203(3):519-27. 
287 Jaensson-Gyllenbäck E, Kotarsky K, Zapata F, Persson EK, Gundersen TE, 
Blomhoff R, et al. 2011. Bile retinoids imprint intestinal CD103+ dendritic cells with 
the ability to generate gut-tropic T cells. Mucosal immunology. 4(4):438-47. 
288 Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song S-YY. 2004. 
Retinoic acid imprints gut-homing specificity on T cells. Immunity. 21(4):527-38. 
289 Campbell DJ, Butcher EC. 2002. Rapid acquisition of tissue-specific homing 
phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. 
The Journal of experimental medicine. 195(1):135-41. 
290 Fujimoto K, Karuppuchamy T, Takemura N, Shimohigoshi M, Machida T, Haseda 
Y, et al. 2011. A new subset of CD103+CD8alpha+ dendritic cells in the small 
intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL 
activity. Journal of immunology (Baltimore, Md : 1950). 186(11):6287-95. 
291 Uematsu S, Fujimoto K, Jang MH, Yang B-GG, Jung Y-JJ, Nishiyama M, et al. 
2008. Regulation of humoral and cellular gut immunity by lamina propria dendritic 
cells expressing Toll-like receptor 5. Nature immunology. 9(7):769-76. 
292 Janine LC, Karima RRS, Carolina VA-C, Jason H, Cheng-Ming S, Yasmine B, et 
al. 2007. A functionally specialized population of mucosal CD103+ DCs induces 
Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism. 
The Journal of experimental medicine. 204(8):1757-64. 
293 Sheridan BS, Lefrançois L. 2010. Intraepithelial lymphocytes: to serve and protect. 
Current gastroenterology reports. 12(6):513-21. 
294 Cheroutre H, Lambolez F, Mucida D. 2011. The light and dark sides of intestinal 
intraepithelial lymphocytes. Nature reviews Immunology. 11(7):445-56. 
295 Qiu Y, Yang H. 2013. Effects of intraepithelial lymphocyte-derived cytokines on 
intestinal mucosal barrier function. Journal of interferon & cytokine research : the 
official journal of the International Society for Interferon and Cytokine Research. 
33(10):551-62. 
296 Qiu Y, Yang Y, Yang H. 2014. The unique surface molecules on intestinal 
intraepithelial lymphocytes: from tethering to recognizing. Digestive diseases and 
sciences. 59(3):520-9. 
297 Witherden DA, Havran WL. 2013. Cross-talk between intraepithelial γδ T cells and 
epithelial cells. Journal of leukocyte biology. 94(1):69-76. 
 61 
 
298 Arstila T, Arstila TP, Calbo S, Selz F, Malassis-Seris M, Vassalli P, et al. 2000. 
Identical T cell clones are located within the mouse gut epithelium and lamina 
propia and circulate in the thoracic duct lymph. The Journal of experimental 
medicine. 191(5):823-34. 
299 Staton TL, Habtezion A, Winslow MM, Sato T, Love PE, Butcher EC. 2006. CD8+ 
recent thymic emigrants home to and efficiently repopulate the small intestine 
epithelium. Nature immunology. 7(5):482-8. 
300 Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL, et al. 1994. 
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and 
the alpha E beta 7 integrin. Nature. 372(6502):190-3. 
301 Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, Lefrançois L. 
2004. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity. 
20(5):551-62. 
302 Masopust D, Vezys V, Wherry EJ, Barber DL, Ahmed R. 2006. Cutting edge: gut 
microenvironment promotes differentiation of a unique memory CD8 T cell 
population. Journal of immunology (Baltimore, Md : 1950). 176(4):2079-83. 
303 Lepage AC, Buzoni-Gatel D, Bout DT, Kasper LH. 1998. Gut-derived intraepithelial 
lymphocytes induce long term immunity against Toxoplasma gondii. Journal of 
immunology (Baltimore, Md : 1950). 161(9):4902-8. 
304 Roberts SJ, Smith AL, West AB, Wen L, Findly RC, Owen MJ, et al. 1996. T-cell 
alpha beta + and gamma delta + deficient mice display abnormal but distinct 
phenotypes toward a natural, widespread infection of the intestinal epithelium. 
Proceedings of the National Academy of Sciences of the United States of America. 
93(21):11774-9. 
305 Dalton JE, Cruickshank SM, Egan CE, Mears R, Newton DJ, Andrew EM, et al. 
2006. Intraepithelial gammadelta+ lymphocytes maintain the integrity of intestinal 
epithelial tight junctions in response to infection. Gastroenterology. 131(3):818-29. 
306 Cerutti A, Chen K, Chorny A. 2011. Immunoglobulin responses at the mucosal 
interface. Annu Rev Immunol. 29:273-93. 
307 Brandtzaeg P. 2013. Secretory IgA: Designed for Anti-Microbial Defense. Frontiers 
in immunology. 4:222. 
308 Andrew JM, Markus BG, Emma S, Siegfried H, Kathy DM. 2012. The habitat, 
double life, citizenship, and forgetfulness of IgA. Immunological reviews. 
245(1):132-46. 
309 Gutzeit C, Magri G, Cerutti A. 2014. Intestinal IgA production and its role in host-
microbe interaction. Immunological reviews. 260(1):76-85. 
310 Suzuki K, Nakajima A. 2014. New aspects of IgA synthesis in the gut. International 
immunology. 26(9):489-94. 
311 Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel 
RM. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA 
responses to commensal bacteria. Science (New York, NY). 288(5474):2222-6. 
312 Cerutti A, Kang C, Alejo C. 2011. Immunoglobulin Responses at the Mucosal 
Interface. Immunology. 29:273-93. 
313 Tsuji M, Komatsu N, Kawamoto S, Suzuki K, Kanagawa O, Honjo T, et al. 2009. 
Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut 
Peyer's patches. Science (New York, NY). 323(5920):1488-92. 
 62 
 
314 Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. 2009. A dominant, 
coordinated T regulatory cell-IgA response to the intestinal microbiota. 
Proceedings of the National Academy of Sciences of the United States of America. 
106(46):19256-61. 
315 Cazac BB, Roes J. 2000. TGF-beta receptor controls B cell responsiveness and 
induction of IgA in vivo. Immunity. 13(4):443-51. 
316 Pabst O. 2012. New concepts in the generation and functions of IgA. Nature 
reviews Immunology. 12(12):821-32. 
317 Wei M, Shinkura R, Doi Y, Maruya M, Fagarasan S, Honjo T. 2011. Mice carrying 
a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have 
impaired gut homeostasis and compromised mucosal defense. Nature 
immunology. 12(3):264-70. 
318 Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov II, et al. 2008. 
Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T 
cell-independent immunoglobulin A generation in the gut. Immunity. 29(2):261-71. 
319 Macpherson AJ, Uhr T. 2004. Induction of protective IgA by intestinal dendritic 
cells carrying commensal bacteria. Science (New York, NY). 303(5664):1662-5. 
320 Mora JR, Iwata M, Eksteen B, Song S-YY, Junt T, Senman B, et al. 2006. 
Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. 
Science (New York, NY). 314(5802):1157-60. 
321 Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, et al. 2002. DCs 
induce CD40-independent immunoglobulin class switching through BLyS and 
APRIL. Nature immunology. 3(9):822-9. 
322 Bos NA, Bun JC, Popma SH, Cebra ER. 1996. Monoclonal immunoglobulin A 
derived from peritoneal B cells is encoded by both germ line and somatically 
mutated VH genes and is reactive with commensal …. Infect Immun. 64(2):616-23. 
323 Mantis NJ, Rol N, Corthésy B. 2011. Secretory IgA's complex roles in immunity 
and mucosal homeostasis in the gut. Mucosal immunology. 4(6):603-11. 
324 Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, et al. 
2010. Reversible microbial colonization of germ-free mice reveals the dynamics of 
IgA immune responses. Science (New York, NY). 328(5986):1705-9. 
325 Nils L. 2012. Recent progress in mucosal vaccine development: potential and 
limitations. Nature Reviews Immunology. 12(8):592-605. 
326 Lycke N, Holmgren J. 1989. Adoptive transfer of gut mucosal antitoxin memory by 
isolated B cells 1 year after oral immunization with cholera toxin. Infection and 
Immunity. 57(4):1137-41. 
327 Lycke N, Holmgren J. 1987. Long-term cholera antitoxin memory in the gut can be 
triggered to antibody formation associated with protection within hours of an oral 
challenge immunization. Scandinavian journal of immunology. 25(4):407-12. 
328 Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T. 2002. Critical 
roles of activation-induced cytidine deaminase in the homeostasis of gut flora. 
Science (New York, NY). 298(5597):1424-7. 
329 Suzuki K, Meek B, Doi Y. 2004. Aberrant expansion of segmented filamentous 
bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A. 101(7):1981-6. 
330 Lycke N, Erlandsson L, Ekman L, Schön K, Leanderson T. 1999. Lack of J chain 
inhibits the transport of gut IgA and abrogates the development of intestinal 
antitoxic protection. Journal of immunology (Baltimore, Md : 1950). 163(2):913-9. 
 63 
 
331 Uren TK, Wijburg OL, Simmons C, Johansen F-EE, Brandtzaeg P, Strugnell RA. 
2005. Vaccine-induced protection against gastrointestinal bacterial infections in the 
absence of secretory antibodies. European journal of immunology. 35(1):180-8. 
332 Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW. 2001. 
IgA immunodeficiency leads to inadequate Th cell priming and increased 
susceptibility to influenza virus infection. Journal of immunology (Baltimore, Md : 
1950). 166(1):226-31. 
333 Silvey KJ, Hutchings AB, Vajdy M, Petzke MM, Neutra MR. 2001. Role of 
immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. 
Journal of virology. 75(22):10870-9. 
334 Harriman GR, Bogue M, Rogers P, Finegold M, Pacheco S, Bradley A, et al. 1999. 
Targeted deletion of the IgA constant region in mice leads to IgA deficiency with 
alterations in expression of other Ig isotypes. Journal of immunology (Baltimore, 
Md : 1950). 162(5):2521-9. 
335 Uren TK, Johansen F-EE, Wijburg OL, Koentgen F, Brandtzaeg P, Strugnell RA. 
2003. Role of the polymeric Ig receptor in mucosal B cell homeostasis. Journal of 
immunology (Baltimore, Md : 1950). 170(5):2531-9. 
336 O'Neal CM, Harriman GR, Conner ME. 2000. Protection of the villus epithelial cells 
of the small intestine from rotavirus infection does not require immunoglobulin A. 
Journal of virology. 74(9):4102-9. 
337 Davitt CJH, Lavelle EC. 2015. Delivery strategies to enhance oral vaccination 
against enteric infections. Advanced drug delivery reviews. 91:52-69. 
338 Savelkoul HF, Ferro VA, Strioga MM, Schijns VE. 2015. Choice and Design of 
Adjuvants for Parenteral and Mucosal Vaccines. Vaccines. 3(1):148-71. 
339 Holmgren J, Svennerholm A-MM. 2012. Vaccines against mucosal infections. 
Current opinion in immunology. 24(3):343-53. 
340 Shewen PE, Carrasco-Medina L, McBey BA, Hodgins DC. 2009. Challenges in 
mucosal vaccination of cattle. Veterinary immunology and immunopathology. 
128(1-3):192-8. 
341 Czerkinsky C, Holmgren J. 2012. Mucosal delivery routes for optimal 
immunization: targeting immunity to the right tissues. Current topics in 
microbiology and immunology. 354:1-18. 
342 Srivastava A, Gowda DV, Madhunapantula SRV. 2015. Mucosal vaccines: a 
paradigm shift in the development of mucosal adjuvants and delivery vehicles. 
APMIS. 123(4):275-88. 
343 Lamichhane A, Azegamia T, Kiyonoa H. 2014. The mucosal immune system for 
vaccine development. Vaccine. 32(49):6711-23. 
344 Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, et al. 
2012. Novel vaccine development strategies for inducing mucosal immunity. 
Expert review of vaccines. 11(3):367-79. 
345 Woodrow KA, Bennett KM, Lo DD. 2012. Mucosal vaccine design and delivery. 
Annual review of biomedical engineering. 14:17-46. 
346 Riese P, Sakthivel P, Trittel S, Guzmán CA. 2014. Intranasal formulations: 
promising strategy to deliver vaccines. Expert opinion on drug delivery. 
11(10):1619-34. 
347 Toussi DN, Massari P. 2014. Immune Adjuvant Effect of Molecularly-defined Toll-
Like Receptor Ligands. Vaccines (Basel). 2(2):323-53. 
 64 
 
348 McGhee JR, Fujihashi K. 2012. Inside the mucosal immune system. PLoS biology. 
10(9):e1001397. 
349 Długońska H, Grzybowski M. 2012. Mucosal vaccination--an old but still vital 
strategy. Annals of parasitology. 58(1):1-8. 
350 Sedgmen BJ, Meeusen EN, Lofthouse SA. 2004. Alternative routes of mucosal 
immunization in large animals. Immunology and Cell Biology. 82(1):10-6. 
351 Debard N, Buzoni-Gatel D, Bout D. 1996. Intranasal immunization with SAG1 
protein of Toxoplasma gondii in association with cholera toxin dramatically reduces 
development of cerebral cysts after oral infection. Infection and Immunity. 
64(6):2158-66. 
352 Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR. 2003. 
Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell 
responses following nasal immunization with protective antigen. Journal of 
immunology (Baltimore, Md : 1950). 170(11):5636-43. 
353 Shi T, Liu W-zZ, Gao F, Shi G-yY, Xiao S-dD. 2005. Intranasal CpG-
oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, 
and T helper 1 type response and interferon-gamma correlate with the protection. 
Helicobacter. 10(1):71-9. 
354 Bhat AA, Seth RK, Babu J, Biswas S, Rao DN. 2009. Induction of mucosal and 
systemic humoral immune responses in murine system by intranasal immunization 
with peptide antigens of P. vivax and CpG oligodeoxynucleotide (ODN) in 
microparticle delivery. International Immunopharmacology. 9(10):1197-208. 
355 Giddings OK, Eickhoff CS, Sullivan NL, Hoft DF. 2010. Intranasal vaccinations with 
the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective 
against conjunctival Trypanosoma cruzi challenges. Infection and Immunity. 
78(3):1333-8. 
356 Uppada SB, Bhat AA, Sah A, Donthamshetty RN. 2011. Enhanced humoral and 
mucosal immune responses after intranasal immunization with chimeric multiple 
antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in 
mice. Vaccine. 29(50):9352-60. 
357 El-Malky MA, Al-Harthi SA, Mohamed RT, El Bali MA, Saudy NS. 2014. 
Vaccination with Toxoplasma lysate antigen and CpG oligodeoxynucleotides: 
comparison of immune responses in intranasal versus intramuscular 
administrations. Parasitology Research. 113(6):2277-84. 
358 Wang H-LL, Zhang T-EE, Yin L-TT, Pang M, Guan L, Liu H-LL, et al. 2014. Partial 
protective effect of intranasal immunization with recombinant Toxoplasma gondii 
rhoptry protein 17 against toxoplasmosis in mice. PLoS One. 9(9): e108377. 
359 Bonenfant C, Dimier-Poisson I, Velge-Roussel F, Buzoni-Gatel D, Del Giudice G, 
Rappuoli R, et al. 2001. Intranasal immunization with SAG1 and nontoxic mutant 
heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun. 
69(3):1605-12. 
360 Rebelatto MC, Guimond P, Bowersock TL. 2001. Induction of systemic and 
mucosal immune response in cattle by intranasal administration of pig serum 
albumin in alginate microparticles. Vet Immunol Immunopathol. 83(1-2):93-105. 
361 Kavanagh OV, Earley B, Murray M, Foster CJ, Adair BM. 2003. Antigen-specific 
IgA and IgG responses in calves inoculated intranasally with ovalbumin 
encapsulated in poly(DL-lactide-co-glycolide) microspheres. Vaccine. 21(27-
30):4472-80. 
 65 
 
362 Stanley AC, Buxton D, Innes EA, Huntley JF. 2004. Intranasal immunisation with 
Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres 
induces humoral and cell-mediated immunity in sheep. Vaccine. 22(29-30):3929-
41. 
363 Zhang XH, He KW, Zhao PD, Ye Q, Luan XT, Yu ZY, et al. 2012. Intranasal 
immunisation with Stx2B-Tir-Stx1B-Zot protein leads to decreased shedding in 
goats after challenge with Escherichia coli O157:H7. Veterinary Record. 
170(7):178. 
364 Kavanagh OV, Adair BM, Welsh M, Earley B. 2013. Immunogenetic responses in 
calves to intranasal delivery of bovine respiratory syncytial virus (BRSV) epitopes 
encapsulated in poly (DL-lactide-co-glycolide) microparticles. Research in 
Veterinary Science. 95(2):786-93. 
365 Mohamed Fawzi E, Cruz Bustos T, Gómez Samblas M, González-González G, 
Solano J, González-Sánchez MEE, et al. 2013. Intranasal immunization of lambs 
with serine/threonine phosphatase 2A against gastrointestinal nematodes. Clinical 
and vaccine immunology : CVI. 20(9):1352-9. 
366 Ayalew S, Step DL, Montelongo M, Confer AW. 2009. Intranasal vaccination of 
calves with Mannheimia haemolytica chimeric protein containing the major surface 
epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, 
and cholera toxin subunit B. Vet Immunol Immunopathol. 132(2-4):295-302. 
367 Plummer PJ, Rohrbach BW, Daugherty RA, Thomas KV, Wilkes RP, Duggan FE, 
et al. 2004. Effect of intranasal vaccination against bovine enteric coronavirus on 
the occurrence of respiratory tract disease in a commercial backgrounding feedlot. 
J Am Vet Med Assoc. 225(5):726-31. 
368 Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. 2008. The immune 
geography of IgA induction and function. Mucosal immunology. 1(1):11-22. 
369 Meeusen EN. 2011. Exploiting mucosal surfaces for the development of mucosal 
vaccines. Vaccine. 29(47):8506-11. 
370 Johansen F-EE, Baekkevold ES, Carlsen HS, Farstad IN, Soler D, Brandtzaeg P. 
2005. Regional induction of adhesion molecules and chemokine receptors 
explains disparate homing of human B cells to systemic and mucosal effector 
sites: dispersion from tonsils. Blood. 106(2):593-600. 
371 Wu HY, Nikolova EB, Beagley KW, Eldridge JH, Russell MW. 1997. Development 
of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes 
after intranasal immunization. Infection and Immunity. 65(1):227-35. 
372 Annalisa C, Elena P, Slavica A, Gianni P, Donata M. 2010. Intranasal 
immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and 
CD8+ T cells in the genital and intestinal tracts. Vaccine. 28(5):1226-33. 
373 Ciabattini A, Pettini E, Fiorino F, Prota G, Pozzi G, Medaglini D. 2011. Distribution 
of primed T cells and antigen-loaded antigen presenting cells following intranasal 
immunization in mice. PLoS One. 6(4):e19346. 
374 Csencsits KL, Jutila MA. 2002. Mucosal addressin expression and 
binding‐interactions with naive lymphocytes vary among the cranial, oral, and 
nasal‐associated lymphoid tissues. Eur J Immunol. 32(11):3029-39. 
375 Ruane D, Brane L, Reis BS, Cheong C, Poles J, Do Y, et al. 2013. Lung dendritic 
cells induce migration of protective T cells to the gastrointestinal tract. The Journal 
of experimental medicine. 210(9):1871-88. 
 66 
 
376 Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT. 2000. 
Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells 
into both NALT and GALT compartments. Infect Immun. 68(2):969-72. 
377 Newsted D, Fallahi F, Golshani A, Azizi A. 2015. Advances and challenges in 
mucosal adjuvant technology. Vaccine. 33(21):2399-405. 
378 Lycke N, Bemark M. 2010. Mucosal adjuvants and long-term memory 
development with special focus on CTA1-DD and other ADP-ribosylating toxins. 
Mucosal immunology. 3(6):556-66. 
379 Lavelle EC, Murphy C, O'Neill LAJ, Creagh EM. 2010. The role of TLRs, NLRs, 
and RLRs in mucosal innate immunity and homeostasis. Mucosal immunology. 
3(1):17-28. 
380 Christian B, Gan Z, Folkert S, Takeshi K, Dennis MK. 2011. CpG DNA as a 
vaccine adjuvant. Expert review of vaccines. 10(4):499-511. 
381 Zimmermann S, Dalpke A, Heeg K. 2008. CpG oligonucleotides as adjuvant in 
therapeutic vaccines against parasitic infections. Int J Med Microbiol. 298(1-2):39-
44. 
382 Krieg AM. 2012. CpG still rocks! Update on an accidental drug. Nucleic acid 
therapeutics. 22(2):77-89. 
 
 67 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Objectives 
  
 68 
 
2.1 Objectives 
 
Neospora caninum is one of the leading abortion-inducing pathogens in 
cattle and therefore responsible for heavy economic losses in cattle livestock 
farms worldwide. Currently no economically viable strategy is available to control 
the transmission of this parasite. Although an effective vaccination protocol is 
regarded as the best cost-effective strategy to prevent neosporosis related 
abortions, the introduction in the market of an effective vaccine against this 
protozoan is still not foreseen in the near future.  
Although N. caninum primary infection is established through the intestinal 
mucosa, the immune response elicited at this site has largely been 
uncharacterized. In this regard, the induction of a parasite-specific immune 
response in the intestinal mucosa, through a mucosal immunization protocol, has 
never been considered in the literature although it could prove to be a determining 
factor to achieve host protection against this protozoan. Therefore the specific 
aims of this thesis were: 
 
1 – To characterize the host immune response elicited in the intestinal 
mucosa and associated lymphoid tissues of mice infected i.g. with N. 
caninum tachyzoites 
 
2 – To established a mucosal immunization protocol, capable of conferring 
protection against neosporosis established i.g. in a murine model, with the 
specific aim of eliciting a parasite-specific mucosal immune response 
 
3 – To assess the immunogenicity of the previously selected mucosal 
immunization protocol in cattle 
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ABSTRACT 
 
The murine model has been widely used to study the host immune 
response to Neospora caninum. However, in most studies, the intraperitoneal 
route was preferentially used to establish infection. Here, C57BL/6 mice were 
infected with N. caninum tachyzoites by the intragastric route, as it more closely 
resembles the natural route of infection through the gastrointestinal tract. The 
elicited T-cell mediated immune response was evaluated in the intestinal 
epithelium and MLN. Early upon the parasitic challenge, IL-12 production by 
conventional and plasmacytoid DC was increased in MLN. Accordingly, increased 
proportions and numbers of TCRαβ+CD8+IFN-γ+ lymphocytes were detected, not 
only in the intestinal epithelium and MLN, but also in the spleen of the infected 
mice. In this organ, IFN-γ-producing TCRαβ+CD4+ T cells were also found to 
increase in the infected mice, however later than CD8+ T cells. These results 
altogether indicate that following intragastric infection N. caninum induces a 
mucosal and systemic cell-mediated immune response 
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INTRODUCTION 
 
Neospora caninum is a protozoan parasite found in a wide range of 
domestic and wild animal hosts1,2, and is responsible for clinical infections in dogs 
and cattle2 having a major impact in dairy and beef industry3. Experimentally, the 
murine model has been the one preferred to study neosporosis, as it presented 
similar features to the infection occurring naturally in permissive hosts such as 
brain lesions4, reproductive loss5 and mother to fetus parasite transmission6. 
Although N. caninum is transplacentally transmitted in cattle with high efficiency7-
12, significant postnatal transmission also occurs in these animals10,13-15, likely 
through oocyst ingestion16. Even though neosporosis can thus be established 
through the gastrointestinal tract even in the murine model17, most studies on the 
host immune response have been carried out in hosts infected via the 
intraperitoneal (i.p.) or subcutaneous routes. Consequently, the mucosal immune 
response to this parasite in infected hosts was barely studied17. As mucosal 
immunizations have been already attempted in experimental models of 
neosporosis18-20, the characterization of the immune response to N. caninum in the 
mucosa and associated lymphoid tissues will be helpful to further understand the 
immunobiology of this parasitic disease. Therefore, a murine model of neosporosis 
established by intragastric (i.g.) administration of N. caninum tachyzoites was used 
here to study the immune response elicited by this parasite in the gut and 
associated lymphoid tissue of the infected hosts. 
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MATERIALS AND METHODS 
 
Animals 
Female C57BL/6 mice, 8–10 weeks old, were purchased from Charles River 
(Barcelona, Spain) and kept under specific pathogen-free conditions at the Animal 
Facility of Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Porto, Portugal. 
All procedures involving mice were performed according to the European 
Convention for the Protection of Vertebrate Animals used for Experimental and 
other Scientific Purposes (ETS 123), 86/609/EEC Directive and Portuguese rules 
(DL 129/92). Authorization to perform the experiments was issued by the 
competent national board authority, Direcção Geral de Veterinária 
(0420/000/000/2008). 
 
Parasites  
Neospora caninum tachyzoites (NC-1 isolate) were cultured and serially passaged 
in VERO cells maintained at 37 °C in Minimum Essential Medium containing 
Earle’s salts (Sigma, St. Louis, USA) supplemented with 10% fetal bovine serum 
(FBS), L-glutamine (2 mM), penicillin (200 IU/mL) and streptomycin (200 μg/mL) 
(all from Sigma) in a humidified atmosphere of 5% CO2 in air. Free parasitic forms 
of N. caninum were obtained as previously described17 with slight modifications. 
Infected VERO cells were cultured until the host cell monolayer was 90% 
destroyed. Culture supernatants and adherent cells, harvested using a cell 
scraper, were centrifuged at 1500 × g for 15 min. The pellet was passed through a 
25G needle and then washed three times in PBS. The obtained pellet was 
suspended in 3 mL of PBS and passed through a PD-10 column filled with 
Sephadex™ G-25 M (Amersham Biosciences Europe GmbH, Freiburg, Germany). 
Parasite concentration was determined with a haemocytometer. 
 
Challenge infections 
N. caninum infections in C57BL/6 mice were performed by the i.g. route using a 
previously described protocol17. Briefly, 5 h before infection mice were deprived of 
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food. Mice were then anesthetized by intramuscular injection of 20 μL of a 4:5 
mixture containing xylazine (Rompum, Bayer Portugal, S.A., Carnaxide) and 
ketamine (Imalgéne 1000, Bayer Portugal, S.A., Carnaxide). Stomach acidity was 
neutralized by directly administering into the stomach, with a gavage feeding 
needle linked to a 1-mL syringe, 50 μL of a 10% sodium bicarbonate solution in 
water. The same procedure was used to inoculate N. caninum tachyzoites 15 min 
later. Mice were i.g. challenged with 5 × 107 tachyzoites in 0.2 mL of PBS or 
similarly inoculated with 0.2 mL of PBS and sacrificed at 18 h, 48 h, and 4 and 7 
days after challenge. 
 
Sample collection 
At the different time points, mice were sacrificed upon isoflurane anesthesia by 
cervical dislocation and the small intestines, spleens and mesenteric lymph nodes 
(MLN) were recovered. Spleens and MLN, from infected mice and non-infected 
controls, were aseptically recovered and homogenized to single cell suspensions 
in HBSS (Sigma) followed by red blood cell lysis with 0.15 M ammonium chloride 
for their usage in flow cytometry analysis. 
 
Intraepithelial lymphocyte isolation 
Gut intraepithelial lymphocytes (IEL) were isolated as previously described21. 
Briefly, mice small intestines were removed and flushed with 20 mL of cold CMF 
(Ca2+, Mg2+ free HBSS with 1 mM HEPES and 2% FBS, all from Sigma) using a 
syringe and needle. The Peyer’s Patches, fat and remaining mucous were 
removed along the intestine. The intestine was opened lengthwise, cut into 5 mm 
pieces and placed in a conical tube with 40 mL CMF. The pieces of tissue were 
washed twice with CMF by inverting the tube 10 times and letting the pieces settle 
before removing the supernatant. The intestine pieces were incubated in 25 mL 
CMF/DTE (CMF with 10% FBS and 1 mM dithioerythritol) (Sigma) at 37 °C and 
100 rpm in an orbital incubator (GFL 3031, GFL Burgwedel, Germany) for 20 min. 
The tube was vortexed at maximum speed for 15 s and the supernatant removed 
to a new tube. 25 mL of CMF/DTE were added to the tube containing the pieces of 
tissue and the vortexing step and collection of supernatant were done once more. 
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All the incubation and supernatant collection steps were repeated. Supernatants 
from each intestine were pooled and centrifuged at 400 × g, 4 °C for 20 min. The 
pellet was suspended in 5 mL HBSS with 2% FBS and passed through a nylon 
wool column pre-wet with HBSS with 2% FBS (0.15 g teased nylon wool in a 5 cc 
syringe) and the column was washed with 20 mL HBSS with 2% FBS. The 
collected cell suspension was centrifuged and suspended in 16 mL of 44% 
Percoll™ (GE Healthcare Bio-Sciences AB, Uppsala, Sweden), adding 8 mL per 
14 mL polystyrene round bottom tube. 5 mL of 67% Percoll were underlaid per 
tube and the 44%/67% Percoll gradients were centrifuged for 20 min at room 
temperature, 1400 × g, with the brake off. Cells from the interface were carefully 
removed with a Pasteur pipette and washed twice with 40 mL cold complete RPMI 
(RPMI 1640 supplemented with 50 U/mL penicillin, 50 μg/mL streptomycin, 1% 
HEPES buffer, 10% FBS and 0.1 μM β-mercaptoethanol, all from Sigma). Cells 
were finally suspended in complete RPMI. 
 
Flow cytometric analysis 
The assessment of cell surface and cytoplasmic lineage or activation markers on 
different leukocyte populations was performed by flow cytometric analysis. From 
spleen, MLN and IEL cell suspensions, prepared as described above, a number of 
1 × 106 leucocytes were stained per sample. The following monoclonal antibodies, 
along with the respective isotype controls were used (at previously determined 
optimal dilutions) for immunofluorescence cytometric data acquisition in a Coulter 
EPICS XL flow cytometer (Beckman Coulter, FL, USA): phycoerythrin (PE) anti-
mouse TCR β (H57-597) and PE- chlorophyll proteins-cychrome 5 (Cy5) rat anti-
mouse CD4 (RM4-5) (both from eBioscience, San Diego, CA, USA); Biotin anti-
mouse PDCA-1 (JF05-1C2.4.1) (Miltenyi Biotech, Inc. Auburn, CA, USA); 
fluorescein isothiocyanate (FITC)  hamster anti-mouse CD11c (HL3), PE-Cy5 rat 
anti-mouse CD8a (53–6.7), Biotin hamster anti-mouse γδ T-cell receptor (GL3), 
FITC anti-mouse IFN-γ (XMG1.2), (all from BD Pharmingen, San Diego, CA, 
USA). Biotin conjugated mAbs were revealed with Streptavidin-PE-chlorophyll 
proteins-cychrome 7 (Cy7) (BD Pharmingen). Cells were pre-incubated for 15 min 
with anti-FcγR (a kind gift of Dr Jocelyne Demengeot, Gulbenkian Institute of 
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Science, Oeiras, Portugal). Data were analyzed by using CELLQUEST software 
(Becton-Dickinson, San Jose, CA, USA). 
 
Intracellular staining 
The intracellular expression of the cytokine IFN-γ was detected in splenic and 
MLN CD8+ and CD4+ T lymphocytes, as well as in IELs (1 × 106 cells), stimulated 
for 4.5 h with 20 ng/mL phorbol myristate acetate and 200 ng/mL ionomycin in the 
presence of 10 ng/mL of brefeldin A (all from Sigma). Staining of cell surface 
markers CD4, CD8, TCR β and TCRγδ was performed as described above, after a 
pre-incubation step of 15 min with anti-FcγR, followed by fixation in 2% 
formaldehyde. Cells were permeabilized with 0.5% saponin in flow cytometric 
buffer (PBS containing 1% BSA and 0.01 M sodium azide) and, subsequently, 
cells were incubated for 15 min with anti-FcγR and stained for 30 min at room 
temperature with the appropriate antibody. The intracellular expression of the 
cytokine IL-12 was assessed in MLN conventional and plasmacytoid dendritic cells 
(cDC and pDC, respectively). MLN suspensions were enriched in DC by magnetic 
sorting using anti-CD11c beads (Miltenyi), according to the manufacturer’s 
instructions. 1 × 106 cells were then placed in 96-well tissue culture plates (Nunc) 
and incubated for 4.5 h with 10 ng/mL of brefeldin A (Sigma). Cells were surface 
stained with PE-Cy5.5 hamster anti-mouse CD11c (HL3) (BD Pharmingen) and 
Biotin anti-mouse PDCA-1 (Miltenyi Biotech) revealed with PE-Cy7 conjugated 
streptavidin (BD Pharmingen). Intracellular staining was performed with PE rat 
anti-mouse IL-12 (p40/p70) (C15.6) (BD Pharmingen). Intracellular staining with 
the isotypic controls was performed to confirm the specificity of antibody binding. 
 
Statistical analysis 
Unless otherwise indicated, statistical significance of results was determined by 
unpaired Student t-test, using the GraphPad Prism 4 (GraphPad Software, Inc., La 
Jolla, CA). In the scatter dot graphs the mean for each group was displayed as a 
horizontal line. Column graphs are represented showing mean plus one standard 
deviation (SD). Results were considered statistically significant with P values of 
less than 0.05  
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RESULTS 
 
MLN cDC and pDC produce IL-12 early upon i.g. challenge with N. caninum 
tachyzoites 
As we have shown in a previous report, a large proportion of splenic 
conventional and plasmacytoid dendritic cells (cDC and pDC, respectively) 
produce IL-12 in BALB/c mice infected i.p. with N. caninum tachyzoites22. This 
cytokine is a crucial factor mediating host immune protection against 
neosporosis23-25. As shown in Figure 3-1, an increased frequency of IL-12-
expressing cDC and pDC was detected in the MLN of infected mice, 18 and 48 h 
upon the parasitic challenge. These results show that N. caninum tachyzoites 
administered i.g. induce IL-12 production by host DC in the draining lymph nodes. 
 
Figure 3-1 - cDC and pDC produce IL-12 in response to N. caninum i.g. infection. (a) 
Representative example of flow cytometric analysis of surface PDCA-1 and CD11c 
expression on total MLN leukocyte cells. Dot plots represent cells collected from C57BL/6 
mice 18 h after i.g. challenge with 5 × 107 N. caninum tachyzoites. Gates were set as 
shown to delineate cDC (CD11chigh) and pDC (CD11clow PDCA-1high). (b) Proportion of IL-
12+ cells within cDC and pDC populations in the MLN of C57BL/6 mice, evaluated by flow 
cytometric analysis, at the specified time points after i.g. treatment with PBS (open bars) 
or i.g. inoculation with 5 × 107 N. caninum tachyzoites (closed bars). Bars represent the 
mean plus one standard deviation of three animals in the PBS group and four animals in 
the infected mice group. This is one representative result of two independent experiments 
(*P<0.05; **P<0.01). 
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Increased frequencies of TCRβ+CD8+IFN-γ+ IEL were observed in C57BL/6 
mice challenged i.g. with N. caninum tachyzoites  
Murine gut IEL comprise both αβ and γδ TCR+ cells26 which have been 
shown to mediate host protection against enteric infections, including those 
caused by protozoans27. Here, an increased frequency of TCRβ+CD8+IFN-γ+ IEL 
was observed in C57BL/6 mice comparatively to mock-infected controls, 48 h 
upon i.g. challenge with N. caninum tachyzoites (Figure 3-2). Conversely, no 
differences were found between infected mice and controls in the frequencies of 
IFN-γ-producing TCRγδ+ (1,30 ± 0,27 vs 1,13 ± 0,29) or TCRβ+CD4+ (2,70 ± 0,82 
vs 1,84 ± 0,76) IEL. These results indicate that in the gut, TCRαβ+CD8+, but not 
TCRγδ+, IEL are activated by i.g. administered N. caninum tachyzoites and 
produce the host protective cytokine IFN-γ. 
 
 
Figure 3-2 - Increased expression of IFN-γ by TCRβ+CD8+ IEL in N. caninum infected 
mice. Representative dot plots of (a) cells isolated from the small intestines of C57BL/6 
mice (IEL were gated as shown); (b) TCRγδ and TCRβ IEL. (c) Gated TCRβ+ CD8+ IEL 
expressing IFN-γ in control (PBS) and N. caninum-infected mice (NcT). (d) Frequency of 
TCRβ+CD8+ IFN-γ+ IEL in control and N. caninum i.g.-infected mice, 48 h after challenge. 
Bars represent mean plus one standard deviation of three animals in the PBS group and 
four animals in the infected mice group. This is one representative result of three 
independent experiments (*P<0.05). 
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CD8+ T cells produce IFN-γ in the MLN of N. caninum i.g. infected mice 
IL-12 drives the differentiation of T cells towards an IFN-γ-producing 
phenotype. As increased production of IL-12 was observed in the MLN of N. 
caninum infected mice, the frequency of CD4+ and CD8+ T cells producing IFN-γ 
were assessed therein, 4 and 7 days upon infection. As shown in Figure 3-3a, an 
increased frequency of CD8+IFN-γ+ T cells was observed in the MLN of infected 
mice. This increase was observed at day 4 post-infection whereas at day 7 it was 
found below control values. No such increase was observed for CD4+IFN-γ+ T 
cells at the assessed days (Figure 3-3c). Nevertheless, at day 7 upon infection 
some mice presented CD4+IFN-γ+ T cells at higher frequency than controls. This 
high variability was observed in the three experiments done. In order to determine 
whether IFN-γ production could also be induced in splenic T cells upon the i.g. 
infection, their frequency and number was similarly assessed. As shown in Figure 
3-3b, increased proportions of CD8+IFN-γ+ T cells were also observed in the 
spleen 4 days upon infection that were found within control values by day 7. In 
contrast, the frequency of CD4+IFN-γ+ T cells, which was similar to controls 4 days 
after infection, significantly increased at day 7 (Figure 3-3d). These results show 
that in the i.g. infected mice CD8+ T cells are early producers of IFN-γ, not only at 
the intestinal mucosa and draining lymph nodes but also systemically, as detected 
in the spleen. 
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Figure 3-3 - Expression of IFN-γ in splenic and MLN CD8+ and CD4+ T cells. 
Scatter plots of frequency of CD8+IFN-γ+ T cells (a and b) or CD4+IFN-γ+ T cells (c 
and d), as indicated, in the MLN (a and c) and spleen (b and d) of control (PBS) or 
N. caninum-infected mice (NcT), 4 and 7 days upon i.g. challenge. Each symbol 
represents an individual mouse; horizontal bars correspond to mean values of the 
respective group. Five mice per group were used. This is one representative result 
of three independent experiments. Statistical significance between groups is 
indicated above symbols (*P<0.05; **P<0.01). 
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DISCUSSION 
 
 Although the gastrointestinal mucosa constitutes the natural route of 
infection for N. caninum in horizontal transmitted neosporosis2, the study and 
characterization of the immune response elicited in this mucosa following N. 
caninum infection has been largely overlooked. This fact can in part be explained 
since experimental infection with the parasite in both cattle and mouse models is 
usually performed trough parental routes although, at least in the murine model, 
i.g. infection with N. caninum tachyzoites was shown to be feasible17. Although this 
parasitic form may present antigenic differences from oocysts and sporozoites, 
this model may nevertheless better mimic the natural infection route used by the 
parasite. In this work we have thus use the i.g. infection model, previously 
established by our group, to characterize the host mucosal and systemic immune 
response in the early time-points after mice infection with N. caninum. In this 
regard, analysis of DC in the MLN either 18 or 48h after infection revealed an 
increased frequency of both cDC and pDC populations producing IL-12, an 
essential cytokine for host resistance against N. caninum infection23-25. This result 
is in agreement with our group’s previous observation that both cDC and pDC 
populations present increase IL-12 production in the spleen of N. caninum i.p. 
infected mice22 as well as with in vitro studies where increase IL-12 production 
was reported following DC activation with N. caninum tachyzoites28,29. In addition, 
similar IL-12 production profiles by cDC and pDC have also been described in 
mice infected with the closely related apicomplexa parasite Toxoplasma 
gondii30,31. On the other hand, and since DC have been implicated in the 
dissemination through the host of N. caninum32 as well as T. gondii33,34, it would be 
worth assessing if the analyzed DC found in MLN were locally activated by the 
parasite or rather migrated from the intestinal mucosa and can thus contribute to 
parasite dissemination through the host. 
Consistent with the early IL-12 production observed in MLN DC, 18 and 48h 
after infection, higher frequencies of TCRαβ+CD8+IFN-γ+ IELs were observed in 
the intestinal epithelium of infected mice. Due to the paramount role of IFN-γ in 
host resistance against neosporosis23,35,36, this early production of IFN-γ by IELs 
could contribute to the host control of the parasite infection and limit its 
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dissemination in the intestinal mucosa. In this regard, T. gondii primed IELs have 
been shown to mediate protective immunity in adoptive cell transfer experiments 
to T. gondii oral infected mice37,38. In these studies, T. gondii primed TCRαβ+CD8+ 
IEL also presented increase IFN-γ expression and protection conferred by 
transferred IELs was also shown to be largely mediated by this cell population 
37,38. Still, despite the increased frequency of IELs producing IFN-γ observed in our 
study, the contribution of these cells for host protection is certainly different in the 
case of N. caninum infection since similar transfer of N. caninum primed IELs 
followed by i.g. challenge of recipient mice with N. caninum tachyzoites did not 
result in increased mice protection when compared with control mice receiving 
unprimed cells (our group’s unpublished results). Although in agreement with the 
increase IL-12 production by DC in MLN, and even though MLN have been shown 
to be a major site for IEL activation and differentiation39, due to the fact that 
increase IFN-γ in TCRαβ+CD8+ IEL was detected just 48h after infection, it would 
also be worth assessing if these IFN-γ producing IELs are newly activated and 
recent emigrants to the intestinal mucosa or resident cells that can be activated 
quickly in situ following parasite encounter. 
Also consistent with the early IL-12 production by DC in the MLN and the 
higher frequency of TCRαβ+CD8+IFN-γ+ IELs, 4 days after infection higher 
frequencies of CD8+ T cells producing IFN-γ were observed in the MLN and in the 
spleen of infected mice. This result implicates CD8+ T cells also as early 
responders to N. caninum in both lymphoid organs. In addition, this result also 
indicates that 4 days after infection a mucosal associated and systemic immune 
response could be observed in N. caninum i.g. infected mice, although we could 
not discard the possibility that higher frequencies of CD8+ T cells in the spleen 
could be the result of cell trafficking to this site of cells from other lymphoid organs 
rather that in situ activation. In this sense, analysis of the activation profile of 
splenic DC could help determine if an active immune response is being 
undertaken at this site and also determine if infected DC could disseminate the 
parasite from the intestinal mucosa to the spleen. Nevertheless, and similar to the 
results observed here, CD8+ T cells were also shown to be early producers of IFN-
γ following T. gondii infection, and were also involved in host resistance during the 
acute infection stage40. Recently, our group has also shown that CD8+ T cell IFN-γ 
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production mediates the host protective effect of this cell population in N. caninum 
infected mice41. In contrast, similar analysis performed 7 days after infection 
revealed reduced frequency of CD8+ T cells producing IFN-γ in the MLN and 
higher frequencies of CD4+IFN-γ+ T cells in the spleen of infected mice. In this 
sense, and although CD4+ T cells have been established as the main mediators of 
host protection following N. caninum infection in comparison with CD8+ T cells42, 
these appear to be late responders in i.g. established neosporosis. Also worth 
assessing is the possibility that the apparent reduction in the frequency of IFN-γ 
producing CD8+ T cells in MLN could be the result of cell migration to effector 
sites. 
 Altogether these results show that in i.g. infected mice, N. caninum 
stimulates an early mucosal and systemic immune response with the production of 
host protective IL-12 and IFN-γ. Furthermore, CD8+ T cells in the intestinal 
mucosa as well as in the spleen and MLN were shown to be the early responders 
to N. caninum infection. Since the intestinal mucosa is the first site to come into 
contact with the parasite during horizontal transmitted neosporosis, the knowledge 
that following i.g. infection N. caninum stimulates both a mucosa and systemic 
immune response can also aid in the development of host protective immunization 
strategies against N. caninum  
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ABSTRACT 
 
Neospora caninum is an Apicomplexa parasite that in the last two decades 
was acknowledged as a main pathogenic agent responsible for economic losses in 
cattle industry. In the present study, the effectiveness of intranasal immunization 
with N. caninum membrane antigens plus CpG adjuvant was assessed in a murine 
model of intragastrically established neosporosis. Immunized mice presented a 
lower parasitic burden in the brain upon infection with 5 × 107 tachyzoites showing 
that significant protection was achieved by this immunization strategy. Intestinal 
IgA antibodies raised by immunization markedly agglutinated live N. caninum 
tachyzoites whereas previous opsonization with IgG antibodies purified from 
immunized mice sera reduced parasite survival within macrophage cells. Although 
an IgG1/IgG2a ratio < 1 was detected in the immunized mice before and after 
infection, indicative of a predominant Th1-type immune response, no increased 
production of interferon-γ was detected in the spleen or mesenteric lymph nodes 
of the immunized mice. Altogether, these results show that mucosal immunization 
with N. caninum membrane proteins plus CpG adjuvant protect against 
intragastrically established neosporosis and indicate that parasite-specific mucosal 
and circulating antibodies have a protective role in against N. caninum infection 
established through the gastrointestinal tract. 
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INTRODUCTION 
 
Neospora caninum is an Apicomplexa parasite initially described as the 
causative agent of neuromuscular disease in dogs1. Although canids have been 
identified as N. caninum definitive hosts, this parasite can infect a wide range of 
intermediate hosts including cattle2,3. Infected cattle display an increase likelihood 
of abortion4-10 which altogether with the high efficiency of vertical transmission7,11-
16 makes neosporosis responsible for severe economic losses17. Therefore, 
effective control methods that could prevent the parasite spread are necessary. 
Lack of intervention is too risky and a test and cull approach despite its 
effectiveness is too expensive18. Moreover, coccidiostatic treatment also appears 
as an expensive option that still raises concerns regarding its usage in animals for 
human consumption18. Vaccination appears thus as the best approach to 
effectively control neosporosis18,19. However, no commercial vaccine is currently 
available for neosporosis upon the recent withdrawal of Bovilis® Neoguard that 
nevertheless had a limited efficacy20,21. Therefore, development of a novel vaccine 
that could prevent this parasitic disease is a pressing necessity.  
Attenuated N. caninum tachyzoites were successfully used to immunize 
mice22-24 or cattle25 against neosporosis. However, the use of attenuated strains is 
undesirable due to a low shelf life26 and the possible regression to a more virulent 
status19. On the other hand, although it was reported that immunization with whole 
parasite lysates could protect mice from N. caninum infection or vertical 
transmission27-32, other studies showed that immunization by using parasite 
lysates conferred little protection or even exacerbate the outcome of murine 
infection33-35 and failed to prevent vertical transmission in cattle36. Recombinant N. 
caninum proteins have also been tested as potential vaccine candidates with 
promising although variable efficacy37-43. Nonetheless, and despite the fact that 
the gastrointestinal mucosa is a natural infection route for N. caninum, mucosal 
(intranasal) immunization against neosporosis has only been attempted in a 
limited number of studies which yield encouraging results44-46. Nevertheless, 
despite the immunization route used therein, the possible immune response 
elicited in the mucosa or associated lymphoid tissue of immunized mice was not 
specifically addressed. 
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Here, our previous described model of N. caninum infection established by the GI 
tract47,48 was used to assess the protective effect against neosporosis of intranasal 
(i.n.) immunization by using N. caninum membrane proteins (NcMP) as target 
antigens. Our results show that immunization with NcMP plus CpG adjuvant 
conferred protection against the parasite infection. Moreover, by showing an in 
vitro effector function of mucosal and circulating antibodies, we provide evidence 
for a protective role of the humoral immune response against neosporosis in our 
model. 
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MATERIALS AND METHODS 
 
Animals 
Seven week-old female C57BL/6 mice were purchased to Charles River 
(Barcelona, Spain). Animals were kept at Instituto de Ciências Biomedicas Abel 
Salazar (ICBAS) animal facility throughout all the experimental procedures in 
specific-pathogen free conditions. Procedures involving mice were performed 
according to the European Convention for the Protection of Vertebrate Animals 
used for Experimental and Other Scientific Purposes (ETS 123) and 86/609/EEC 
Directive and Portuguese rules (DL 129/92). Authorization for the experiments was 
issued by the competent national board (Direcção Geral de Veterinária, document 
0420/000/000/2008). 
 
Parasites  
N. caninum tachyzoites (Nc1 isolate) were kept by serial passages in VERO cells 
cultures, maintained in Minimal Essential Medium containing Earle’s salts (Sigma, 
St. Louis, USA), supplemented with 10% fetal calf serum (PAA laboratories, 
Austria), L-Glutamine (2 mM), Penicillin (200 IU/ml) and Streptomycin (200 µg/ml) 
(all from Sigma), in a humidified atmosphere with 5% CO2 at 37 ⁰C. Tachyzoites 
were maintained until destruction of 80% of the host cell monolayer and were 
isolated as previously described47. Briefly, free parasites and adherent cells were 
recovered using a cell scraper and centrifuged at 1 500 × g for 15 min. The pellet 
was passed through a 25 G needle and then washed three times in PBS by 
centrifugation at 1 500 × g for 15 min. The resulting pellet was resuspended and 
passed through a PD-10 desalting column, containing Sephadex™ G-25M (GE 
Healthcare, Freiburg, Germany). Tachyzoites concentration was determined in a 
haemocytometer. 
 
Preparation of whole tachyzoite lysates and cell-membrane extracts 
N. caninum membrane proteins (NcMP) were extracted using a modification of a 
previously described method49,50. Briefly, free tachyzoites were resuspended in 
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PBS containing 0.75% triton X-114 (Sigma), incubated 10 min on ice and 
centrifuged at 10 000 × g for 30 min at 4 ⁰C and the supernatant was recovered 
and placed in a water bath at 30 ⁰C during 3 min. The procedure was repeated 
and the supernatant was centrifuged at 1 000 × g for 3 min at room temperature. 
The aqueous phase was discarded and the NcMP were precipitated with the 
addition of absolute ethanol, vortexed vigorously during 15 sec and incubated 1 h 
on ice. The samples were centrifuged at 12 000 × g for 20 min at 4 ⁰C and the 
resulting pellet was dried, resuspended in PBS and stored at -20 ⁰C.  
Whole N. caninum lysates were prepared by disruption of tachyzoites following 
sonication (20 cycles of 15 s at 100 W) with a Branson cell disrupter model W 185 
D in an ice bath. The obtained N. caninum sonicates (NcS) were sequentially 
passed through 0.45 and 0.2 µm pore-size filters and stored at -20 ⁰C. 
Quantification of NcMP or NcS was performed by using the Lowry protein assay.  
 
Electrophoretic analysis and western blot transfer of NcMP and NcS 
Evaluation of protein migration profile in each extraction was performed using a 
sodium dodecyl sulphate polyacrylamide gel electrophoresis. Briefly a 
discontinuous (4-10% acrylamide) gel was loaded with 10 µg of NcMP or NcS, 
previously heated at 95 ⁰C during 5 min, and electrophoresis was carried out at a 
25 mA constant current. Protein migration profiles were visualized by using silver 
nitrate staining. Western blot analysis of NcMP and NcS protein fractions was 
performed by transfer to an activated polyvinylidene difluoride membrane (GE 
Healthcare) the previously separated proteins by gel electrophoresis under 
constant current of 60 mA.  
 
Immunizations and tissue sample collections 
Eight week-old female mice were used in 3 independent experiments with random 
distribution into 4 groups per experiment. Mice were immunized intranasally (i.n.) 
at day zero under light isoflurane anesthesia with 20 µl of: PBS containing 30 µg of 
NcMP (NcMP group, n=13) or 30 µg of NcMP plus 10 µg of CpG ODN 1826 
VacciGrade (invivogen, San Diego, CA) (NcMP/CpG group, n=14). Sham-
immunized control mice were immunized with PBS alone (PBS group, n=14) or 
 94 
 
PBS containing, 10 µg of CpG ODN 1826 VacciGrade (CpG group, n=13). The 
immunization procedure was repeated 3 weeks upon the first immunization. All 
mice were intragastrically (i.g.) challenged, 3 weeks after the last immunization 
with 5 × 107 freshly isolated N. caninum tachyzoites as previously described47. 
One week after infection, mice were sacrificed by cervical dislocation and spleens 
and mesenteric lymph nodes (MLN) were aseptically removed for the analysis of 
the immune response, while the brains were collected and stored at -20 ⁰C for 
DNA extraction. One week after boost immunization and 1 week after infection 
serum from all mice was collected in the submandibular vein for detection of N. 
caninum-specific IgG. At the same time-points, vaginal and intestinal lavages 
fluids (VLF and ILF, respectively) were collected respectively, for detection of N. 
caninum-specific IgA.  
 
Antibody detection  
Serum IgG1 and IgG2a titres specific for NcMP were quantified by ELISA. Briefly, 
96-well plates (Maxisorp, Nunc, Denmark), were coated overnight at 4 ⁰C with 
NcMP diluted in PBS at a concentration of 5 µg/ml. All the wells were saturated 
with 2% bovine serum albumin (BSA) (Sigma) in TST buffer (150 mM NaCl, 10 
mM EDTA and 0.05% Tween 20, pH=8) for 1 h. Serum samples were serial diluted 
in 1% BSA TST buffer and incubated for 1 h, followed by washing and addition of 
alkaline phospatase-coupled monoclonal goat anti-mouse IgG1 or IgG2a 
monoclonal antibodies (Southern Biotechnology Associates, Birmingham, USA) 
and incubation for 1 h. After washing, the specifically bound antibodies were 
detected by the development with the substrate solution of p-nitrophenyl 
phosphate (Sigma) and the reaction was stopped with the addition of 0.1 M EDTA, 
pH=8 solution. The absorbance was measured at 405 nm, subtracting for each 
well the value for the absorbance at 570 nm. The antibody titres were expressed 
as the log10 value of the reciprocal highest dilution with an absorbance higher than 
the value of the control (no serum added). Detection of IgA antibodies specific for 
NcMP were quantified by ELISA as previously described, using alkaline 
phospatase-coupled goat anti-mouse anti IgA mAb (Southern Biotech).  
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Purification of serum IgG antibodies and mucosal IgA  
Mice serum samples and ILF collected at the day mice euthanasia were 
respectively used for IgG and IgA purification. Pooled sera of mice from the 
NcMP/CpG and CpG groups were used to purify IgG antibodies by using a HiTrap 
Protein G HP purification column (GE healthcare), according to manufacturer’s 
instructions. Recovered antibodies were buffer exchanged against sterile PBS to a 
final concentration of 4.5 mg/ml as determined by Lowry protein assay and stored 
at -20 ⁰C. The purified IgG fractions obtained from the sera of CpG or NcMP/CpG 
mice groups were respectively designated as IgG-CpG or IgG-NcMP/CpG. The 
NcMP-specific antibody titre of the IgG-CpG and IgG-NcMP/CpG preparations 
were below detection limit and 1.559 × 109, respectively, as determined by ELISA. 
To obtain purified IgA antibodies, pooled ILF were passed through a 0.2 µm pore-
size filter before being introduced in a Protein L/Agarose (Invivogen) column. 
Antibody purification was carried out according to manufacturer’s instructions. 
Recovered antibodies were buffer exchanged against sterile PBS, and stored at -
20 ⁰C. The purified IgA fractions obtained from the ILF of CpG or NcMP/CpG mice 
groups were respectively designated as IgA-CpG or IgA-NcMP/CpG. The total IgA 
titres for the IgA-CpG and IgA-NcMP/CpG preparations were of 657648 and of 
786788, respectively, and both fractions were normalized to 650 × 103 for further 
usage. The NcMP-specific IgA titres of the IgA-CpG and IgA-NcMP/CpG 
preparations were below detection limit and 8995, respectively. 
 
Western blot analysis 
Western blot membranes containing NcMP and NcS protein extracts were used to 
determine the immunoreactivity of the purified IgG-NcMP/CpG and IgA-
NcMP/CpG fractions and confirm the existence of immunodominant antigens 
present in each protein extract. Briefly, membranes were saturated with 1% BSA 
(Sigma) in TST buffer for 2 h. IgG-NcMP/CpG and IgA-NcMP/CpG antibody 
fractions were incubated with the membranes at a dilution of 1:2000 and 1:1000, 
respectively for 1 h in 0.1% BSA TST, followed by washing and addition of either 
alkaline phospatase-coupled monoclonal goat anti-mouse IgG1 or IgG2a or IgA 
monoclonal antibodies (Southern Biotech) at a dilution of 1:2000. After washing, 
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the specifically bound antibodies were detected by the development with the 
substrate solution of NBT/BCIP (Roche, Basel, Switzerland) and the reaction was 
stopped by washing the membrane with deionized water. 
 
Antibody-binding and parasite-agglutination assays. 
To evaluate the ability of antibodies present in IgG- or IgA-CpG, or IgG- or IgA-
NcMP/CpG fractions to bind N. caninum, different dilutions of these preparations 
were incubated with 1 × 106 tachyzoites, for 25 min on ice. Detection of bound 
antibodies was made using flow cytometry, for which parasites were further 
incubated with polyclonal anti-IgG antiserum, fluorescein isothiocyanate (FITC) 
conjugate (Southern Biotech), or with anti IgA-FITC conjugate (BDbiosciences, 
San Diego, USA) mAb (clone C10-3) for 25 min on ice and then washed with PBS 
containing 1% BSA and 10mM sodium azide (FACS buffer). Parasite samples 
were analyzed in an EPICS XL flow cytometer using the EXPO32ADC software 
(Beckman Coulter, MI). The collected data files (100,000 events per sample) were 
converted for analysis with the Cell Quest software, v3.2.1f1 by using FACS 
convert, v1.0 (both from Becton Dickinson, San Jose, USA). Agglutination assays 
were performed by incubating 1 × 106 tachyzoites with either IgA-CpG or IgA-
NcMP/CpG or PBS alone 1h at 4 ºC. After incubation smears of each sample were 
prepared on microscopic slides that were fixed in cold methanol for 5 min. 
Samples were then stained with Hemacolor 2 and 3 (Merk, Darmstadt, Germany) 
according to manufacturer’s instructions. Mounted slides were observed in a light 
microscope and 20 pictures at 20× magnification were taken (Leica Qwin plus 
v3.5.1) as a representative display of each slide. Analysis of the number and size 
of parasite clusters were performed by using ImageJ software (Version 1.47, 
National Institutes of Health, Bethesda, MD) 
 
Intracytoplasmic staining  
For intracellular cytokine detection by flow cytometry, spleens and MLN were 
aseptically removed from the euthanized infected mice, homogenised in HBSS 
(Sigma) and red blood cells were lysed. The remaining cells were counted and 
plated in round bottom 96-well plates (Nunc), at a concentration of 1 × 106 cells/ml 
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in RMPI-1640 (Sigma) supplemented with 10% fetal calf serum (PAA laboratories), 
HEPES (10 mM), Penicillin (200 IU/ml) and Streptomycin (200 µg/ml) (all from 
Sigma), β-mercaptoethanol (0.1 μM) (Merk) (RPMI complete medium). Cells were 
incubated in a humidified atmosphere with 5% CO2 at 37 ⁰C for 4.5 h under 
stimulation with 20 ng/ml phorbol myristate acetate (Sigma) and 200 ng/ml 
ionomycin (Merk) and 10 ng/ml of Brefeldin A (Epicentre Biotechologies, Madison, 
USA). Then, cells were recovered and unspecific antibody binding was prevented 
by the pre-incubation with anti-FcγR mAb followed by incubation with either anti-
CD4 Peridinin-chlorophyll proteins-cychrome 5.5 (PerCP-Cy5.5)-conjugate (clone 
RM4-5) or anti-CD8 PerCP-Cy5.5-conjugate (clone 53-6.7) mAb (both from 
BDbiosciences). Following extracellular staining the cells were washed, fixed in 
2% formaldehyde, washed again and permeabilized with 0.05% saponin (Sigma) 
PBS solution and intracytoplasmic staining was carried out with anti-IFN-γ FITC-
conjugate (clone XMG1.2), anti-IL-4 Phycoeritrin (PE)-conjugate (clone BVD4-
1D11) and anti-IL-10 PE-conjugate (clone JES5-16E3) (all from BDbiosciences) 
after pre-incubation of the cells with anti-FcγR mAb. Antibody-labelled cells were 
analyzed in an EPICS XL flow cytometer using the EXPO32ADC software 
(Beckman Coulter). At least 150,000 events were acquired per sample. The 
collected data files were converted using FACS convert, v1.0 (Becton Dickinson) 
and analyzed using Cell Quest software, v3.2.1f1 (Becton Dickinson).  
 
In vitro cell cultures and cytokine detection. 
To assess in vitro cytokine production by NcMP-stimulated spleen cells, 5 ml 
aliquots of cell suspensions prepared as described above for intracytoplasmic 
staining, were layered onto 2.5 ml of a polysucrosesodium ditrizoate solution 
(Histopaque 1083, Sigma) and centrifuged at 800 × g for 20 min. Mononuclear 
cells collected from the medium-Histopaque interface were washed, suspended in 
RPMI complete medium, plated (5 × 105/well) in round bottom 96-well plates 
(Nunc), and stimulated with NcMP (100 μg/ml) for 5 days at 37 ºC and 5% CO2. 
Four animals from each group were used and triplicate wells were set for cells 
cultured from each animal. The concentration of IFN-γ and IL-4 in cell culture 
supernatants were respectively quantified with the Mouse IFN-γ DuoSet® ELISA 
development system (R&D Systems, Minneapolis, MN) and IL-4 ELISA Ready-
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Set-Go!® (eBioscience, San Diego, CA) kits, both according to manufacturer’s 
instructions. 
 
Macrophage cell cultures and parasite opsonization survival 
Mouse bone marrow-derived macrophages (BMDM) were differentiated from bone 
marrow precursors. The BMDM cultures were generated in 6-well plates (Nunc) by 
culturing 5 × 106 cells in 5 ml of RPMI complete medium supplemented with 10% 
of L-929 cell line conditioned medium (LCCM) and incubated at 37 ºC in a 5% CO2 
humidified chamber. On day 4, the cell culture medium was renewed and 5 ml of 
fresh medium supplemented with LCCM was added. Differentiated macrophages 
were harvested on day 7 by gently scraping the wells. The cells were counted and 
plated in 24-well plates (Nunc) at a concentration of 1 × 106 cells/ml. BMDM were 
then infected at a multiplicity of infection (MOI) of 1:1 with N. caninum tachyzoites 
incubated with IgG-NcMP/CpG or IgG-CpG, as described above, at different 
dilutions or untreated parasites as control. Cells were incubated for 6 h at 37 ºC in 
a 5% CO2 humidified chamber. 
 
DNA extraction  
DNA from the brain of infected mice and in vitro BMDM cell cultures was extracted 
as previously described51. Briefly, brains were weighted and homogenized. 
Samples were incubated overnight at 55 ⁰C in a solution containing 1% SDS and 1 
mg/ml Proteinase K (sigma). DNA was extracted by the phenol (Sigma)-
Chlorophorm (Merk) method followed by ammonium acetate/ethanol precipitation. 
 
Real-time PCR analysis 
The parasite burden in the brain of infected mice and macrophage cell cultures 
was assessed by a quantitative real-time PCR (qPCR) analysis of the parasite 
DNA performed in a Corbett rotor gene 6000 system (Corbett life science, Sydney, 
Australia). Brain analysis was performed by using Rotor-Gene probe PCR kit 
(Quiagen, Hilden, Germany), for the amplification of a 103 bp sequence of the Nc5 
region of N. caninum genome using the primers NcA 5’ 
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GCTACCAACTCCCTCGGTT 3’ and NcS 5’ GTTGCTCTGCTGACGTGTCG 3’ 
both at a final concentration of 0.2 µM, and the florescent probe FAM-
CCCGTTCACACACTATAGTCACAAACAAAA-BBQ at a final concentration of 0.1 
µM (all design and obtained from TIB-Molbiol, Berlin, Germany). The DNA 
samples were amplified using the following program: 95 ⁰C for 3 min, 95 ⁰C for 5 
sec, 60 ⁰C for 20 sec with fluorescence acquisition. The second and third steps 
were repeated 50 times. Length of the amplified DNA was confirmed in a 3% 
agarose gel stained with ethidium bromide. BMDM samples were analyzed using 
Express Sybr green ER qPCR supermix universal (Invitrogen), for the amplification 
of a 337 bp sequence of the Nc5 region of N. caninum genome using the primers 
Np21plus 5’ CCCAGTGCGTCCAATCCTGTAAC 3’ and Np6plus 5’ 
CTCGCCAGTCAACCTACGTCTTCT 3’ (both from TIB-Molbiol), both at a final 
concentration of 0.25 µM. The DNA samples were amplified using the following 
program: 95 ⁰C for 10 min, 95 ⁰C for 30 sec, 63 ⁰C for 20 sec, 72 ⁰C for 45 sec 
with fluorescence acquisition, the second, third and fourth step were repeated 45 
times. A melting curve was performed in each run in order to access the PCR 
amplified fragments: from 65 ⁰C to 95 ⁰C, with increments of 1 ⁰C for 5 seconds. In 
all runs parasite burden was determined by interpolation of a standard curve, 
ranging from 10 to 10-4 ng of DNA extracted from N. caninum tachyzoites included 
in each run and the data analyzed in the Rotor gene 6000 software v1.7 (Corbett 
life science).  
 
Statistical analysis 
Statistical analyses were performed using GraphPad prism, Version 5.0 
(GraphPad Software, Inc., La Jolla, CA). In the scatter dot graphs the mean for 
each group was displayed as a horizontal line. Column graphs are represented 
showing the mean plus one standard error of the mean (SEM). Mean florescence 
intensity (MFI) values in flow cytometry analysis are presented with mean plus one 
standard deviation (SD) Statistical analysis was performed by using one-way 
ANOVA with Newman-Keuls post-hoc analysis. 
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RESULTS 
 
NcMP electrophoresis migration profile and western blot analysis  
In order to determine the NcMP and NcS protein migration profile, both 
extracts were separated in a reducing and denaturating SDS-Page gel. As shown 
in Figure 4-1a, and following silver nitrate staining, the NcMP extraction protocol 
presented an enrichment of the proteins with approximately 55, 35 and 29 kDa as 
compared with the protein profile observed in NcS preparation. Additionally, the 
NcMP extraction protocol yielded two proteins with an estimated molecular weight 
of 39 and 17 kDa that could not be observed in the NcS protein migration profile.  
In order to determine the existence of immunodominant antigens in both 
protein extracts, a western blot analysis of previously separated NcMP and NcS 
was performed using purified serum IgG and intestinal IgA obtained from mice i.n. 
immunized with NcMP and CpG. As shown in Figure 4-1b, incubation with purified 
serum IgG and development with either anti-IgG1 or IgG2a revealed that all 
previously identified NcMP protein bands reacted strongly with IgG of both 
isotypes. In contrast, only faint development was observed in similarly incubated 
and revealed NcS extracts. Additionally, a previously unobserved protein band in 
the silver nitrate stained gel with approximately 45 kDa also presented strong 
reactivity in the NcMP extracts. Similar incubation with purified intestinal IgA 
revealed similar results although protein reactivity with anti-IgA incubation was 
substantially lower. Once again, NcS incubation with purified intestinal IgA 
revealed only faint protein bands. Altogether these results indicate that the NcMP 
extraction protocol was enriched in some proteins already present in NcS 
fractions. They also show that proteins corresponding to major bands in NcMP 
extracts were immunogenic following i.n. immunization with CpG adjuvant. 
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Figure 4-1 - (a) Electrophoretic migration profiles of N. caninum protein extracts. SDS-
Page gel stained with silver nitrate, representative of the pattern of protein migration 
obtained for N. caninum membrane proteins (NcMP) (lane 2) and N. caninum sonicates 
(NcS) (lane 3). Numbers on the left correspond to the molecular weight, in kDa, of the 
molecular weight marker (lane 1). (b) Western blot analysis of NcMP and NcS following 
protein separation in a SDS-Page gel. Western blot was incubated with purified serum IgG 
and intestinal IgA from NcMP/CpG immunized mice and respectively revealed with anti-
IgG1, IgG2a or IgA, as indicated. Molecular weight marker (lane 1), NcS (lanes 2, 4 and 6) 
and NcMP (lanes 3, 5 and 7).  
 
Intestinal mucosa IgA produced upon immunization binds to and 
agglutinates N. caninum tachyzoites 
Production of IgA is the hallmark of specific immune responses at the 
mucosa52-55. As IgA levels in the small intestine were difficult to ascertain without 
invasive procedures, NcMP-specific IgA titres were measured in VLF to monitor 
the effectiveness of the mucosal immunization. As shown in Figure 4-2a, higher 
titres of antigen-specific IgA were detected in the VLF of mice from the NcMP/CpG 
group than in the other groups 1 week upon the boosting i.n. immunization. 
Accordingly, elevated levels of NcMP-specific IgA were detected in ILF of the 
 102 
 
NcMP/CpG mice group, as compared with the other groups studied, 1 week after 
infection (Figure 4-2b). Mice of the NcMP group also presented higher antibody 
levels in the VLF and ILF than control groups at both assessed time points, 
although lower than those of the NcMP/CpG group, thus highlighting the adjuvant 
effect of CpG.  
 
Figure 4-2 - N. caninum membrane proteins (NcMP)-specific IgA titres detected by ELISA 
in vaginal and intestinal lavage fluids (VLF and ILF, respectively). IgA titres were 
determined by ELISA in (a) VLF collected one week upon the second immunization from 
mice immunized twice i.n. with NcMP with or without CpG adjuvant (NcMP and 
NcMP/CpG, respectively) or sham-immunized with PBS (PBS) or CpG adjuvant alone 
(CpG); (b) ILF collected from the same groups one week after i.g. challenged with 5 × 107 
N. caninum tachyzoites performed 3 weeks upon the last immunizing administration. Data 
is presented as log10 of the antibody titres, as indicated. Results correspond to pooled 
data of three independent experiments (PBS n=14; CpG n=13; NcMP n=13; NcMP/CpG 
n=14). Each dot represents an individual mouse. Horizontal lines correspond to the mean 
value in each group; * p<0.05; *** p<0.001; detection limit (DL) is indicated by a horizontal 
line. 
 
The ability of the raised IgA antibodies to bind N. caninum tachyzoites was 
confirmed using flow cytometry. As shown in Figure 4-3a, a significant increase in 
the MFI value due to parasite-bound IgA was observed in tachyzoites incubated 
with IgA-NcMP/CpG as compared to that of parasites incubated with IgA-CpG, 
thus confirming the specificity of the antibodies raised by immunization. The 
agglutination of pathogens is one recognized effector function of IgA in the 
 103 
 
intestinal mucosa, thus preventing their attachment to host cells56. To assess the 
agglutinating capacity of the intestinal IgA produced upon i.n. immunization, N. 
caninum tachyzoites were incubated with IgA-NcMP/CpG and IgA-CpG and the 
formation of parasitic agglutinates assessed by optical microscopy. Upon 
incubation, a higher number of parasite clusters and a higher area per cluster 
(Figure 4-3b and c, respectively) were found when the tachyzoites were incubated 
with IgA-NcMP/CpG than with IgA-CpG or PBS alone. Parasites incubated with 
IgA-CpG or PBS were mainly observed as single cells, while parasites treated with 
IgA-NcMP/CpG were mainly observed agglutinated in large bodies (Figure 4-3d). 
Altogether, these results show that mucosal parasite-agglutinating IgA antibodies 
are produced upon i.n. immunization targeting NcMP. 
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Figure 4-3 - (a) Flow cytometric analysis of anti-IgA-FITC staining of N. caninum 
tachyzoites incubated with intestinal IgA antibodies collected from mice one week upon 
i.g. infection with 5 × 107 N. caninum tachyzoites 3 weeks upon the second of two i.n. 
immunizations with N. caninum membrane proteins plus CpG adjuvant (IgA-NcMP/CpG) 
or similarly treated with CpG alone (IgA-CpG), or with anti-IgA FITC alone (Secondary 
Ab), or untreated (Nc). Histograms are of a representative example from 3 independent 
experiments with n=3 for each condition. The mean fluorescence intensity (MFI) ± one SD 
is indicated. Statistical significance of the IgA-NcMP/CpG condition as compared with any 
of the other conditions is indicated (** p<0.01). Parasite agglutination was assessed by 
Hemacolor staining of tachyzoites incubated with PBS (Nc) or IgA-CpG or IgA-NcMP/CpG 
fractions for 1 h at 4 ºC. Analysis of the number (b) and size (c) of parasite clusters was 
made with pooled results of 20 micrographs taken from each condition at a 200× 
magnification. Parasite clustering was considered for 4 or more parasites appearing 
bound together. Bars correspond to tachyzoites incubated in: PBS alone (Nc), IgA-CpG 
alone (IgA-CpG) or with IgA-NcMP/CpG (IgA-NcMP/CpG), as indicated. Results are of 
one representative example out of three independent experiments. Each bar represents 
the mean value for each group. Error bar = SEM (*** p<0.001). (d) Representative 
microscopic analysis of N. caninum tachyzoites clustering assessed by Hemacolor 
staining. Tachyzoites were incubated with (A) PBS, (B) IgA-CpG or (C) IgA-NcMP/CpG 
fractions. Micrographs for each condition were obtained at 400× magnification. 
 
Serum IgG antibodies elicited upon immunization with NcNP plus CpG   bind 
to N. caninum and reduce parasite survival in infected macrophages 
To determine whether parasite-specific IgG antibodies were also induced by 
the i.n. immunization, serum samples were analyzed for the presence of NcMP-
specific antibodies of that isotype. As shown in Figure 4-4, the majority of the 
immunized mice presented high levels of antigen-specific IgG antibodies, detected 
prior to or after the i.g. parasitic challenge. All but one mice i.n. treated with CpG 
or PBS alone presented detectable serum IgG antibodies with this specificity by 1 
week upon the parasitic challenge. Analysis of the IgG isotype profile revealed a 
mixed IgG1 and IgG2a response in the NcMP and NcMP/CpG groups. However, 
disparate IgG1/IgG2a ratios were detected in these groups. While in mice 
immunized with NcMP alone, this ratio was > 1 prior or after infection, a ratio < 1 
was observed for the NcMP/CpG group (Figure 4-4). As the IgG2a and IgG1 
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isotypes were respectively associated to a Th1 and a Th2-type immune 
response57, these results indicate that a predominant Th1-type immune response 
was induced in the NcMP/CpG group while a Th2-type immune response was 
elicited by NcMP immunization in the absence of adjuvant.  
 
Figure 4-4 - Titres of N. caninum membrane proteins (NcMP)-specific serum IgG1 (open 
circles) and IgG2a (closed circles) antibodies determined by ELISA (a) one week upon the 
second immunization in mice immunized twice i.n. with NcMP with or without CpG 
adjuvant (NcMP and NcMP/CpG, respectively) or sham-immunized with PBS (PBS) or 
CpG adjuvant alone (CpG) or (b) in the same groups, one week after an i.g. challenge 
with 5 × 107 N. caninum tachyzoites performed 3 weeks upon the last immunizing 
administration. Data is presented as log10 of the antibody titres, as indicated .Numbers 
above each group represent the IgG1/IgG2a ratio, calculated with the mean log10 titres for 
the correspondent IgG isotype. Results correspond to pooled data of three independent 
experiments (PBS n=14; CpG n=13; NcMP n=13; NcMP/CpG n=14). Each dot represents 
an individual mouse. Horizontal lines correspond to the mean value in each group (* 
p<0.05; *** p<0.001; detection limit (DL) is indicated by a horizontal line. 
 
To determine the ability of serum IgG produced in the immunized mice to bind N. 
caninum parasites, tachyzoites were incubated with either IgG-NcMP/CpG or IgG-
CpG and analyzed by flow cytometry. As shown in Figure 4-5a, IgG-NcMP/CpG 
antibodies bound N. caninum tachyzoites more markedly than those in the IgG-
CpG preparation.  
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N. caninum is an obligate intracellular parasite and therefore the capacity to 
infect new cells once inside the host is essential for its survival. Therefore, 
blocking the infection of new cells could be an important factor for parasite control. 
In order to test the effects of the IgG preparations in the capacity of N. caninum to 
survive in BMDM cell cultures, tachyzoites were incubated with the IgG antibody 
preparations. The opsonized tachyzoites as well as non-opsonized counterparts 
were used to challenge macrophage cell cultures for 6 h upon which the number of 
parasites therein was evaluated by qPCR. As shown in Figure 4-5b, parasite 
opsonization with IgG raised by immunization resulted in a dose-dependent 
reduction in the total number of parasites detected in the cultures. 
 
Figure 4-5 - (a) Flow cytometric analysis of anti-IgG-FITC polyclonal antibody staining of 
N. caninum tachyzoites incubated with serum IgG antibodies collected from mice one 
week upon i.g. infected with 5 × 107 N. caninum tachyzoites 3 weeks upon immunized 
twice i.n. with N. caninum membrane proteins plus CpG adjuvant (IgG NcMP/CpG) or 
similarly treated with CpG alone (IgG-CpG), or with anti-IgG-FITC alone (Secondary Ab), 
or untreated (Nc). Histograms are a representative example from one out of 3 
independent experiments (n=3 for each condition). The mean fluorescence intensity (MFI) 
± one SD is indicated. Statistical significance of the IgG-NcMP/CpG condition as 
compared with any of the other conditions is indicated (*** p<0.001). (b) Number of 
parasites, assessed by qPCR in bone marrow-derived macrophage cell cultures 
challenged at a MOI of 1:1 for 6h with 1 × 106 tachyzoites previously incubated with IgG-
CpG or IgG-NcMP/CpG at the indicated dilutions, or untreated parasites (Nc). Results are 
of a representative example out of 3 independent experiments. Each bar represents the 
mean of 3 wells. Error bar = SEM (* p<0.05) 
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Protective effect of mucosal immunization against i.g. established 
neosporosis. 
Neosporosis is thought to be horizontally transmitted by oocyst ingestion in 
naturally infected hosts3. Therefore, it is conceivable that boosting the immune 
response in the gastrointestinal mucosa by parasite-specific immunization may 
increase host resistance against this parasitic disease. To assess whether the 
immunization procedures used here could be protective, we evaluated by using 
qPCR the parasitic burden in the brain of mice of the different groups, one week 
upon i.g. administration of 5 × 107 N. caninum tachyzoites performed three weeks 
upon the last immunization. As shown in Figure 4-6, a significant reduction of the 
mean parasitic DNA level in mice of the NcMP/CpG group was detected, as 
compared with that in control mice, which received CpG or PBS alone. Moreover, 
the NcMP/CpG group was the one showing the highest number of mice with 
absent or below detection-limit parasitic DNA (n=4; n=5 and n=10 in the PBS, CpG 
and NcMP, and NcMP/CpG groups, respectively). Interestingly, the mouse within 
the NcMP/CpG group showing higher parasitic colonization was the only that did 
not present detectable levels of IgA in either VLF or ILF, as shown in Figure 4-2. 
No significant differences were found among any other groups, although the mean 
parasitic burden detected in the NcMP/CpG group was greatly reduced as 
compared to that of the NcMP group. These results altogether show that i.n. 
immunization with NcMP plus CpG adjuvant confers protection against 
neosporosis established by the gastrointestinal tract. 
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Figure 4-6 - Parasitic load assessed by qPCR one week upon i.g. challenge with 5 × 107 
N. caninum tachyzoites in the brain of mice previously immunized twice i.n. with N. 
caninum membrane proteins with or without CpG adjuvant (NcMP and NcMP/CpG, 
respectively) or sham-immunized with PBS (PBS) or CpG adjuvant alone (CpG). Results 
are from pooled data of three independent experiments. (PBS n=14; CpG n=13; NcMP 
n=13; NcMP/CpG n=14). Each dot represents an individual mouse. Horizontal lines 
correspond to the mean value in each group (* p<0.05); detection limit (DL) is indicated by 
a horizontal line. 
 
Cytokine production in the immunized mice 
Production of IFN-γ is associated with host resistance to neosporosis 
whereas production of IL-4 and IL-10 associate with host susceptibility to this 
infection58,59. Therefore, the frequency and numbers of cells producing these 
cytokines were assessed in the spleen and MLN of immunized mice and controls 
one week upon i.g. infection. Unexpectedly, no differences were observed among 
the different analyzed groups in the frequency of splenic CD4+ T cells producing 
any of these cytokines (Figure 4-7a). Similarly, no significant difference in the 
frequency of splenic IFN-γ-producing CD8+ T cells was observed among groups 
(Figure 4-7a). In order to determine whether, despite present in similar frequencies 
to those of controls, CD4+IFN-γ+ and CD8+IFN-γ+ T cells of immunized mice could 
be producing higher amounts of this cytokine the MFI due to the IFN-γ staining 
was assessed in these lymphocyte populations. Results shown in Figure 4-7a 
indicate that such is not the case, as MFI values detected among all assessed 
groups did not significantly very. Nevertheless, and surprisingly, lower numbers of 
splenic CD4+IFN-γ+ cells were observed in the NcMP/CpG group as compared 
with the respective CpG control group (Figure 4-7b). Similarly, lower numbers of 
CD8+IFN-γ+ cells were also observed in the NcMP/CpG group, although not 
reaching statistical significance (Figure 4-7b). Furthermore, no significant 
differences between all analyzed groups were observed regarding the number of 
CD4+ T cells producing IL-10 and IL-4 (Figure 4-7b). The NcMP/CpG group also 
presented significantly lower numbers of total CD4+ and CD8+ T cells, as 
compared with the CpG and NcMP groups (Figure 4-7c). Similar analyses to all 
those performed in the spleen were also done in the MLN that did not show any 
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significant difference among mice groups (data not shown). Moreover, no 
significant differences among groups were observed in the levels of IFN-γ or of IL-
4 detected in cell culture supernatants of NcMP-stimulated splenocytes collected 
from the different analyzed mice, week upon infection (Figure 4-7d). Cytokine 
levels in similarly stimulated MLN cell cultures were consistently found near or 
below detection limits (data not shown). Altogether, these results indicate that in 
the NcMP/CpG group, the cellular immune response elicited upon the parasitic 
challenge was comparable to that of non-immunized PBS-treated infected mice 
and less noticeable than in the mice that received CpG adjuvant or NcMP alone.  
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Figure 4-7 - Frequency (a) and total numbers (b) of splenic IFN-γ+ or IL-4+ or IL-10+ CD4+ 
or IFN-γ+CD8+ T cells, or of (c) total splenic CD8+ and CD4+ T cells, detected one week 
after i.g. challenge with 5 × 107 N. caninum tachyzoites in mice previously immunized with 
N. caninum membrane proteins with or without CpG adjuvant (NcMP and NcMP/CpG, 
respectively) or sham-immunized with PBS (PBS) or CpG adjuvant alone (CpG). The 
mean fluorescence intensity (MFI) ± one SEM due to IFN-γ staining is indicated for each 
group for both CD4+ and CD8+ T cells in (a). Results correspond to pooled data of two 
independent experiments. PBS, CpG and NcMP n=8; NcMP/CpG n=9. Each bar 
represents the mean value for each group. Error bar = SEM (* p<0.05; ** p<0.01). (d) IFN-
γ and IL-4 concentrations detected in the supernatant of NcMP-stimulated (100 μg/ml) 5-
day cultures of spleen mononuclear cells collected from mice of the above referred groups 
and at the same post-infection time. Results are of a representative example out of 3 
independent experiments with four mice per group. Triplicate wells were set per animal. 
Bars represents the mean value for each group. Error bar = SEM 
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DISCUSSION 
 
In this study we have evaluated the host protective effect of i.n. 
immunization using NcMP and CpG adjuvant against i.g. established murine 
neosporosis. Since in horizontal transmitted neosporosis infection is established 
through the intestinal mucosa60, the potentiation of a specific immune response at 
this site could be one of the key factors to confer protection against this parasite. 
In this sense, previous studies by our group have shown that following mice i.g. 
infection with N. caninum this elicits an intestinal mucosa immune response 
marked by an early production of IL-12 and IFN-γ48 (Chapter 3). Regarding the use 
of NcMP as the target antigens in this immunization protocol, early works that 
determined immunodominant antigens of N. caninum tachyzoites have identified 
proteins with the exact or very similar molecular weights to the ones observed in 
NcMP extracts to be the most prominent antigens recognized by serum of different 
experimentally and naturally infected animals49,61-63. In addition, these proteins 
were found to be mainly associated with the membrane or secretory organelles. In 
this regard, several studies have shown that antibodies directed to several of 
these proteins were capable of preventing N. caninum invasion of new host cells64-
66, making them valued target antigens for immunization protocols. In the particular 
case of the NcMP extraction, a clear enrichment in several proteins and the 
isolation of previously unobserved proteins in NcS was achieved, as shown by the 
protein gel and western blot analysis clearly distinguishing our antigenic 
composition from others used in previous studies. Still, future work in this area is 
needed in order to fully characterize and identified the exact proteins used herein. 
Regarding the host protective capacity of our immunization strategy, in this 
study we shown that mice i.n. immunized with NcMP plus CpG adjuvant presented 
a lower parasitic burden in the brain when infected i.g. with N. caninum tachyzoites 
than controls receiving CpG or PBS alone, proving the host protective effect of this 
protocol. Although previous works have indicated the potential of i.n. immunization 
to confer protection in N. caninum intraperitoneally infected mice44-46, our data 
extend the protective effect of i.n. immunization to N. caninum infection 
established through the gastrointestinal tract, a route more closely resembling the 
one naturally followed by parasite in horizontally transmitted neosporosis. A higher 
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number of mice without detectable parasite DNA were observed in the NcMP/CpG 
group than in the other studied groups. This result might indicate that the 
immunization procedure used here might completely prevent parasite colonization 
in some of the infected mice. Nevertheless, further experiments will be necessary 
to more rigorously determine to what extent this may have happened as some of 
the mice that received CpG or PBS alone also presented parasite DNA below the 
detection limit. In this regard, absence of detectable colonization in a small 
percentage of mice following i.g. infection have previously been reported, which 
could account for the lower number of undetectable parasitic burdens observed in 
sham-immunized control groups47,48. 
CpG adjuvant typically promotes a Th1-type immune response67. Therefore, 
and as could be expected, the immunization procedure assessed here induced a 
predominant production of antigen-specific antibodies of the IgG2a isotype which 
is associated with a Th1-type immune response57, although IgG1 antibodies were 
also raised by the i.n. immunization. As previously remarked, a balanced Th1/Th2 
response might be more adequate in the course of neosporosis by conferring 
protection against the parasite, nonetheless avoiding fetal rejection46. 
Immunization with NcMP alone also induced the production of antigen-specific 
IgG. However, and in contrast with NcMP plus CpG immunization, this response 
was mainly characterized by the production of IgG1, indicative of a predominant 
Th2-type response. These results may indicate that NcMP antigens promote a 
Th2-type polarization of the immune response, associated with host susceptibility 
to neosporosis68, that could be overcome by the usage of CpG adjuvant. A similar 
effect of CpG was previously observed in mice subcutaneously immunized with N. 
caninum lysates or soluble antigen preparations28. Our results also reinforce the 
adequateness of using CpG adjuvant to achieve immunoprotection against N. 
caninum infection as described by others using alternative immunization 
strategies28,69. 
Despite the fact that the serum IgG isotype profile might indicate that a Th1-
type immune response was elicited in the NcMP/CpG group, no significant 
differences in the frequencies of splenic or MLN T cells producing IFN-γ, IL-10 and 
IL-4 could be detected among the studied groups. Since the majority of mice from 
the NcMP/CpG group presented no detectable parasitic colonization in the 
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absence of a significant increase in IFN-γ production the achieved protection could 
be, at least partially, independent of a strong Th1 response. Vaccine-induced 
protection in the absence of a Th1-type response was previously reported in mice 
infected by the protozoan Leishmania amazonensis70.  
Both immunized groups in this study presented parasite-specific IgA in the 
intestinal mucosa. Nevertheless, NcMP/CpG immunized mice presented higher 
IgA titres highlighting the mucosal adjuvant capacity of CpG also in the induction 
of IgA production. Still, although IgA is regarded as an hallmark of the induction of 
mucosal immunity53,54, and even though primed cells in the nasal mucosa 
following i.n. immunization were shown to be capable of trafficking to the intestinal 
mucosa71,72, in future works it would be worth confirming the presence of parasite-
specific IgA producing cells in the intestinal lamina propria since transfer of IgA to 
the intestine from the serum through the bile has also been described in mice73. 
Nevertheless, in this study we have shown that parasite-specific IgA obtained from 
the intestinal lumen of immunized mice was capable of agglutinating N. caninum 
parasites. In this sense, and since previous studies have reported a host 
protective role of intestinal IgA in cats74 and mice75 infected with the closely related 
protozoan Toxoplasma gondii, it might be hypothesized that the lack of a 
noticeable Th1-type cytokine bias in the NcMP/CpG group could result from the 
impairment of host invasion across the intestinal mucosa due to parasite-
agglutinating IgA that could also account for the higher number of mice with 
undetectable colonization levels. Supporting this hypothesis, the only animal in 
that group that did not present detectable levels of IgA in both analyzed mucosa 
was the one showing higher parasite DNA levels. In this scenario, although a cell 
mediated immune response, polarized to a Th1 phenotype, might be generated by 
the immunization its full activation upon infection in the immunized mice could 
have been prevented by lack of antigenic stimulation in the NcMP/CpG group. The 
lack of an exacerbated cellular immune response in the spleen and MLN of the 
NcMP/CpG group further support this hypothesis. In this sense, and as a strong 
production of IFN-γ in dams has previously been shown to compromise fetus 
viability76,77, it would be valuable to assess if the immunizing protocol used herein 
could also be protective in a pregnant mice model of N. caninum infection.  
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In addition to the possible host-protective effects of IgA, we also show that 
IgG antibodies obtained from immunized mice can opsonize N. caninum 
tachyzoites and reduce parasite survival in murine macrophages challenged with 
this parasitic form. As N. caninum is an obligate intracellular pathogen, a cell-
mediated rather than a humoral immune response could be expected to be host 
protective. However, these results indicate that antibodies specific for N. caninum 
might contribute for host protection against this parasite. These data are in 
agreement with previous reports demonstrating that antibodies specific for 
different membrane proteins of N. caninum are capable of interfering and even 
block the parasite entry in host cells64-66. However, such a protective role needs to 
be confirmed in further experiments, namely as the effect of IgG opsonization on 
leukocyte killing of tachyzoites of the closely related protozoan T. gondii remains 
controversial with previous studies showing either enhanced killing78 or no effect in 
this regard79.  
Only a limited number of reports specifically studied the mucosal immune 
response to this parasite47,48, and to the best of our knowledge no study had 
previously addressed the immune response in the intestinal mucosa and 
associated lymphoid tissue of mice immunized with N. caninum antigens. The 
widespread usage of i.p. inoculation in experimental studies on neosporosis likely 
contributed to the overlooking of the mucosal layer of immune defense against this 
parasitosis. By showing that intestinal lumen antibodies induced by mucosal 
immunization can agglutinate N. caninum tachyzoites we provide the first evidence 
indicating that stimulating antibody production in the gut by means of mucosal 
immunization may worth be attempted as a protective strategy against horizontally 
transmitted neosporosis.  
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ABSTRACT 
 
Neospora caninum is an obligate intracellular protozoan parasite 
responsible for severe economic losses in dairy and beef cattle farms.  Although 
vaccination is widely regarded as the preferable strategy to control or prevent 
cattle neosporosis no commercial vaccine is currently available. We have 
previously shown that intranasal immunization with N. caninum membrane 
antigens and CpG adjuvant protected mice against intragastrically established 
neosporosis. Nevertheless, the long-term protective effect of this immunization 
strategy was not determined. Here, we show that the previously reported 
protective effect of this immunization procedure could still be observed 20 weeks 
upon immunization. This protection was accompanied by long-lasting elevated 
levels of parasite-specific serum IgG and intestinal IgA. In accordance with an 
observed IgG1/IgG2a ratio < 1, splenocytes from immunized mice responded to 
parasite-antigen recall by producing interferon-γ (IFN-γ). Nevertheless, one week 
after the infectious challenge no significant differences in IFN-γ production were 
observed between immunized mice and sham-immunized controls, regardless of 
the achieved protection. This work shows that the previously reported mucosal 
immunization strategy is effective in the long-term in protecting mice against N. 
caninum infection established through the gastrointestinal tract. Moreover, the 
results reported herein provide additional evidence suggesting that protection may 
primarily depend on antibody production. 
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INTRODUCTION 
 
Neospora caninum is an apicomplexan protozoan closely related to 
Toxoplasma gondii. Initially recognized as the causative agent of 
neurodegenerative disease in dogs1, N. caninum was further shown to infect a 
wide range of mammalian hosts among which cattle is the most economically 
relevant2,3. Recent estimates indicate that the annual worldwide economic losses 
in beef and dairy industries due to neosporosis, the disease caused by this 
parasite, surpass one billion dollars4. Transmission of N. caninum from infected 
cows to their fetuses is a major infection route2,3 that accounts for the marked 
increase in the likelihood of abortion observed in infected dams5-11. However, 
ample evidence suggests that oral transmission to pregnant cows is responsible 
for ‘storm-like’ epidemic abortions12. Although economic analysis of different 
control strategies indicated that vaccination would be the most cost effective 
approach to manage this parasitic infection in cattle13, no commercial vaccine is 
currently available in the market14. Nevertheless, natural infected dams can 
develop to some extent long-term protection against fetal loss in consecutive 
pregnancies5,15,16. In addition, inoculation with live and attenuated parasites have 
yield encouraging results regarding the prevention of vertical transmission and 
fetal loss in cattle indicating that a successful vaccine against this parasite can be 
achieved17-20. Nevertheless, despite their high effectiveness, vaccination with live 
attenuated strains have considerable drawbacks due to possible regression of the 
used strain to a more virulent status, as well shelf-life and logistical issues20,21. On 
the other hand, immunization with proteins involved in the parasite host cell 
invasion process are generally considered safe and have, for the most part, 
produced encouraging results in mice models of neosporosis, mainly leading to a 
reduction in parasitic burdens in infected animals22-29. Still, the success of these 
protocols in pregnant mice models of infection has shown some limitations in 
preventing vertical transmission or fetal loss30,31.  
Although the gastrointestinal tract constitutes the natural route of infection in 
horizontally transmitted neosporosis, and even though a recent characterization of 
the immune response in a mice model of intragastric infection showed that the 
parasite elicits both a mucosal and systemic immune response32 (chapter 3), 
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mucosal immunization as a means to confer protection against this parasite has 
only been employed in a limited number of occasions despite encouraging 
results33-35. Recently, we have shown that intranasal (i.n.) immunization targeting 
N. caninum membrane proteins conferred protection against murine neosporosis 
established through the gastrointestinal tract35 (chapter 4). Nevertheless, an ideal 
immunization protocol must prove effective in conferring long-lasting protection 
against the targeted pathogen. Therefore in this study, we evaluated whether the 
immune response and protective effect of our previously developed mucosal 
immunization strategy could be maintained in the long-term. 
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MATERIALS AND METHODS 
 
Animals 
Seven week-old female C57BL/6 mice were purchased to Charles River 
(Barcelona, Spain). Animals were kept at Instituto de Ciências Biomedicas Abel 
Salazar (ICBAS) animal facility under specific-pathogen free conditions throughout 
all the experimental procedures. Procedures involving mice were performed 
according to the European Convention for the Protection of Vertebrate Animals 
used for Experimental and Other Scientific Purposes (ETS 123) and 86/609/EEC 
Directive and Portuguese rules (DL 129/92). Authorization for the experiments was 
issued by the competent national board (document 0420/000/000/2010). 
Experiments were approved by the institutional board responsible for animal 
welfare (ORBEA) at ICBAS. 
 
Parasites  
N. caninum tachyzoites (Nc1 isolate) were kept by serial passages in VERO cells 
cultures, maintained in Minimal Essential Medium containing Earle’s salts (Sigma, 
St. Louis, USA), supplemented with 10% fetal calf serum (Biowest, Nuaillé, 
France), L-Glutamine (2 mM), Penicillin (200 IU/ml) and Streptomycin (200 µg/ml) 
(all from Sigma), in a humidified atmosphere with 5% CO2 at 37 ⁰C. Tachyzoites 
were maintained until destruction of 80% of the host cell monolayer and were 
isolated as previously described36. Briefly, free parasites and adherent cells were 
recovered using a cell scraper and centrifuged at 1 500 × g for 15 min. The pellet 
was passed through a 25 G needle and then washed three times in PBS by 
centrifugation at 1 500 × g for 15 min. The resulting pellet was resuspended and 
passed through a PD-10 desalting column, containing Sephadex™ G-25M (GE 
Healthcare, Freiburg, Germany). Tachyzoites concentration was determined in a 
haemocytometer. 
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Preparation of whole tachyzoite lysates and cell-membrane extracts 
N. caninum membrane proteins (NcMP) were extracted using a modification of a 
previously described method37,38. Briefly, free tachyzoites were resuspended in 
PBS containing 0.75% triton X-114 (Sigma), incubated 10 min on ice and 
centrifuged at 10 000 × g for 30 min at 4 ⁰C and the supernatant was recovered 
and placed in a water bath at 30 ⁰C during 3 min. The procedure was repeated 
and the supernatant was centrifuged at 1 000 × g for 3 min at room temperature. 
The aqueous phase was discarded and the NcMP were precipitated with the 
addition of absolute ethanol, vortexed vigorously during 15 sec and incubated 1 h 
on ice. The samples were centrifuged at 12 000 × g for 20 min at 4 ⁰C and the 
resulting pellet was dried, resuspended in PBS and stored at -20 ⁰C.  
Whole N. caninum lysates were prepared by disruption of tachyzoites following 
sonication (20 cycles of 15 s at 100 W) with a Branson cell disrupter model W 185 
D in an ice bath. The obtained N. caninum sonicates (NcS) were sequentially 
passed through 0.45 and 0.2 µm pore-size filters and stored at -20 ⁰C. 
Quantification of NcMP or NcS was performed by using the Lowry protein assay. 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis followed by silver 
nitrate staining was performed following each protein extraction in order to 
determine and confirm the protein migration profile.  
 
Immunizations and tissue sample collections 
Eight week-old female mice, were used with random distribution into 3 groups and 
immunized intranasally (i.n.) twice with three weeks interval under light isoflurane 
anesthesia with 20 µl of: PBS alone (PBS group, n=13) or PBS containing, 10 µg 
of CpG ODN 1826 VacciGrade (invivogen, San Diego, CA) (CpG group, n=13), or 
PBS containing 30 µg of NcMP plus 10 µg of CpG ODN 1826 VacciGrade 
(NcMP/CpG group, n=13). At weeks 1, 7 and 13 after the last immunization serum 
and vaginal lavages fluids (VLF) from all mice were collected for the detection of 
NcMP-specific IgG and IgA, respectively. At week 19, 3 animals per group were 
euthanized by cervical dislocation. Blood and intestinal lavage fluids (ILF) were 
collected for analysis of NcMP-specific IgG and IgA, respectively while the 
mesenteric lymph nodes (MLN) and spleen were aseptically removed for the 
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analysis of the immune response. All remaining mice were intragastrically (i.g.) 
challenged, 20 weeks after the last immunization, with 5 × 107 freshly isolated N. 
caninum tachyzoites as previously described36. One week after infection all the 
remaining mice were sacrificed by cervical dislocation and spleens were 
aseptically removed for the analysis of the immune response, while the brain was 
collected and stored at -20 ⁰C for DNA extraction. At this day, serum and ILF from 
all mice were collected for the detection of N. caninum specific IgG and IgA, 
respectively. 
 
Antibody detection 
Serum IgG1 and IgG2a titres specific for NcMP were quantified by ELISA. Briefly, 
96-well plates (Maxisorp, Nunc, Denmark), were coated overnight at 4 ⁰C with 
NcMP diluted in PBS at a concentration of 5 µg/ml. All the wells were saturated 
with 2% bovine serum albumin (BSA) (Sigma) in TST buffer (150 mM NaCl, 10 
mM EDTA and 0.05% Tween 20, pH=8) for 1 h. Serum samples were serial diluted 
in 1% BSA TST buffer and incubated for 1 h, followed by washing and addition of 
alkaline phospatase-coupled monoclonal goat anti-mouse IgG1 or IgG2a 
monoclonal antibodies (Southern Biotechnology Associates, Birmingham, USA) 
and incubation for 1 h. After washing, the specifically bound antibodies were 
detected by the development with the substrate solution of p-nitrophenyl 
phosphate (Sigma) and the reaction was stopped with the addition of 0.1 M EDTA, 
pH=8 solution. The absorbance was measured at 405 nm, subtracting for each 
well the value for the absorbance at 570 nm. The antibody titres were expressed 
as the log10 value of the reciprocal highest dilution with an absorbance higher than 
the value of the control (no serum added). Detection of IgA antibodies specific for 
NcMP were quantified by ELISA as previously described, using alkaline 
phospatase-coupled goat anti-mouse anti IgA mAb (Southern Biotech).  
 
In vitro cell cultures and cytokine detection. 
To assess NcS-specific cytokine production spleens and MLN were aseptically 
removed from euthanized mice at the time-points previously described and 
homogenized in HBSS (Sigma). Spleen red blood cells were lysed and the spleen 
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and MLN cells were suspended in RPMI-1640 (Sigma), supplemented with 10% 
fetal calf serum (Biowest), HEPES (10 mM), Penicillin (200 IU/ml) and 
Streptomycin (200 µg/ml) (all from Sigma), β-mercaptoethanol (0.1 μM) (Merk) and 
plated (5 × 105/well) in triplicates per animal/organ in round bottom 96-well plates 
(Nunc), and stimulated with NcS (60 µg/ml) for 3 days at 37 ºC and 5% CO2. 
Unstimulated conditions were set per animal/organ to assess the cells basal 
cytokine production level. The concentration of IFN-γ and IL-4 in cell culture 
supernatants were respectively quantified with the Mouse IFN-γ DuoSet® ELISA 
development system (R&D Systems, Minneapolis, MN, USA) and IL-4 ELISA 
Ready-Set-Go!® (eBioscience, San Diego, CA, USA) kits, both according to 
manufacturer’s instructions. 
 
DNA extraction  
DNA from the brain of infected mice was extracted as previously described39. 
Briefly, brains were weighted and homogenized. Samples were incubated 
overnight at 55 ⁰C in a solution containing 1% SDS and 1 mg/ml Proteinase K 
(sigma). DNA was extracted by the phenol (Sigma)-Chlorophorm (Merk) method 
followed by ammonium acetate/ethanol precipitation. 
 
Real-time PCR analysis 
The parasite burden in the brain of infected mice was assessed by quantitative 
real-time PCR (qPCR) analysis of the parasite DNA performed in a Corbett rotor 
gene 6000 system (Corbett life science, Sydney, Australia).  Analysis was 
performed by using KAPA PROBE FAST 2xMasterMix, Universal (Grisp, 
Portugal), for the amplification of a 103 bp sequence of the Nc5 region of N. 
caninum genome using the primers NcA 5’   GCTACCAACTCCCTCGGTT 3’ and 
NcS 5’ GTTGCTCTGCTGACGTGTCG 3’ both at a final concentration of 0.2 µM, 
and the florescent probe FAM-CCCGTTCACACACTATAGTCACAAACAAAA-BBQ 
at a final concentration of 0.1 µM (all design and obtained from TIB-Molbiol, Berlin, 
Germany). The DNA samples were amplified using the following program: 95 ⁰C 
for 3 min, 95 ⁰C for 5 sec, 60 ⁰C for 20 sec with fluorescence acquisition and the 
second and third steps were repeated 50 times. Length of the amplified DNA was 
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confirmed in a 3% agarose gel stained with ethidium bromide. In all runs parasite 
burden was determined by interpolation of a standard curve, ranging from 10 to 
10-4 ng of DNA extracted from N. caninum tachyzoites included in each run and 
the data analyzed in the Rotor gene 6000 software v1.7 (Corbett life science).  
 
Statistical analysis 
Statistical analyses were performed using GraphPad prism, Version 5.0 
(GraphPad Software, Inc., La Jolla, CA). In the scatter dot graphs the mean for 
each group was displayed as a horizontal bar. Column graphs are represented 
showing the mean plus one standard error of the mean (SEM). Statistical analysis 
between groups was performed by using one way ANOVA analysis of the variance 
with a Newman-Kleus post-hoc. 
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RESULTS 
 
Intranasal immunization with NcMP induces long-lasting humoral immunity  
In a previous work, we have shown that i.n. immunization with NcMP plus 
CpG adjuvant raised parasite-specific serum IgG and parasite-agglutinating 
intestinal IgA. Both showed effector function as the specific IgG facilitated in vitro 
parasite clearance by macrophages while the IgA antibodies strongly agglutinated 
N. caninum tachyzoites35 (chapter 4). In order to determine whether the increased 
production of parasite-specific IgG and IgA antibodies induced by this 
immunization protocol could be maintained in the long term, mice were immunized 
by i.n. administration of 20 µl of PBS containing 30 µg NcMP and 10 µg CpG. 
Controls were sham-immunized with PBS alone or PBS plus CpG adjuvant. Prior 
to the infectious challenge, parasite-specific IgA production was assessed in VLF 
to monitor the effectiveness of immunization with minimal invasiveness, as 
previously reported35 (chapter 4). As shown in Figure 5-1a, NcMP-specific IgA was 
detected in VLF samples collected from immunized mice at all assessed time-
points. As expected no antigen-specific IgA was detected in similar samples 
obtained from sham-immunized controls. Nevertheless, and although elevated as 
compared to controls, NcMP-specific IgA titres in the VLF collected from 
immunized mice slowly decreased from week 1 to 13 upon the boost 
immunization. Still, analysis of IgA levels in ILF of non-infected mice collected 19 
weeks after the boost immunization, showed these to be higher in the mucosa of 
immunized mice than in controls (Log10 IgA titre in NcMP/CpG group: 2.85±0.26 vs 
below detection limit in PBS and CpG sham-immunized groups; n=3 per group). 
As could be anticipated by this preliminary analysis, NcMP-specific IgA levels in 
ILF collected from immunized mice one week after i.g. infection revealed high 
NcMP-specific IgA levels, similar to those detected in the VLF one week after the 
boost immunization, while these were found below detection limit in both control 
mouse groups (Figure 5-1b). 
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Figure 5-1 - Titres of N. caninum membrane proteins (NcMP)-specific IgA in vaginal and 
intestinal lavage fluids (VLF and ILF, respectively). IgA titres were determined by ELISA in 
(a) VLF collected one, seven and thirteen weeks upon boost immunization from mice 
immunized twice i.n. with NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with 
CpG adjuvant (CpG) or PBS alone and (b) in ILF collected from mice one week after i.g. 
challenge with 5 × 107 N. caninum tachyzoites. Data is presented as log10 of the antibody 
titres. Number of mice per VLF/ILF analyses were performed using: PBS n=13/9; CpG 
n=13/10; NcMP/CpG n=13/9. Each dot represents an individual mouse. Horizontal lines 
correspond to the mean value in each group; detection limit (DL) is indicated by a 
horizontal line; (* p<0.05). 
 
In order to determine NcMP-specific IgG titres, serum samples were also 
collected from mice of all groups 1, 7 and 13 weeks following the boost 
immunization. As shown in Figure 5-2a, immunized mice serum NcMP-specific 
IgG antibodies were elevated in all time-points accessed without significant 
decrease in the mean titre of this immunoglobulin overtime. Parasite-specific IgG 
titres in sham-immunized control groups fell below detection limit in all assessed 
time-points. Analysis of the IgG isotype showed a mixed IgG1 and IgG2a 
production. Production of IgG1 and IgG2a are respectively associated with an 
underlying Th2- and Th1-type immune response40. As the IgG1/IgG2a ratio, 
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calculated with the mean titre values for each IgG isotype was lower than 1 in all 
analysis performed after the boost immunization, this indicates that the used 
immunization induced a Th1-type immune response bias. Serum parasite-specific 
IgG titres detected one week after the i.g. parasitic challenge were still below the 
detection limit in both sham-immunized groups while immunized mice presented a 
mixed IgG1 and IgG2a production with an IgG1/IgG2a ratio below 1 (Figure 5-2b). 
In summary, analysis of both IgG and IgA isotypes indicates that a long-lasting 
systemic and mucosal humoral response is elicited by i.n. immunization with 
NcMP and CpG. 
 
Figure 5-2 - Titres of N. caninum membrane proteins (NcMP)-specific IgG1 (closed 
circles) and IgG2a (open circles) in serum. IgG titres were determined by ELISA in serum 
collected (a) one, seven and thirteen weeks upon boost immunization and (b) one week 
after i.g. challenge with 5 × 107 N. caninum tachyzoites from mice immunized twice i.n. 
with NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant (CpG) 
or PBS alone. Data is presented as log10 of the antibody titres. Numbers above each 
group represent the IgG1/IgG2a ratio, calculated with the mean log10 titres for the 
correspondent IgG isotype. Number of mice per analysis in (a)/(b): PBS n=13/9; CpG 
n=13/10; NcMP/CpG n=13/9. Each dot represents an individual mouse. Horizontal lines 
correspond to the mean value in each group; detection limit (DL) is indicated by a 
horizontal line. 
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Long-lasting Th1-type immune memory was maintained upon immunization 
with NcMP  
The previous IgG isotype analysis indicated that i.n. immunization with 
NcMP plus CpG adjuvant induced a parasite-specific biased Th1-type immune 
response. In order to confirm this indication and to analyze the memory response 
following antigen recall, spleen and MLN cells collected from immunized mice and 
controls 19 weeks after the boost immunization were stimulated in vitro with NcS 
in order to simulate the complex antigenic composition that these cells would 
encounter following host infection with N. caninum. As shown in Figure 5-3, a 
marked increase in IFN-γ levels was observed in the culture supernatants of NcS-
stimulated splenocytes and MLN cells obtained from immunized mice, in 
comparison with similarly stimulated cells obtained from sham-immunized mouse 
groups. Regarding the levels of IL-4, and although IgG1 was found elevated in all 
time-points analyzed in the immunized group, these were found within control 
values, close to detection limits, in the NcS-stimulated splenocyte and MLN 
cultures in all assessed groups. The above results, altogether, indicate that 
parasite-specific immune memory persisted for at least 19 weeks following the 
boost immunization. Importantly, the memory response was found biased towards 
the production of host protective cytokine IFN-γ. 
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Figure 5-3 – IFN-γ and IL-4 concentration in the supernatants of (a) MLN or (b) 
splenocytes cell cultures unstimulated or stimulated for 3 days with N. caninum sonicates 
(NcS). Cells were isolated from the spleens and MLN of mice 19 weeks upon the last of 
two i.n. with NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG 
adjuvant (CpG) or PBS alone. Number of mice per analysis: PBS n=3; CpG n=3; 
NcMP/CpG n=3. Stimulated cells were placed in triplicates per mouse. Stimulated cells 
were placed in triplicates per mouse. Bars represent mean plus one SEM. Detection limit 
(DL) is indicated by a horizontal line (15 pg/mL) (*** p<0.001) 
 
Long-term protection conferred by i.n. immunization against N. caninum 
infection 
Having determined the persistence of immune memory, the long-term 
protective effect of i.n. immunization with NcMP plus CpG adjuvant was evaluated. 
In all groups, mice were infected i.g. with 5 × 107 N. caninum tachyzoites 20 weeks 
upon the boost immunization. One week after infection the parasitic burden was 
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assessed in the brain by parasite DNA-specific qPCR. As shown in Figure 5-4, a 
drastic reduction in the number of colonized animals could be observed in the 
NcMP/CpG group where all but mouse presented detectable parasite DNA. In 
contrast, high parasitic DNA levels were observed in the brain of the two sham-
immunized control groups. This result shows that i.n. immunization with NcMP 
plus CpG confers long-lasting protection against N. caninum infection. 
 
Figure 5-4 - Parasitic load assessed by qPCR one week upon i.g. challenge with  5 × 107 
N. caninum tachyzoites in the brain of mice previously immunized twice i.n. with NcMP 
and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant (CpG) or PBS 
alone. Data is presented as log10 of the number of parasites by gram of organ. Number of 
mice per group: PBS n=9; CpG n=10; NcMP/CpG n=9. Each dot represents an individual 
mouse. Horizontal lines correspond to the mean value in each group; Not detected (ND) is 
indicated by a horizontal line; (* p<0.05; **p<0.01) 
 
Parasite-antigen recall induced a similar IFN-γ production by splenocytes of 
NcMP immunized mice and sham-immunized controls  
One week upon the i.g. N. caninum challenge, the production of IFN-γ and 
IL-4 was evaluated in splenocyte cell cultures stimulated with NcS, by assessing 
the levels of these cytokines in the cell culture supernatants. As shown in Figure 5-
5, cell culture NcS stimulation induced the production of IFN-γ in all assessed 
groups. However, no significant difference was found in the levels of IFN-γ 
between culture supernatants of splenocytes from immunized mice and PBS-
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treated controls that were however significantly lower than the ones detected in 
the supernatants of cells collected from controls sham-immunized with CpG. The 
levels of IL-4 were found within control values in all groups. These results indicate 
that in the immunized mice the i.g. challenge did not induce a parasite-specific 
immune response, as assessed by IFN-γ production, more marked than that of 
controls sham-immunized with PBS. Results moreover show that CpG-priming, 
although not protective, predisposed the mice to respond with IFN-γ production 
when challenged with N. caninum.  
 
Figure 5-5 – IFN-γ and IL-4 concentration in the supernatants of splenocytes cell cultures 
unstimulated or stimulated for 3 days with N. caninum sonicates (NcS). Cells were 
isolated from the spleens of mice one week upon i.g. challenge with 5 × 107 N. caninum 
tachyzoites that have been previously immunized twice i.n. with NcMP and CpG adjuvant 
(NcMP/CpG) or sham-immunized with CpG adjuvant (CpG) or PBS alone. Number of 
mice per analysis: PBS n=9; CpG n=10; NcMP/CpG n=9. Stimulated cells were placed in 
triplicates per mouse. Bars represent mean plus one SEM. Detection limit (DL) is 
indicated by a horizontal line (15 pg/mL) (* p<0.05; *** p<0.001).   
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DISCUSSION 
 
Cattle infection with N. caninum is a major cause of economic losses 
worldwide and although vaccination is regarded as the preferable option for the 
control of this parasite infection13, the introduction in the market of an effective 
vaccine against this protozoan is still not foreseen in the near future14. 
Nevertheless, recent experimental immunization studies using either live 
attenuated strains or parasite subunits yielded promising results14,41 suggesting 
that a viable vaccination strategy can be achieved. One factor that should be 
accounted in the development of an effective vaccine against neosporosis is that 
horizontal parasite transmission in cattle occurs via the gastrointestinal mucosa2. 
In fact, some studies have shown that horizontal transmission can occur more 
frequently than initially thought in cattle herds42-44 and that this form of parasite 
transmission could be associated with the most severe cases of “abortion-storm” 
events12. Still, despite the recent evidence that following intragastric infection in 
mice N. caninum induces a mucosal and systemic immune response32 (chapter 3) 
and that an ideal N. caninum vaccine should elicit both systemic and mucosal 
immunity45, mucosal immunization in mice was only evaluated in a few 
studies31,33,34 and has never been attempted in cattle in the context of 
neosporosis. In addition, the induction of a parasite-specific mucosal immune 
response as a means to achieve protection against this parasite has only been 
attempted in one study so far. In this regard, we have previously shown that i.n. 
immunization with NcMP as target antigen and CpG adjuvant could successfully 
protect mice challenged i.g. with N. caninum35 (chapter 4). Here we further 
explored this immunization strategy by assessing the long-term elicited immune 
response and host protective effect. The induction of long-lasting memory is an 
essential point in the development of an effective immunization strategy that has 
never been addressed in previous studies on experimental vaccination against 
neosporosis. The obtained results showed that the used immunization strategy 
conferred long-lasting protection against i.g.-established neosporosis, still 
noticeable 20 weeks upon a single boost immunization. More importantly, and in 
agreement with our previous results35 (chapter 4), parasitic DNA was detected 
only in the brain of a single immunized mouse. The achieved protection might 
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indicate that immunization prevented N. caninum penetrance across the 
gastrointestinal mucosa and/or elicited a parasite-specific immune response 
capable of clearing the infection. Still, further understanding of the exact host 
protective mechanisms elicited by this immunization protocol is necessary to 
clarify this point. Due to the unique immune regulation that occurs during 
pregnancy which could be a contributing factor for N. caninum high rate of vertical 
transmission46,47, prevention of host infection could prove to be the best strategy to 
prevent N. caninum induced abortions in cattle. 
We have previously determined that the humoral immune response elicited 
by the used immunization involved production of parasite-agglutinating IgA in the 
vaginal and intestinal mucosa, and parasite-opsonizing serum IgG which facilitated 
in vitro parasite clearance by bone-marrow-derived macrophages35 (chapter 4). 
Therefore, we assessed here whether parasite-specific Ig of both isotypes could 
still be produced in the long-term upon immunization. IgA produced in mucosal 
surfaces is regarded as a hallmark of mucosal immunity48-50 namely due to its 
immune exclusion function through pathogen agglutination48,50-52. Therefore, the 
parasite-specific intestinal IgA elicited by immunization might be a key contributor 
to the observed protection by promoting parasite agglutination and prevention of 
intestinal epithelial barrier penetration. Still, in this study we found that the levels of 
parasite-specific IgA in the vaginal mucosa steadily decreased over-time though 
its mean titre was still well above control levels 13 weeks following the boost 
immunization.  
Previous studies addressing the kinetics of IgA production in the intestinal 
mucosa indicated that in the absence of an antigen-specific stimulus the 
production of antigen-specific IgA decreases over-time due to a dynamic 
modulation of the population of IgA producing plasma cells in the mucosa lamina 
propria where newly arrived IgA producing cells displace previously resident 
cells53. In accordance, a previous work showed that in mice i.n. immunized with T. 
gondii antigen SAG1 plus cholera toxin adjuvant antigen-specific IgA production in 
the gut gradually decreased in the 150 days following the boost immunization. This 
decrease could be partially reversed by an additional boost immunization54. 
Similarly, in mice inoculated i.g. with rotavirus, virus-specific IgA could be detected 
in the intestine 10 months after priming although at 3-fold lower levels than at 42 
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days after infection55. Here, parasite-specific IgA levels detected in ILF of 
immunized mice, either 19 weeks after the boost immunization in uninfected mice 
or one week after infection were similar to those detected 4 weeks after the boost 
immunization, as previously reported35 (chapter 4). This indicates that parasite-
specific IgA production in the intestinal mucosa induced by the NcMP plus CpG 
prime-boost immunization was sustained for at least 20 weeks. In agreement, 
mice i.n. immunized with Yersinia pestis peptides plus CpG adjuvant displayed 
sustained intestinal IgA production, detected for at least 120 days upon 
immunization56. This report in conjunction with the results shown here could 
indicate that CpG adjuvant might induce long-lasting IgA production in the 
intestinal mucosa following i.n. immunization. Furthermore, following oral 
immunization with cholera toxin IgA-producing memory cells could still be 
observed 1 year later in the MLN, although toxin-specific IgA production was found 
to decrease over time in the intestinal mucosa57.  
In this study we also observed that in the immunized mice, parasite-specific 
IgG titres were significantly elevated in the long term showing no significant 
decrease overtime. Several studies have indicated that IgG raised against N. 
caninum surface and apical vesicle complex proteins could prevent parasite 
invasion of host cells58-62. Moreover, and in line with these results, we have 
previously reported that NcMP-specific serum IgG elicited by the immunization 
procedure used here also displayed in vitro effector function35 (chapter 4). 
Therefore, it can be hypothesized that the IgG raised by the immunization might 
also contribute to host protection. Still, and to the best of our knowledge, 
protection conferred by N. caninum-specific IgG has never been shown in vivo in 
either mice or cattle, making it an interesting point to be explored in future studies. 
In addition, and in accordance with our previous results35 (chapter 4) isotype 
profile of the produced IgG showed a preponderant production of IgG2a over 
IgG1, indicative of a Th1-type response bias40. Nevertheless, in this study it was 
found that this higher IgG2a production was sustained in all subsequent analysis 
performed, indicating the induction of a long-lasting biased Th1-type immune 
response in the NcMP immunized mice. In agreement, IFN-γ and IL-4 produced by 
MLN and spleen cells of the immunized mice upon in vitro parasite-specific 
antigen recall 19 weeks after the boost immunization, confirmed the Th1-type bias 
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by showing a clear increase in the production of IFN-γ and negligible IL-4 
production, as compared to sham-immunized groups. These results also confirm 
the well-known Th1-type immunomodulatory capacity of the CpG adjuvant when 
used as a mucosal adjuvant63-65. In addition, and due to the known host protective 
role of IFN-y in N. caninum infection66-68, recently shown to be the main mediator 
of host protection conferred by CD8+ T cells69, the induction of a memory IFN-γ 
producing response could be a contributing factor to the observed protection. 
Nevertheless, the same analysis performed using splenocytes obtained one week 
after the i.g. infection showed that IFN-γ production in sham-immunized mice 
reached levels similar to those of immunized mice. A similar observation was 
made in mice infected 3 weeks upon the boost immunization that was previously 
suggested to be the result of IgA-mediated prevention of parasite penetration in 
the host across the gastrointestinal tract and consequent deprivation of antigen 
stimulation in the immunized mice35 (chapter 4). In fact, while the mean IFN-γ 
levels in both sham-immunized groups increase following mice infection when 
compared with pre-infection levels, the mean IFN-γ concentration detected one 
week after infection in immunized mice was similar to that previously observed in 
similarly stimulated splenocytes prior to infection. This would be in agreement with 
the observation reported here that all but one of the immunized mice presented no 
detectable parasitic DNA in the brain.  
Altogether, in this study we have used a mice model as proof of the concept 
to assess the long-term protective effect of our i.n. immunization protocol using 
NcMP and CpG adjuvant. We have successfully shown that long-lasting protection 
accompanied by a mucosal and systemic humoral and cell-mediated parasite-
specific immune response could be induced in i.n. immunized mice. This result 
further strengthens the robustness of our immunization strategy in the mice model 
of neosporosis which makes it a prime candidate for a future evaluation of its 
immunogenicity and protective effect in cattle 
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Mucosal immunization confers protection against infection with the 
intracellular apicomplexa Neospora caninum in a highly susceptible IL-
12p40-/--deficient mice model 
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ABSTRACT 
 
Neospora caninum is an obligate intracellular apicomplexa protozoan that is 
associated with high economic losses due to abortions induced by neosporosis in 
cattle. Despite the worldwide distribution of this parasitic infection in cattle and that 
vaccination is regarded as the preferable option for its control, no commercial 
vaccine is currently available. In this regard, we have recently demonstrated the 
protective effect of an intranasal immunization protocol, using N. caninum 
membrane proteins, in a murine model of intragastrically established neosporosis. 
Regardless of the intracellular nature of this pathogen, the obtained results hinted 
that the achieved protection could be mediate by a parasite-specific mucosal and 
systemic humoral immune response in the absence of a marked Th1-type cellular 
immunity. As such, and in order to confirm this hypothesis, we determined if 
protection could be achieved in immunized mice lacking IL-12/IL-23 p40 chain (IL-
12p40-/-) expression. Immunized mice presented increased protection following 
intragastric or intraperitoneal infection with N. caninum tachyzoites. Protection was 
accompanied by a mucosal and systemic parasite-specific immune response. 
Although high levels of interferon-γ were detected following infection, no significant 
differences between immunized and sham-immunized controls were observed. 
These results indicate that our immunization strategy is capable of conferring 
protection in a highly susceptible mouse model with compromised cell-mediated 
immunity.  
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INTRODUCTION 
 
  Neospora caninum is an obligate intracellular apicomplexa protozoan 
initially described in dogs presenting several neuromuscular disorders1. In the 
following decades, dogs2 and other canids3-5 have been described as definitive 
hosts. However, the parasite infects a wide range of intermediate hosts from which 
cattle is recognized as the most relevant6-8. Cattle infection with N. caninum is 
associated with high economic losses9 due to an increased abortion rate observed 
in infected animals10-16 as a consequence of the parasite high rate of vertical 
transmission16-22. Even though infected herds have been described worldwide6,7 
and economic losses are estimated to be as high as 2 billion dollars/annum9, no 
effective or economically viable control option to manage cattle neosporosis is 
currently available23,24. Nevertheless, economic models indicate that the 
development of an effective vaccine that could either prevent the primary infection 
or vertical transmission of this parasite could constitute a viable cost effective 
strategy to control neosporosis23,24. Since other successful vaccines against 
closely related apicomplexa protozoans are currently available25,26, there is a 
consensus on the feasibility to develop an effective vaccine against N. caninum. 
 As previously mentioned, N. caninum is an intracellular protozoan and as 
such it can be expected that a Th1-type cell-mediated immunity should be 
essential for parasite control. In this regard, several studies have shown that 
defects in the IL-12/IFN-γ axis rendered mice lethally susceptible to the parasite 
infection27-32. Nevertheless, B cells were previously shown to be essential for host 
resistance against N. caninum infection, indicating that antibodies should have a 
role to play in host protection33. In fact, several studies have confirmed that 
antibodies against proteins that mediate parasite attachment and invasion of host 
cells are capable preventing N. caninum infection of host cells in vitro34-40.  
 Although N. caninum primary infection in cattle is established through the 
gastrointestinal tract, very few studies have previously characterize or considered 
the host immune response in the gastrointestinal mucosa following parasite 
infection. Nevertheless, it is known that intragastric (i.g.) infection with N. caninum 
tachyzoites elicits the production of parasite-specific intestinal IgA and serum 
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IgG41 in addition to an early increase production of IFN-γ in intestinal epithelial 
lymphocytes and in the draining mesenteric lymph nodes (MLN)42 (chapter 3). Still, 
in spite of these studies, and although the induction of a parasite-specific mucosal 
immune response could prove a prime strategy to achieve host protection against 
N. caninum infection, very few studies have attempted mucosal immunization as a 
means to confer protection against this parasite43-45 and in those studies, the 
possible protective effect of the elicited mucosal immune response was 
overlooked. In this regard, the protective effect of intranasal (i.n.) immunization 
using N. caninum membrane proteins (NcMP) and CpG as adjuvant in conferring 
protection against i.g. established neosporosis in mice was recently 
demonstrated46 (Chapter 4 and 5). The observed protection was largely 
characterized by undetectable parasite colonization in immunized mice which 
could indicate that primary infection was averted or efficiently cleared. In addition, 
protection appeared to be mediated by parasite-agglutinating intestinal IgA and 
parasite-opsonizing serum IgG. Supporting this hypothesis, immunized mice did 
not present a significant increase in IFN-γ production compared to sham-
immunized controls, indicating that the achieved protection was to some extent 
independent of a robust Th1-type immune response46 (Chapter 4). As such, in this 
study, and in order to confirm our hypothesis and further characterize the 
protective mechanism elicited by our immunization protocol we analyzed its 
protective effect in IL-12p40-/- mice which are highly susceptible to N. caninum 
infection due to their compromised Th1-type cell-mediated immunity32. 
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MATERIALS AND METHODS 
 
Animals 
Seven week-old female C57BL/6 IL-12p40-/- mice were purchased from Jackson 
laboratories (Bar Harbor, Maine, USA). Animals were kept under specific 
pathogen-free conditions and bred at Instituto de Ciências Biomédicas Abel 
Salazar (ICBAS) animal facility. Animals were maintained in the same installations 
throughout all the experimental procedures. Procedures involving mice were 
performed according to the European Convention for the Protection of Vertebrate 
Animals used for Experimental and Other Scientific Purposes (ETS 123) and 
86/609/EEC Directive and Portuguese rules (DL 129/92). Authorization for the 
experiments was issued by the animal welfare section of the competent national 
board, Direcção Geral de Veterinária (0420/000/000/2008, 0420/000/000/2010). 
Experiments were approved by the institutional board responsible for animal 
welfare (ORBEA) at ICBAS. 
 
Parasites  
N. caninum tachyzoites (Nc1 isolate) were kept by serial passages in VERO cells 
cultures, maintained in Minimal Essential Medium containing Earle’s salts (Sigma, 
St. Louis, USA), supplemented with 10% fetal calf serum (Biowest, Nuaillé, 
France), L-Glutamine (2 mM), Penicillin (200 IU/ml) and Streptomycin (200 µg/ml) 
(all from Sigma), in a humidified atmosphere with 5% CO2 at 37 ⁰C. Tachyzoites 
were maintained until destruction of 80% of the host cell monolayer and were 
isolated as previously described41. Briefly, free parasites and adherent cells were 
recovered using a cell scraper and centrifuged at 1 500 × g for 15 min. The pellet 
was passed through a 25 G needle and then washed three times in PBS by 
centrifugation at 1 500 × g for 15 min. The resulting pellet was resuspended and 
passed through a PD-10 desalting column, containing Sephadex™ G-25M (GE 
Healthcare, Freiburg, Germany). Tachyzoites concentration was determined in a 
haemocytometer. 
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Preparation of whole tachyzoite lysates and cell-membrane extracts 
N. caninum membrane proteins (NcMP) were extracted using a modification of a 
previously described method47,48. Briefly, free tachyzoites were resuspended in 
PBS containing 0.75% triton X-114 (Sigma), incubated 10 min on ice and 
centrifuged at 10 000 × g for 30 min at 4 ⁰C and the supernatant was recovered 
and placed in a water bath at 30 ⁰C during 3 min. The procedure was repeated 
and the supernatant was centrifuged at 1 000 × g for 3 min at room temperature. 
The aqueous phase was discarded and the NcMP were precipitated with the 
addition of absolute ethanol, vortexed vigorously during 15 sec and incubated 1 h 
on ice. The samples were centrifuged at 12 000 × g for 20 min at 4 ⁰C and the 
resulting pellet was dried, resuspended in PBS and stored at -20 ⁰C.  
Whole N. caninum lysates were prepared by disruption of tachyzoites following 
sonication (20 cycles of 15 s at 100 W) with a Branson cell disrupter model W 185 
D in an ice bath. The obtained N. caninum sonicates (NcS) were sequentially 
passed through 0.45 and 0.2 µm pore-size filters and stored at -20 ⁰C. 
Quantification of NcMP or NcS was performed by using the Lowry protein assay. 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis followed by silver 
nitrate staining was performed following each protein extraction in order to 
determine and confirm the protein migration profile.  
 
Immunizations and tissue sample collection 
Eight week-old female mice, were used in 2 independent experiments with random 
distribution of mice into 2 groups and immunized i.n. twice with three weeks 
interval under light isoflurane anesthesia with 20 µl of PBS containing, 10 µg of 
CpG ODN 1826 VacciGrade (Invivogen, San Diego, CA) (CpG group, n=16), or 
PBS containing 30 µg of NcMP plus 10 µg of CpG ODN 1826 VacciGrade 
(NcMP/CpG group, n=18). Vaginal lavages fluids (VLF) and serum samples were 
collected 1 week after the boost immunization for the detection of NcMP-specific 
IgA and IgG, respectively. All mice were i.g. challenged, 3 weeks after the last 
immunization, with 5 × 107 freshly isolated N. caninum tachyzoites as previously 
described41. One week after infection all mice were sacrificed by cervical 
dislocation and spleens were aseptically removed for the analysis of the immune 
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response, while the brain was collected and stored at -20 ⁰C for DNA extraction. 
Additionally, serum and intestinal lavage fluids (ILF) were collected from all mice 
for the detection of NcMP-specific IgG and IgA, respectively. 
Eight week-old female mice were also similarly immunized in 2 independent 
experiments (CpG, n=14 and NcMP/CpG, n=14) and samples were collected at 
the same time-points as described above. These mice were however infected 
intraperitoneally ( i.p.) with 1 × 104 freshly isolated N. caninum tachyzoites. 
 
Antibody detection 
Serum titres of NcMP-specific IgG1 and IgG2a were quantified by ELISA. Briefly, 
96-well plates (Maxisorp, Nunc, Denmark) were coated overnight at 4 ⁰C with 
NcMP diluted in PBS at a concentration of 5 µg/ml. All the wells were saturated 
with 2% bovine serum albumin (BSA) (Sigma) in TST buffer (150 mM NaCl, 10 
mM EDTA and 0.05% Tween 20, pH=8) for 1 h. Serum samples were serially 
diluted in 1% BSA TST buffer and incubated for 1 h, followed by washing and 
addition of alkaline phospatase-coupled monoclonal goat anti-mouse IgG1 or 
IgG2a monoclonal antibodies (Southern Biotechnology Associates, Birmingham, 
USA) and incubation for 1 h. After washing, the specifically bound antibodies were 
detected by the development with the substrate solution of p-nitrophenyl 
phosphate (Sigma) and the reaction was stopped with the addition of 0.1 M EDTA, 
pH=8 solution. The absorbance was measured at 405 nm, subtracting for each 
well the value for the absorbance at 570 nm. The antibody titres were expressed 
as the log10 value of the reciprocal highest dilution with an absorbance higher than 
the value of the control (no serum added). Detection of IgA antibodies specific for 
NcMP were quantified by ELISA as previously described, using alkaline 
phospatase-coupled goat anti-mouse anti-IgA (Southern Biotech).  
 
Purification of serum IgG antibodies and passive immunization 
Mouse serum samples collected at the day of euthanasia were used for IgG 
purification. Two pools of sera were prepared using samples collected from 
previously immunized mice of the NcMP/CpG and CpG groups, and respectively 
named IgG-NcMP and IgG-CpG. For each of the prepared pools, IgG antibody 
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purification was carried out using a HiTrap Protein G HP purification column (GE 
healthcare), according to manufacturer’s instructions. Recovered antibodies were 
buffer exchanged against sterile PBS, normalized to a final concentration of 1.5 
mg/ml, using the Lowry protein assay and stored at -20 ⁰C. The NcMP-specific 
antibody titre of the IgG-NcMP and IgG-CpG preparations were of 1.559 × 109 and 
below the detection limit, respectively, as determined by ELISA. Passive 
immunization was performed in eight week-old female mice randomly distribution 
into 2 groups per experiment. Purified IgG-CpG (IgG-CpG group, n=5) and IgG-
NcMP (IgG-NcMP group, n=5) fractions were transferred by intravenous (i.v.) 
injection (200 µg of total IgG per mice). Twelve hours following IgG transfer all 
mice were infected i.p. with 1 × 104 freshly isolated N. caninum tachyzoites. Mice 
were sacrificed one week after infection by cervical dislocation and the brains were 
collected and stored at -20 ⁰C for DNA extraction. 
 
In vitro cell cultures and cytokine detection 
To assess NcS-specific cytokine production, spleens were aseptically recovered 
from euthanized mice at specific time-points and homogenized. Spleen red blood 
cells were lysed and recovered splenocytes were suspended in RPMI-1640 
(Sigma), supplemented with 10% fetal calf serum (Biowest), HEPES (10 mM), 
Penicillin (200 IU/ml) and Streptomycin (200 µg/ml) (all from Sigma) and β-
mercaptoethanol (0.1 μM) (Merk, Darmstadt, Germany) (complete RPMI), plated 
(5 × 105/well) in triplicates per animal in round bottom 96-well plates (Nunc) and 
stimulated with NcS (60 µg/ml) for 3 days at 37 ºC and 5% CO2. Unstimulated 
conditions were set per animal to assess the cells basal cytokine production level. 
The concentration of IFN-γ and IL-4 in cell culture supernatants were respectively 
quantified with the Mouse IFN-γ and IL-4 ELISA Ready-Set-Go!® (eBioscience, 
San Diego, CA) kits, both according to manufacturer’s instructions. 
 
Intracytoplasmic staining  
For intracellular cytokine detection by flow cytometry, spleen cells previously 
obtained in complete RPMI were plated in round bottom 96-well plates (1 × 106 
cells/well) (Nunc). Cells were incubated in a humidified atmosphere with 5% CO2 
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at 37 ⁰C for 5 h under stimulation with 20 ng/ml phorbol myristate acetate (Sigma), 
200 ng/ml ionomycin (Merk) and 10 ng/ml Brefeldin A (Sigma). Following stimulus, 
cells were recovered and unspecific antibody binding was prevented by the pre-
incubation with anti-FcγR mAb followed by incubation with either anti-CD4 
Peridinin-chlorophyll proteins-cychrome 5.5-conjugate (clone RM4-5) or anti-CD8 
Phycoeritrin-conjugate (clone 53-6.7) mAb (both from BDbiosciences, San Diego, 
CA). Following extracellular staining the cells were washed, fixed in 2% 
formaldehyde (Merck), washed again and permeabilized with 0.05% saponin 
(Sigma) PBS solution and intracytoplasmic staining was carried out with anti-IFN-γ 
fluorescein isothiocyanate-conjugate (clone XMG1.2, BDbiosciences) after pre-
incubation of the cells with anti-FcγR mAb. Antibody-labeled cells were analyzed 
in an EPICS XL flow cytometer using the EXPO32ADC software (Beckman 
Coulter, Miami, FL). At least 150,000 events were acquired per sample. The 
collected data files were converted using FACS convert, v1.0 (Becton Dickinson, 
San Diego, CA) and analyzed using Cell Quest software, v3.2.1f1 (Becton 
Dickinson).  
 
DNA extraction  
DNA from the brain of infected mice was extracted as previously described49. 
Briefly, brains were weighted and homogenized. Samples were incubated 
overnight at 55 ⁰C in a solution containing 1% SDS and 1 mg/ml Proteinase K 
(sigma). DNA was extracted by the phenol (Sigma)-Chlorophorm (Merk) method 
followed by ammonium acetate/ethanol precipitation. 
 
Real-time PCR analysis 
The parasite burden in the brain of infected mice was assessed by quantitative 
real-time PCR (qPCR) analysis of the parasite DNA performed in a Corbett rotor 
gene 6000 system (Corbett life science, Sydney, Australia).  Analysis was 
performed by using KAPA PROBE FAST 2xMasterMix, Universal (Grisp, 
Portugal), for the amplification of a 103 bp sequence of the Nc5 region of N. 
caninum genome using the primers NcA 5’ GCTACCAACTCCCTCGGTT 3’ and 
NcS 5’ GTTGCTCTGCTGACGTGTCG 3’ both at a final concentration of 0.2 µM, 
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and the florescent probe FAM-CCCGTTCACACACTATAGTCACAAACAAAA-BBQ 
at a final concentration of 0.1 µM (all design and obtained from TIB-Molbiol, Berlin, 
Germany). The DNA samples were amplified using the following program: 95 ⁰C 
for 3 min, 95 ⁰C for 5 sec, 60 ⁰C for 20 sec with fluorescence acquisition while the 
second and third steps were repeated 50 times. Length of the amplified DNA was 
confirmed in a 3% agarose gel stained with ethidium bromide. In all runs parasite 
burden was determined by interpolation of a standard curve, ranging from 10 to 
10-4 ng of DNA extracted from N. caninum tachyzoites included in each run and 
the data analyzed in the Rotor gene 6000 software v1.7 (Corbett life science).  
 
Statistical analysis 
Statistical analyses were performed using GraphPad prism, Version 5.0 
(GraphPad Software, Inc., La Jolla, CA). In the scatter dot graphs the mean for 
each group was displayed as a horizontal bar. Column graphs are represented 
showing the mean plus one standard error of the mean (SEM). Statistical analysis 
between groups was performed by using student’s t-test. 
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RESULTS 
 
Production of parasite-specific mucosal IgA and serum IgG in immunized 
p40-/- mice 
In previous studies46 (Chapter 4 and 5), i.n. immunization of C57Bl/6 WT 
mice with NcMP and CpG resulted in the production of parasite-specific intestinal 
IgA and serum IgG, respectively capable of agglutinating and opsonizing N. 
caninum. Considering the possible host protective effect of these 
immunoglobulins, we assessed if these could also be detected in the mucosa and 
serum of similarly immunized p40-/- mice. As shown in Figure 6-1a and 6-2a, one 
week after the boost immunization, and as expected, no parasite-specific IgA or 
IgG in VLF and serum samples respectively, were detected in sham-immunized 
mice receiving CpG alone. In comparison, immunized mice presented parasite-
specific VLF IgA and serum IgG. IgG isotype analysis in the immunized group 
revealed a mixed IgG1 and IgG2a production. Since production of IgG1 and IgG2a 
can respectively be associated with an underlying Th2- and Th1-type immune 
response50, the analysis of these immunoglobulin isotypes can be an indicator of 
the type of elicited cellular immune response. The IgG1/IgG2a ratio in immunized 
mice, calculated with the mean titres values for each IgG isotype, was below 1 
indicating that a small bias towards a Th1-type immune response was induced in 
p40-/- mice upon the i.n. immunization.  
One week after either i.g. (Figure 6-1b and 6-2b) or i.p. (Figure 6-1c and 6-
2c) infection with N. caninum tachyzoites, and as indicated by the VLF analysis, 
parasite-specific IgA could be detected in ILF samples of all immunized mice. In 
accordance, parasite-specific IgG titres were also detected in the serum of 
NcMP/CpG mice, and in this instance an IgG1/IgG2a < 1 could still be observed. 
In both cases no parasite-specific IgA or IgG was detected in sham-immunized 
controls. Altogether, these results show that i.n. immunization with NcMP and CpG 
is capable of inducing the production of parasite-specific mucosal IgA and serum 
IgG in a p40-/- mice with a small bias towards a Th1-type immune response. 
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Figure 6-1 - Titres of N. caninum membrane proteins (NcMP)-specific IgA in vaginal and 
intestinal lavage fluids (VLF and ILF, respectively). IgA titres were determined by ELISA in 
(a) VLF collected one week upon boost immunization from mice immunized twice i.n. with 
NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant alone 
(CpG) or (b) ILF collected from mice one week after i.g. challenge with 5 × 107 N. caninum 
tachyzoites or (c) ILF collected from mice one week after i.p. challenge with 1 × 104 N. 
caninum tachyzoites. Data is presented as log10 of the antibody titres, as indicated. 
Results correspond to pooled data of two independent experiments with a total number of 
mice per group of: CpG n=16; NcMP/CpG n=18 for i.g. infected mice and CpG n=14; 
NcMP/CpG n=14 for i.g. infected mice. Each dot represents an individual mouse. 
Horizontal lines correspond to the mean value in each group; detection limit (DL) is 
indicated by a horizontal line. 
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Figure 6-2 - Titres of N. caninum membrane proteins (NcMP)-specific IgG1 (closed 
circles) and IgG2a (open circles) in serum. IgG titres were determined by ELISA in serum 
collected one week upon boost immunization (a) from mice immunized twice i.n. with 
NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant alone 
(CpG) or (b) from mice serum one week after i.g. challenge with 5 × 107 N. caninum 
tachyzoites or (c) from mice serum one week i.p. challenge with 1 × 104 N. caninum 
tachyzoites. Data is presented as log10 of the antibody titres, as indicated. Numbers above 
each group represent the IgG1/IgG2a ratio, calculated with the mean log10 titres for the 
correspondent IgG isotype. Results correspond to pooled data of two independent 
experiments with a total number of mice per group of: CpG n=16; NcMP/CpG n=18 for i.g. 
infected mice and CpG n=14; NcMP/CpG n=14 for i.g. infected mice. Each dot represents 
an individual mouse. Horizontal lines correspond to the mean value in each group; 
detection limit (DL) is indicated by a horizontal line. 
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Prevention of parasite colonization in immunized p40-/- mice following i.g. 
infection 
We have previously demonstrated that the i.n. immunization strategy used 
here was capable of conferring protection to WT mice against i.g. established 
neosporosis in the absence of increase IFN-γ production46 (chapter 4). As p40-/- 
mice are lethally susceptible to N. caninum infection32, we assessed if similar i.n. 
immunization with NcMP and CpG in p40-/- mice could also protect this host 
against i.g. established neosporosis. Sham and immunized mice groups were i.g. 
infected with 5 × 107 N. caninum tachyzoites 3 weeks after the boost 
immunization. One week after the parasitic challenge we assessed the brain 
parasitic burden by qPCR. As shown in Figure 6-3, a clear reduction in the number 
of animals colonized in this organ was observed in the NcMP/CpG group with 9/18 
mice negative for the presence of N. caninum DNA. In comparison, only 2/16 mice 
in the CpG group were negative for the presence of N. caninum DNA. 
Nevertheless, similar parasitic burdens were detected in the colonized mice of 
sham- and immunized groups. Overall this result shows that protection against i.g. 
established neosporosis could be achieved following i.n. immunization of p40-/- 
mice, characterized by an absence of detectable colonization levels in protected 
mice. 
 
Figure 6-3 - Parasitic load assessed by qPCR one week upon i.g. challenge with  5 × 107 
N. caninum tachyzoites in the brain of mice previously immunized twice i.n. with NcMP 
and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant alone (CpG). 
Data is presented as log10 of the number of parasites by gram of organ. Results are from 
pooled data of two independent experiments. Total number of mice per group: CpG n=16; 
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NcMP/CpG n=18. Each dot represents an individual mouse. Horizontal lines correspond 
to the mean value in each group; detection limit (DL) is indicated by a horizontal line; (* 
p<0.05) 
 
Protected mice present lower IFN-γ production following N. caninum-
specific cell stimulation  
IFN-γ is the hallmark cytokine of the Th1-type immune response and its 
paramount importance for the host resistance against neosporosis has been 
shown in different studies29,30. Since half of the p40-/- immunized mice were 
protected upon i.g. challenge with N. caninum, and an IgG1/IgG2a ratio < 1 was 
observed in spite of IL-12 prominent role in Th1 polarization, we assessed if an 
increase in parasite-specific IFN-γ production elicited by the immunization protocol 
could be mediating the observed protection. Therefore, splenocytes from one-
week infected immunized and control animals were in vitro stimulated for 3 days 
with NcS. As shown in Figure 6-4a IFN-γ levels in the cell culture supernatants 
were not significantly different among the assessed groups. Nevertheless, in this 
analysis, non-colonized immunized mice presented lower IFN-γ concentrations in 
comparison with similarly immunized but colonized animals. In fact, when we 
plotted (Figure 6-4c) the concentrations of IFN-γ in the culture supernatants of 
splenocytes from non-colonized versus colonized mice in the immunized group we 
observed a lower production of this cytokine in the former. Additionally, and as 
shown in Figure 6-4b, no significant differences were observed in the production of 
IL-4, the prototypic Th2 cytokine, associated with host susceptibility to 
neosporosis51,52. 
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Figure 6-4 - IFN-γ (a) and IL-4 (b) concentration in the supernatants of splenocytes cell 
cultures unstimulated or stimulated for 3 days with N. caninum sonicates (NcS). Cells 
were isolated from the spleens of mice one week upon i.g. challenge with  5 × 107 N. 
caninum tachyzoites that have been previously immunized twice i.n. with NcMP and CpG 
adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant alone (CpG). (c) Separation 
and comparison of data regarding IFN-γ concentration between colonized and 
uncolonized mice in the NcMP/CpG group. Results are from pooled data of two 
independent experiments and stimulated conditions were analyzed in duplicate for each 
mouse. Total number of mice per group: CpG n=16; NcMP/CpG n=18. Horizontal lines in 
scatter plots correspond to the mean value in each group while bars in column graphs 
represent mean plus one SEM. DL - below detection limit of the kit (15 pg/mL); (* p<0.05). 
 
 
 
 166 
 
Reduced parasitic burden in immunized p40-/- mice infected i.p. with N. 
caninum 
Since no detectable parasite DNA was found in immunized mice following 
the i.g. parasitic challenge in the absence of increased IFN-γ production, other 
protective mechanisms could account for the observed protection. As we have 
previously shown that parasite-specific intestinal IgA produced following i.n. 
immunization with NcMP and CpG could agglutinate N. caninum tachyzoites46 
(chapter 4), this immunoglobulin could be mediating protection in the immunized 
p40-/- mice by preventing host infection. Therefore, in order to rule out the possible 
host protective effect of intestinal IgA in vivo, we i.p infected similarly immunized 
mice and sham-immunized controls with 1 × 104 N. caninum tachyzoites. One 
week following infection we analyzed by qPCR the brain parasitic burden. As 
shown in Figure 6-5, mice receiving NcMP plus CpG presented a clear reduction 
in parasite burden following i.p. challenge when compared with sham-immunized 
controls. In addition, no N. caninum DNA was detected in 6 out of 14 immunized 
mice once again indicating that this immunization strategy elicited a host protective 
immune response even when the i.p. infection route was used in p40-/- mice.  
 
Figure 6-5 - Parasitic load assessed by qPCR one week upon i.p. challenge with  1 × 104 
N. caninum tachyzoites in the brain of mice previously immunized twice i.n. with NcMP 
and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant alone (CpG). 
Data is presented as log10 of the number of parasites by gram of organ. Results are from 
pooled data of two independent experiments. Total number of mice per group: CpG n=14; 
NcMP/CpG n=14. Each dot represents an individual mouse. Horizontal lines correspond 
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to the mean value in each group; detection limit (DL) is indicated by a horizontal line. (*** 
p<0.001) 
 
Passive immunization slightly reduces parasite burden in i.p. infected p40-/- 
mice 
Parasite-specific IgG elicited following i.n. immunization of WT mice was 
capable of opsonizing N. caninum tachyzoites and reduce parasite survival in in 
vitro infected  macrophages46 (chapter 4). Therefore, it was conceivable that 
parasite-specific IgG in the serum of immunized p40-/- mice could contribute to the 
observed protection in i.p. infected mice. In order to confirm the existence of this 
host protective mechanism, we purified IgG from the serum of previously i.n. 
immunized (IgG-NcMP) and sham-immunized (IgG-CpG) mice and respectively 
transferred each IgG fraction into recipient naïve p40-/- mice. Twelve hours 
following passive immunization all mice were i.p. infected with 1 × 104 N. caninum 
tachyzoites and the parasite burden analyzed one week after infection by qPCR. 
As shown in Figure 6-6, a small reduction in parasitic burden could be observed 
between mice receiving control IgG-CpG and mice receiving the IgG-NcMP 
fraction although not reaching statistical significance.  
 
Figure 6-6 - Parasitic load assessed by qPCR one week upon i.p. challenge with 1 × 104 
N. caninum tachyzoites in the brain of mice passively immunized with control IgG purified 
form the serum of sham-immunized mice (IgG-CpG) or with IgG isolated from the serum 
of previously immunized mice (IgG-NcMP). Data is presented as log10 of the number of 
parasites by gram of organ. Results are from pooled data of two independent 
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experiments. Total number of mice per group: CpG n=5; NcMP/CpG n=5. Each dot 
represents an individual mouse. Horizontal lines correspond to the mean value in each 
group 
 
Immunized p40-/- mice infected i.p. did not present increase IFN-γ production 
Since a protective effect of serum parasite-specific IgG was not evident, we 
also analyzed IFN-γ production by spleen CD4+ and CD8+ T cells in immunized 
p40-/- mice infected i.p. As shown in Figure 6-7a, no significant differences in CD4+ 
and CD8+ T cell numbers were observed between sham- and immunized mouse 
groups. The analysis of the frequency of CD4+ and CD8+ T cells producing IFN-γ 
(Fig 6-7b) revealed a higher proportion of CD8+IFN-γ+ T cells in comparison with 
the proportions observed for CD4+IFN-γ+ T cells. However, no significant 
differences in the frequencies (Figure 6-7b) and numbers (Figure 6-7c) of CD4+ 
and CD8+ T cells producing IFN-γ were observed between the two groups. As 
could be expected, in vitro splenocyte cell cultures stimulated with NcS did not 
revealed any significant difference regarding the production IFN-γ or IL-4 between 
cells of immunized and sham-immunized groups (Figure 6-7d). 
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Figure 6-7 - Total number of splenic CD8+ and CD4+ T cells (a) and frequencies (b) or 
numbers (c) of splenic CD8+IFN-γ+ or CD4+ IFN-γ+  T cells, detected one week after i.p. 
challenge with 1 × 104 N. caninum tachyzoites in mice previously immunized twice i.n. 
with NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant alone 
(CpG). (d) IFN-γ and IL-4 concentration in the supernatants of splenocytes cell cultures 
unstimulated or stimulated for 3 days with N. caninum sonicates (NcS). Results 
correspond to pooled data of two independent experiments. Cytokine analysis in cell 
culture supernatants in stimulated conditions were analyzed in duplicate for each mouse. 
CpG n=14; NcMP/CpG n=14. Each dot represents an individual mouse. Horizontal lines 
correspond to the mean value in each group. DL - below detection limit of the kit (15 
pg/mL) 
 
 
  
 171 
 
DISCUSSION 
 
In this work we have used an IL-12-deficient mouse model in order to 
further study the host protective mechanisms elicited by i.n. immunization with 
NcMP and CpG adjuvant. In our previous work we have demonstrated that this i.n. 
immunization strategy conferred long-term protection against i.g. established 
neosporosis in the absence of a marked Th1-type immune response in C57Bl/6 
WT mice46 (chapter 4 and 5). Although the IL-12/IFN-y axis has been shown to be 
essential for host resistance against N. caninum infection27-32, our results hinted to 
the existence of a protective mechanism that could be mediated by intestinal 
parasite-agglutinating IgA and serum parasite-opsonizing IgG. In this model, the 
undetectable parasite colonization observed in the majority of immunized animals 
along with the absence of increased IFN-γ production could indicate that a 
humoral mediated mechanism prevented host infection46 (chapter 4 and 5).  
Analysis of the humoral response elicited in the immunized p40-/- mice 
revealed that these presented similar levels of parasite-specific intestinal IgA and 
serum IgG in comparison with those previously reported in similarly immunized 
WT mice46 (chapter 4). Although p40-/- mice were not described has having a 
compromised humoral response53, to our knowledge this is the first time that IgA 
titres have been assessed in the mucosa of IL-12-deficient mice following mucosal 
immunization showing that absence of this cytokine did not significantly impact IgA 
production. Surprisingly, taking into consideration the IL-12-deficient phenotype, 
but in accordance with our previous observations46 (chapter 4 and 5), an 
IgG1/IgG2a ratio < 1 was detected in the serum of immunized p40-/- mice. Due to 
the importance of IFN-γ in IgG2a production50, this result indicates that a small 
bias towards a Th1-type immune response was induced. A likely candidate that 
could explain this observation due to its known Th1 immunostimulatory properties 
is CpG54-56 that can also lead to the production of IL-1857, an important cytokine 
inducing IFN-γ production by natural killer and T cells58,59. In fact, IL-18 has been 
shown in previous studies to mediate IFN-γ production in IL-12-deficient mice60. 
Nevertheless, and to our knowledge, CpG has never been used as an adjuvant in 
IL-12-deficient mice and therefore it would be worth assessing in future studies if 
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this adjuvant could indeed also have Th1-type immunostimulatory proprieties in 
the absence of IL-12, a key Th1-inducing cytokine induced by this adjuvant54-56. 
 In accordance with the IgG1/IgG2a ratio, following i.g. infection of 
immunized p40-/- mice and although IFN-γ was detected in both experimental 
groups, no significant differences were observed in the production of this cytokine 
between immunized and sham-immunized controls. In this regard, IFN-γ 
production in IL-12-deficient mice has already been described following infection 
with different protozoa60-62 in a process dependent on IL-1860. On the other hand, 
and once again in accordance with our previous results46 (chapter 4), very low 
levels of IL-4 were detected in both immunized and control mice splenocyte 
cultures. Additionally, although presenting a compromised Th1-type immune 
response, infection of IL-12-deficient mice without increase IL-4 production has 
been reported in previous studies61.  
 Following the assessment of the elicited immune response, we infected 
immunized p40-/- mice i.g., in order to further understand if protection conferred by 
the i.n. immunization protocol used here could indeed be attained in the absence 
of a strong Th1-type immune response. Parasitic burden analysis by qPCR 
revealed that protection could indeed be achieved and that protected p40-/- mice 
did not present detectable parasite colonization levels, in agreement with the 
protection profile observed in our previous studies46 (chapter 4 and 5). Protection 
against other pathogens61,63,64, including the apicomplexa Plasmodium berghei62, 
has already been shown to be possible in the absence of IL-12. Still, to our 
knowledge, this is the first time that protection against N. caninum infection 
through immunization has been shown in a mouse model with a compromised 
Th1-type immune response. Although a significant number of mice could be 
protected following i.g. infection, when successful parasite colonization did occur, 
no significant differences were observed between the mean parasitic burdens of 
immunized and sham-immunized controls. In addition, immunized mice with 
undetectable parasitic DNA presented a much lower IFN-γ production in 
comparison with immunized and infected mice. Both results support our previously 
proposed model46 (chapter 4), whereby protection induced by i.n. immunization 
with NcMP and CpG could be mediated through intestinal parasite-agglutinating 
IgA that in turn could prevent host infection, leading to undetectable parasite DNA 
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and reduced antigen stimulation, resulting in lower cytokine production following 
antigen recall. Nevertheless, future analysis will be needed to fully confirm this 
hypothesis. In this regard, immunization of intestinal IgA-deficient mice would help 
ascertain if parasite-agglutinating IgA in the intestinal mucosa could be mediating 
host protection. 
 In order to further explore the possible host protective effect of parasite-
specific intestinal IgA elicited following i.n. immunization, we infected i.p. p40-/- 
mice immunized i.n., therefore bypassing the intestinal mucosal barrier. 
Surprisingly, immunized mice still presented a reduced number of colonized 
animals and a reduction in the overall colonization levels in comparison with sham-
immunized controls. Furthermore, and in contrast with i.g. infected mice, following 
i.p. infection immunized mice presented lower parasitic burdens than sham-
immunized controls. Despite the relatively high levels of IFN-γ produced by 
splenocytes in vitro following parasite-specific antigenic recall, once again no 
major differences in IFN-γ production was observed between immunized and 
sham-immunized controls. Additionally, and in contrast with the observations 
made in i.g. infected immunized mice, non-colonized and immunized p40-/- mice 
infected i.p. did not present reduced IFN-γ production. However, in this case, and 
due to the used infection route, antigenic stimulation should have occurred in all 
mice regardless of their colonization status. Furthermore, although affording a 
slight reduction in parasitic burdens, IgG transfer by passive immunization did not 
recapitulate the protection observed in i.p. infected immunized p40-/- mice. This 
result indicates that despite the previously shown in vitro host protective capacity 
of elicited parasite-specific IgG46 (chapter 4), these could at best marginally 
contribute to the observed protection. Nevertheless, and since IgG specific for 
some membrane proteins of N. caninum have been shown in vitro to be capable of 
preventing parasite infection of host cells34-40, it would be worth confirming if 
passive immunization trough IgG transfer could indeed confer some degree of 
protection in vivo, a point that has never been assessed following N. caninum 
infection. Still, the protection observed in i.p. infected immunized p40-/- mice 
indicates that other mechanism besides the possible host protective role of IgA 
should be elicited following immunization. Since IgG appears to have a marginally 
protective effect, a cell-mediated immune response is most likely responsible for 
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the protection observed in i.p. infected mice. In this regard, consecutive priming 
with P. berghei has shown that an early and strong production of IFN-γ in IL-12-
deficient mice can be induced, which could confer protection against an otherwise 
lethal challenge62. It could be speculated that a similar priming of a Th1-type 
immune response could be achieved following i.n. immunization of p40-/- mice. In 
this sense, an early production of IFN-γ in immunized mice could allow a quicker 
control of parasite dissemination in contrast with sham-immunized controls. 
Although no difference between groups was found regarding IFN-γ production one 
week after infection, since higher IFN-γ production was observed in similarly 
immunized WT mice prior to infection (chapter 5), it would be of interest to see if a 
similar response could be observed in immunized and uninfected p40-/- mice. 
Another point that should be taken into consideration is the difference in cellular 
composition and elicited immune response in the intestinal mucosa and in the 
peritoneal cavity. Due to the widespread use of i.p. infection in murine models of 
N. caninum infection it should be kept in mind that the protective effect elicited 
trough immunization can be dependent on the infection route used. In this regard, 
the i.g. infection route used here more closely mimics the natural route taken by 
the parasite during horizontally transmitted neosporosis. 
 Altogether, the obtained results show that i.n. immunization with NcMP and 
CpG conferred protection to both i.g. and i.p. infected mice harboring a mutation 
compromising Th1-type immunity. The results showed here support a model in 
which protection against N. caninum could be mediated by parasite-specific IgA 
preventing host infection. Nevertheless different protective mechanism elicited by 
immunization might account for the observed results as i.g. versus i.p. infection 
evidenced that the route of infection used can have a great impact in determining 
the protective effect of immunization against this protozoan.  
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ABSTRACT 
 
Successful or practical control options to manage or prevent infection with 
the abortive intracellular cattle pathogen Neospora caninum are currently 
unavailable in spite of the high economic losses associated with this parasite 
infection. In this regard, we have previously demonstrated the host protective 
effect of an intranasal immunization protocol using N. caninum membrane proteins 
in different mice models following intragastric or intraperitoneal challenge. In this 
work we evaluated the immunogenicity and elicited immune response following 
intranasal immunization with N. caninum membrane proteins and cattle-optimized 
CpG adjuvant in Holstein calves. Three weeks following a single boost 
immunization animals presented elevated parasite-specific serum IgG and IgA 
titres. In addition, in vitro cell cultures of peripheral blood mononuclear cells 
collected at the same time point presented a significant increase in interferon-γ 
production when co-cultured with N. caninum tachyzoites in comparison with 
similarly stimulated cells obtain from sham-immunized control animals. Altogether, 
these results demonstrate the immunogenicity of our intranasal immunization 
protocol and prove that this strategy can induce a humoral and cellular parasite-
specific immune response in immunized calves. 
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INTRODUCTION 
 
  Although initially described in dogs1, the apicomplexa parasite Neospora 
caninum has in the last decades gain notoriety as an abortive pathogen in cattle2,3. 
N. caninum is one of the most successful vertically transmitted parasites in cattle 2 
and although, in most instances, in utero infection leads to the birth of a 
congenially infected but otherwise healthy calf4-6, infected dams present a 
considerable increase in abortion rates7-13. This reproductive impairment has been 
recognized and associated with severe economic losses in beef and dairy cattle 
livestock farms leading to worldwide losses estimated above 1.3 billion dollars per 
year14. Although vaccination is regarded as the preferable option to control this 
parasitic infection15 no commercial vaccine is nowadays available16,17. 
Nevertheless, a great effort to develop an effective immunization strategy that 
could block vertical transmission or prevent cattle infection altogether has been 
undertaken in the last decades as evidenced by the considerable number of 
experimental immunization studies16-18. 
Although not normally considered a natural host for N. caninum, for several 
years mice have been established in laboratory conditions as a suitable model to 
study neosporosis19-21. In this regard, mice have been extensively used to explore 
and characterized N. caninum host-parasite relationship as well as to assess the 
protective effect of several immunization protocols16-18. Still, despite the usefulness 
of mice for large scale screening of promising vaccination strategies, confirmation 
in cattle of the immunogenicity and host protective effect of promising 
immunization protocols is essential. In this regard, most immunization protocols 
assessed in cattle, although reporting encouraging results in the prevention of 
abortion and vertical transmission, have achieved this protection with the use of 
live22 and attenuated23-26 parasite strains which present considerable drawbacks of 
production, safety and stability26,27. In contrast, cattle immunization with sub-unit 
vaccines has been performed in very limited occasions and with mixed protection 
outcomes despite promising results of several protocols in mouse models, and 
their advantages for mass vaccination implementation28-30. Furthermore, and in 
spite of the fact that in horizontal transmitted neosporosis N. caninum infects the 
host through the gastrointestinal mucosa2, the use of a mucosal vaccination 
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strategy has never been attempted in cattle despite the recent encouraging results 
obtained in mice models with intranasal (i.n.) immunization protocols31-33 (chapter 
4). We have recently demonstrate the protective effect of an i.n. immunization 
protocol using N. caninum membrane proteins (NcMP) and CpG adjuvant against 
intragastrically (i.g.)-established neosporosis in different mouse models33 (chapter 
4, 5 and 6). Nevertheless the immunogenicity of our developed formulation has 
never been assessed in cattle. As such, in this study we i.n. immunized Holstein 
calves with NcMP and a cattle-optimized CpG and evaluated the induction of 
humoral and cellular parasite specific immune responses. 
 
  
 184 
 
MATERIALS AND METHODS 
 
Animals 
Nine month-old N. caninum and Bovine viral diarrhea virus seronegative female 
Holstein calves were used in experimental immunization protocols. Animals were 
kept at the Large Animal Farm of Instituto de Ciências Biomédicas Abel Salazar 
(ICBAS) throughout the experimental procedures. Experiments were approved by 
the institutional board responsible for animal welfare (ORBEA) at ICBAS. 
 
Parasites  
N. caninum tachyzoites (Nc1 isolate) were kept by serial passages in VERO cells 
cultures, maintained in Minimal Essential Medium containing Earle’s salts (Sigma, 
St. Louis, USA), supplemented with 10% fetal calf serum (Biowest, Nuaillé, 
France), L-Glutamine (2 mM), Penicillin (200 IU/ml) and Streptomycin (200 µg/ml) 
(all from Sigma), in a humidified atmosphere with 5% CO2 at 37 ⁰C. Tachyzoites 
were maintained until destruction of 80% of the host cell monolayer and were 
isolated as previously described34. Briefly, free parasites and adherent cells were 
recovered using a cell scraper and centrifuged at 1 500 × g for 15 min. The pellet 
was passed through a 25 G needle and then washed three times in PBS by 
centrifugation at 1 500 × g for 15 min. The resulting pellet was resuspended and 
passed through a PD-10 desalting column, containing Sephadex™ G-25M (GE 
Healthcare, Freiburg, Germany). Tachyzoites concentration was determined in a 
haemocytometer. 
 
Preparation of whole tachyzoite lysates and cell-membrane extracts 
N. caninum membrane proteins (NcMP) were extracted using a modification of a 
previously described method35,36. Briefly, free tachyzoites were resuspended in 
PBS containing 0.75% triton X-114 (Sigma), incubated 10 min on ice and 
centrifuged at 10 000 × g for 30 min at 4 ⁰C and the supernatant was recovered 
and placed in a water bath at 30 ⁰C during 3 min. The procedure was repeated 
and the supernatant was centrifuged at 1 000 × g for 3 min at room temperature. 
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The aqueous phase was discarded and the NcMP were precipitated with the 
addition of absolute ethanol, vortexed vigorously during 15 sec and incubated 1 h 
on ice. The samples were centrifuged at 12 000 × g for 20 min at 4 ⁰C and the 
resulting pellet was dried, resuspended in PBS and stored at -20 ⁰C. NcMP 
quantification was performed by using the Lowry protein assay. Sodium dodecyl 
sulphate polyacrylamide gel electrophoresis followed by silver nitrate staining was 
performed following each protein extraction in order to determine and confirm the 
protein migration profile.  
 
Immunizations and blood sample collection 
Nine-month old calves were distribution into 2 groups and immunized i.n. twice 
with three weeks interval with 500 µl of PBS containing, 400 µg of the previously 
described37 bovine optimized CpG ODN 2135 (TCGTCGTTTCTCGTTTTGTCGTT, 
obtained from Invitrogen, MA, USA) (CpG group, n=4), or PBS containing 500 µg 
of NcMP plus 400 µg of CpG ODN 2135 (NcMP/CpG group, n=4). i.n. application 
was performed by administering 250 µl in each nostril with a syringe coupled with 
an intranasal dispersion unit (Rispoval, Pfizer, NY, USA). The animals’ head was 
contained in an upright position for 30s to prevent rejection of the administered 
formulation. Blood samples were collected by tail venipuncture 3 weeks after the 
boost immunization for humoral and cell mediated immune response analysis.  
 
Antibody detection 
Serum samples obtained from blood collected 3 weeks after the boost 
immunization were used to evaluate by ELISA the presence of NcMP-specific 
IgG1, IgG2 and IgA antibodies. Briefly, 96-well plates (Maxisorp, Nunc, Denmark) 
were coated overnight at 4 ⁰C with NcMP diluted in PBS at a concentration of 5 
µg/ml. All the wells were saturated with 2% bovine serum albumin (BSA) (Sigma) 
in TST buffer (150 mM NaCl, 10 mM EDTA and 0.05% Tween 20, pH=8) for 1 h. 
Serum samples were serially diluted in 1% BSA TST buffer and incubated for 1 h, 
followed by washing and addition of alkaline phospatase-coupled polyclonal sheep 
anti-bovine IgG1, IgG2 or IgA (all from Bethyl, TX, USA) and incubation for 1 h. 
After washing, the specifically bound antibodies were detected by the development 
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with the substrate solution of p-nitrophenyl phosphate (Sigma) and the reaction 
was stopped with the addition of 0.1 M EDTA, pH=8 solution. The absorbance was 
measured at 405 nm, subtracting for each well the value for the absorbance at 570 
nm. The antibody titres were expressed as the log10 value of the reciprocal highest 
dilution with an absorbance higher than the value of the control (no serum added).  
 
In vitro cell cultures and cytokine detection 
Blood mononuclear cells (PBMC) were collected from blood samples obtained 3 
weeks after the boost immunization to assess parasite-specific cytokine production 
in peripheral blood. Briefly, collected blood was diluted and layered over a solution 
of polysucrose-sodium ditrizoate (Histopaque 1077, Sigma) and centrifuged at 800 
× g for 20 min at room temperature. Recovered cells in the blood Histopaque 
interface were washed, twice and suspended in RPMI-1640 (Sigma), 
supplemented with 10% fetal calf serum (Biowest), HEPES (10 mM), Penicillin 
(200 IU/ml) and Streptomycin (200 µg/ml) (all from Sigma), and β-mercaptoethanol 
(0.1 μM, Merk, Darmstadt, Germany). Cells were plated in triplicates per animal in 
round bottom 96-well plates (5 × 105 cells/well) (Nunc) and stimulated with 200 Gy 
gamma-irradiated N. caninum tachyzoites (Gammacell1000Elite irradiator, Nordion 
International, Inc., Ottawa, Canada; 1x106 tachyzoites/well) for 5 days at 37 ºC 
and 5% CO2. The concentration of IFN-γ and IL-4 in cell culture supernatants was 
assessed by ELISA using the Bovine IFN-γ or IL-4 screening set kit (Thermo 
scientific, IL, USA), respectively and according to manufacturer’s instructions. 
 
Statistical analysis 
Statistical analyses were performed using GraphPad prism, Version 5.0 
(GraphPad Software, Inc., La Jolla, CA). Column graphs are represented showing 
the mean plus one standard error of the mean (SEM). Statistical analysis between 
groups was performed by using student’s t-test. 
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RESULTS 
 
NcMP/CpG immunized calves present antigen-specific serum IgG and IgA 
In previous studies33 (Chapter 4 and 5), i.n. immunization in C57Bl/6 WT 
mice with NcMP and CpG induced the production of parasite-specific mucosal IgA 
and serum IgG. In order to assess if a similar immunization procedure in calves 
could also induce an antigen-specific humoral immune response, we screen 
immunized calves serum samples obtained 3 weeks after the last immunization for 
the presence of NcMP-specific IgA and IgG. As shown in Figure 7-1a, immunized 
calves presented an antigen-specific IgG response with mixed production of IgG1 
and IgG2, while no detectable antigen-specific IgG titres were observed in sham-
immunized controls, as expected. Since production of IgG1 and IgG2 has also 
been shown to be associated in cattle with an underlying Th2- and Th1-type 
immune response, respectively38,39, we determined the ratio between the 
production of these two immunoglobulins as an indicator of the elicited cellular 
immune response in immunized animals. Using the mean titre values for each IgG 
isotype, we obtain a calculated IgG1/IgG2a ratio < 1 indicating that a small bias 
towards a Th1-type was achieved in i.n. immunized calves.  
Since the induction of IgA production is considered a hallmark of successful 
induction of a mucosal immune response40-43, and since direct analysis of the 
small intestine IgA production was impossible under the described experimental 
conditions, we determined the existence of NcMP-specific IgA in the serum of 
immunized calves as an indicator of mucosal immune response induction. As 
shown in Figure 7-1b, three weeks after the last immunization NcMP/CpG 
immunized calves presented elevated antigen-specific IgA titres. Once again and 
as expected, no detectable NcMP-specific IgA titres were found in sham-
immunized controls. Altogether, these results indicate that i.n. immunization of 
calves with NcMP and CpG is capable of inducing a parasite-specific humoral 
response 
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Figure 7-1 - Serum titres of N. caninum membrane proteins (NcMP)-specific IgG (a) (IgG1 
- closed bar and IgG2 - open bar) and IgA (b). Immunoglobulin titres were determined by 
ELISA in serum samples collected 3 weeks upon boost immunization from calves 
immunized twice i.n. with NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with 
CpG adjuvant alone (CpG). Data is presented as log10 of the antibody titres, as indicated. 
Total number of calves per group: CpG n=4; NcMP/CpG n=4. Numbers above bars 
represent the IgG1/IgG2 ratio calculated with the mean log10 titres of each respective IgG 
isotype. Graphs are presented with mean plus one SEM; ND – not detected 
 
PBMC from i.n. immunized calves present increased parasite-specific IFN-γ 
production   
To evaluate if i.n. immunization with NcMP/CpG could induce a cell-
mediated immune response in immunized calves we collected PBMC 3 weeks 
after the boost immunization. These cells were co-culture in vitro with irradiated N. 
caninum tachyzoites for 5 days after which we analyzed the cell culture 
supernatants for the presence of IFN-γ and IL-4 since these cytokines have been 
implied in host resistance and susceptibility to N. caninum infection, 
respectively44,45. As shown in Fig 7-2, and as indicated by the previously 
calculated IgG1/IgG2a ratio, N. caninum stimulated PBMC obtained from 
immunized calves presented higher IFN-γ production levels when compared with 
similarly stimulated PBMC collected from sham-immunized controls. In sharp 
contrast, undetectable levels of IL-4 were observed in similarly stimulated cells 
from both immunized and sham-immunized calves (data not shown) 
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Figure 7-2 - IFN-γ concentration in the supernatants of PBMC cell cultures stimulated for 
5 days with 1x106 gamma-irradiated N. caninum tachyzoites. Cells were isolated from 
blood samples collected 3 weeks upon boost immunization from calves immunized twice 
i.n. with NcMP and CpG adjuvant (NcMP/CpG) or sham-immunized with CpG adjuvant 
alone (CpG). Total number of calves per group: CpG n=4; NcMP/CpG n=4. Graphs are 
presented with mean plus one SEM (** p<0.01).   
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DISCUSSION 
 
 Although economic losses due to N. caninum related abortions constitute a 
significant burden in affected cattle livestock farms14, cost-effective control options 
to manage this parasitic infection are still not available46. Economic models have 
indicated that a successful vaccination protocol that could prevent primary 
infection or the parasite’s vertical transmission constitute the best strategy to 
control neosporosis15,27, but with the exception of the now withdrawn and largely 
unsuccessful commercial vaccine Bovilis® Neoguard47,48, no other vaccine has 
ever made it into the market. Nevertheless, in the last decades several promising 
immunization strategies against neosporosis have been tested, mainly in mice 
models of neosporosis16,17. Still, and due to obvious limitations of performing 
experimental work with large animals, the evaluation of promising immunization 
protocols in cattle, the final target species, although necessary and mandatory has 
been limited.  
In previous works we have demonstrated that i.n. immunization with NcMP 
and CpG as adjuvant could confer long-term protection against intragastrically 
established murine neosporosis33 (Chapter 4 and 5), making this protocol a 
promising strategy to induce a cattle protective immune response against 
neosporosis. Therefore, in this work we have assessed the immunogenicity and 
the elicited immune response in similarly i.n. immunized Holstein calves using a 
cattle-optimized CpG37. Since the natural route of infection in horizontally 
transmitted neosporosis is through the gastrointestinal tract, the induction of a 
parasite-specific mucosal immune response trough vaccination could be a 
determining factor to achieve host protection against this parasite. Still, and to best 
of our knowledge, this work reports the results of the first mucosal immunization 
protocol that has ever been used in cattle to induce a host protective immune 
response directed against N. caninum. In addition, and although CpG has already 
been employed in combination with other adjuvants in the formulation of 
experimental vaccines in cattle49-53, this is also the first time that CpG has been 
used in this species in a mucosal immunization protocol, despite its known 
powerful mucosal adjuvant properties already described in both human and mouse 
models54,55.  
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 Taking into account that i.n. immunization with NcMP in mice induced the 
production of parasite-agglutinating intestinal IgA and opsonizing serum IgG 
antibodies that could be active mediators in the reported protection33 (Chapter 4), 
we wondered if similar immunization in calves could also induce a comparable 
parasite-specific humoral response. Isotype analysis of the humoral response in 
the serum of immunized calves revealed the presence of parasite-specific IgA and 
IgG indicating that this protocol was successful at inducing a humoral parasite-
specific response. Since IgA is regard as a hallmark of the induction of successful 
mucosal immunity40-43, this preliminary analysis suggests that our immunization 
protocol should have successfully induced a parasite-specific mucosal immune 
response. Still, despite the fact that serum IgA has already been used in previous 
studies to evaluate an characterize the effectiveness of i.n. immunization in 
cattle56, serum IgA levels have been known to not always give the best readout 
regarding mucosal production of this immunoglobulin41,57. Therefore, and since 
parasite-agglutinating intestinal IgA elicited in similarly i.n. immunized mice could 
be a major mediator of the previously observed protection33 (chapter 4), it would 
be worth assessing in future studies if parasite-specific IgA is also present in the 
intestinal mucosa or in fecal contents of i.n. immunized calves. This analysis would 
also confirm if an intestinal mucosal immune response could be induced following 
i.n. immunization in calves, a point never assessed in cattle. In this regard, 
previous studies indicate that i.n. immunization, although capable of inducing both 
mucosal and systemic immune response to target antigens in mice, induced 
somewhat weak responses in the intestinal mucosa41,58, despite evidence of cell 
trafficking between the two mucosas following i.n. immunization in mice59,60. Since 
in i.n. immunized sheep, antigen-specific IgA has been found in fecal contents 
following immunization61, a similar cellular trafficking between the nasal and 
intestinal associated lymphoid tissues should also exist in ruminants.  
Isotype analysis of the elicited parasite-specific serum IgG response 
revealed an IgG1/gG2 ratio < 1 indicating that a small bias towards a Th1-type 
immune response was achieved. This result is consistent with the known Th1-type 
immunomodulatory activity of CpG58,62,63, that has also been previously reported in 
cattle immunized with CpG containing formulations49-52. Furthermore, a 
IgG1/IgG2a ratio < 1 has been found in similarly i.n. immunized mice with NcMP 
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and CpG33 (chapter 4), indicating that a comparable immune response was 
achieved in immunized calves. On the other hand, and since similarly i.n. 
immunized mice present serum parasite-opsonizing IgG that could reduce parasite 
survival when in co-culture with macrophages33 (chapter 4), it would also be worth 
assessing if the elicited IgG in the serum of immunized cattle could also mediate a 
similar and possibly host-protective mechanism. In this regard, and although our 
preliminary results following passive immunization with parasite-specific IgG in IL-
12p40-/- revealed a marginal protective effect of this immunoglobulins in vivo 
(chapter 6), a possible host-protective effect of serum IgG against N. caninum 
infection has never been explored in cattle. 
In line with the humoral analysis indication that in immunized calves a Th1-
biased immune response was achieved, and taking into account that IFN-γ is 
widely known for its paramount importance in host resistance against N. caninum 
infection44,45, cytokine production analysis in PBMC following parasite-specific 
stimulation revealed that cells obtained from immunized calves presented elevated 
levels of IFN-γ in comparison with similarly stimulated cells obtain from sham-
immunized controls. In sharp contrast, the Th-2 associated cytokine IL-4, linked 
with host susceptibility to this parasite infection44,45 was undetected in similarly 
stimulated PBMC from both immunized and sham-immunized controls. These 
results are in agreement with previous results obtained in immunized mice where 
parasite-specific stimulation of MLN and spleen cells also resulted in increased 
IFN-γ in comparison with sham-immunized controls (chapter 5). Nevertheless, and 
despite the fact that a successful parasite-specific immune response was induced 
in immunized calves, we were at this time unable to determine the host protective 
effect of this protocol. Although this is a point certainly worth assessing in future 
studies, cattle oral based infection with N. caninum could prove a significant 
challenge to overcome. In this regard, oral infection in cattle has only been 
achieved using N. caninum oocysts isolated from experimentally infected dogs64,65. 
Furthermore, so far no viable in vitro protocol has been developed for the 
production of either oocysts or tissue cysts of N. caninum. 
 Altogether these results indicate that our i.n. immunization protocol is 
capable of inducing a parasite-specific humoral and cell-mediated immune 
response in cattle. More importantly, a parasite-specific Th1 immune response 
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was induced in immunized calves, which is a good indicator that this protocol 
could be host protective against N. caninum challenge. 
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Chapter 8 
Final discussion 
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8.1 Final Discussion 
Concluding remarks and future perspectives 
 
 Neospora caninum is a parasite transmitted vertically with high efficiency in 
cattle1,2 and responsible for increased abortion rates leading to high economic 
losses worldwide3. The lack of effective strategies to control this protozoan 
transmission4,5 and infection has been the driving force behind the majority of the 
studies performed with this parasite which have greatly contributed to the 
understating of the host-parasite relationship during infection6-9. Although the life 
cycle of N. caninum, decoded for over a decade1,10 following the identification of 
the parasite’s definitive host11, and despite the fact that the intestinal mucosa has 
been established as the crucial site for the initiation of infection in horizontally 
transmitted neosporosis, the understanding of the host-parasite interactions at this 
mucosa has been largely overlooked.  
In chapter 3 and taking into consideration the first proposed objective of this 
thesis, a previously developed murine model of i.g. established neosporosis12 was 
used to study the immune response elicited following parasite infection. We have 
focused this work on the elicited cell-mediated immune response due to its well 
established importance for host resistance against this parasite13,14. Nevertheless, 
previous work by our group has already shown that a parasite-specific humoral 
immune response, both systemic and in the intestinal mucosa, is also elicited 
following i.g. infection with N. caninum12. As depicted in the schematic model 
summarizing our findings represented in Figure 8-1, it was found that an i.g. 
challenge with N. caninum rapidly stimulates the production of IL-12 by different 
DC populations in the MLN. In accordance with this result, an early increase in 
IFN-γ production was observed in CD8αβ+TCRαβ+ IEL on the intestinal mucosa as 
well as in CD8+ T cells in both the spleen and MLN, while only on later time-points 
CD4+ T cells in the spleen were shown to be activated. Interestingly, although 
CD4+ T cells are thought to have a more prominent role than CD8+ T cells in host 
resistance against neosporosis15, these results indicate that CD8+ T cells could be 
a key population in the early control of parasite dissemination following i.g. 
infection.  
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Figure 8-1 – Schematic representation of the results shown in chapter 3  
 
In fact, a very recent study by our group involving i.p. infection of CD8-/- mice 
confirmed that mice without this cell population were also resistant to N. caninum 
infection but nevertheless presented increased parasitic burdens in different 
organs which shows that CD8+ T cells are important in the early control of parasite 
proliferation16. In this regard, it would be worth assessing in future studies if CD8+ 
T cells in the intestinal mucosa do indeed have a role in limiting parasite 
dissemination through the host. Additionally, results presented here show that in 
the first days after i.g. infection the host initiates a Th1-type immune response, in 
the intestinal mucosa and associated lymphoid tissue, deemed essential for host 
protection against this parasitic infection17-20. Although similar results were 
observed in mice infected with the closely related protozoan T. gondii, where CD8+ 
T cells were also shown to be early responders to parasitic challenge21, this is the 
first time that a more in depth characterization of the host immune response in the 
intestinal mucosa following N. caninum infection has been performed.  
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The second objective of this thesis was to develop and establish a mucosal 
immunization protocol capable of conferring protection against i.g. established 
neosporosis. Due to the importance of the intestinal mucosa in the establishment 
of N. caninum infection it was hypothesized that the induction of a parasite-specific 
immune response in the intestine trough mucosal immunization could be a 
privileged strategy to confer host protection against neosporosis. Previous studies 
with T. gondii have already demonstrated that following i.n. immunization a 
parasite-specific mucosal immune response conferred protection against oral 
infection with this parasite22,23. Although i.n. immunization against N. caninum has 
already been performed in mice24-26, evaluation of the conferred protection was 
made through i.p. infection, thus overlooking and neglecting the possible host 
protective effect of mucosal immunity.  
In chapter 4 of this thesis we have confirmed our proposed hypothesis and 
successfully established a host protective i.n. immunization protocol using N. 
caninum membrane proteins and CpG adjuvant in a mouse model of i.g. 
established neosporosis. As represented in figure 8-2, this protection was 
accompanied by the production of parasite-agglutinating intestinal IgA and serum 
parasite-opsonizing IgG. Somewhat unexpectedly considering the IgG isotype 
analysis and the known host protective role of IFN-γ against this parasitic 
infection17-19, immunized mice did not presented increase production of this 
cytokine. Although a reduction in N. caninum colonization levels through 
immunization has been shown to be possible in the absence of a strong Th1-type 
immune response24-28, the immune mechanisms mediating such protection were 
not yet characterized. Nevertheless, since antibodies specific for membrane 
proteins of N. caninum have been shown to prevent parasite entry into host cells29-
32, we hypothesized that the described effector functions of parasite-specific 
antibodies elicited by the immunization protocol assessed here, could mediate the 
observed protection. That would explain the absence of detectable parasite 
colonization observed in the majority of immunized mice, by immune exclusion of 
the parasite in the intestinal mucosa due to parasite-agglutinating IgA and 
parasite-opsonizing IgG. As such and although a biased Th-1 type immune 
response could have been induced in immunized mice, the absence of increase 
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IFN-γ production could be explained by a lack of antigenic stimulation of the host 
immune response as a consequence of the antibody-mediated protection.  
 
Figure 8-2 – Schematic representation of the results and proposed model of protection in 
chapter 4  
 
Following the results and model proposed in chapter 4, in chapter 5 the 
long-term protective effect of the immunization procedure used here was studied. 
Although an essential characteristic for a successful vaccine, the long-term 
protective effect of any immunization strategy against neosporosis has never been 
assessed before. Here, it was demonstrated that protection against i.g. 
established neosporosis conferred by i.n. immunization with NcMP and CpG was 
long-lasting. Importantly, the maintenance at long-term of a parasite-specific IgA 
response in the intestinal mucosa of immunized mice was demonstrated. Although 
antigen-specific IgA production at this mucosa has been described as decreasing 
overtime in the absence of antigenic stimulation33, our data confirms other 
reports34 showing that a long-lasting production of antigen-specific IgA can be 
achieved through mucosal immunization in the intestine. Cytokine production 
analysis confirmed that induction of a Th1-type immune response was indeed 
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achieved in immunized mice, since parasite-specific stimulation of MLN or spleen 
cells resulted in increased IFN-γ production. This result also confirms the presence 
of parasite-specific cells in MLN nodes following i.n. immunization thus showing 
that activated cells in the nasal mucosa can migrate and possibly acquire a 
resident-memory phenotype in lymphoid organs associated to the intestinal 
mucosa. However further studies will be necessary to fully characterize which cell 
types were responsible for this increased IFN-γ production, was well as their 
possible memory phenotype. Still, and in accordance with the results obtained in 
chapter 4, similar analysis performed one week following i.g. infection once again 
revealed no significant differences in IFN-γ production between immunized and 
sham-immunized controls. Furthermore, when comparing pre- and post-infection 
IFN-γ production in chapter 5 these were found to be very similar in immunized 
mice and thus in agreement with the proposed model of protection, through 
prevention of parasite penetration into the host and consequent lack of antigenic 
stimulation. Nonetheless, and taking into account the results in chapter 3, in 
chapters 4 and 5 the existence of a parasite-specific cellular immune response in 
the intestinal mucosa effector sites was not demonstrated. The possibility that the 
observed protection could also be mediated by parasite-specific IFN-γ producing 
cells directly in the intestinal mucosa cannot therefore be ruled out. This point 
needs to be addressed in future studies. Interestingly, in mice immunized i.n. 
against T. gondii, IEL were shown to mediate host protection against 
toxoplasmosis35.  
In chapter 6 and in order to confirm if host protection conferred by the i.n. 
immunization could indeed be achieved in the absence of a Th1-type immune 
response, we assessed it in a highly susceptible IL-12-defiecient mice36. Once 
again, and confirming the model proposed here, host protection characterized by 
lack of detectable parasitic DNA could still be observed in i.g infected immunized 
p40-/- mice. Nevertheless, when parasitic DNA was detected in immunized mice it 
reached levels similar to those observed in sham-immunized controls. This result 
further supported the hypothesis that prevention of host infection could be due to 
mucosally produced IgA. However and due to the marked susceptibility of IL-12-
deficient mice to N. caninum infection36, if the parasite could overcome this initial 
mucosal protective mechanism, than it could be expected that this could easily 
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disseminate in the host due to a compromised Th-1 cell immunity. As such and in 
order to confirm the host protective effect of parasite-specific intestinal IgA, 
similarly immunized p40-/- mice were i.p. infected allowing the parasite to 
overcome the intestinal barrier. However and surprisingly, immunized mice were 
still protected following N. caninum i.p. challenge. Furthermore, some mice even 
had undetectable parasitic DNA. Since previous studies in IL-12-deficient mice 
have shown that an increase IFN-γ production can be induced trough 
immunization prior to infection37 it can be hypothesized that a similar mechanism 
could account for the observed protection since a smaller but still below 1 
IgG1/IgG2a ratio was observed in immunized p40-/- mice. Nevertheless the 
analysis of IFN-γ production by splenocytes from mice infected i.p. did not 
revealed such an increase. This could be due to different kinetics of IFN-γ 
production between sham and immunized mice. To assess this, analysis done 
prior to and in different time points after i.p. infection would help to clarify this 
point. Nonetheless, and taking into consideration the protection profile observed in 
i.g. infected p40-/- mice, and if a higher production of IFN-γ could have been 
induced in the immunized mice it is intriguing as to why a similar reduction in 
parasitic burden was not observed in i.g. infected immunized p40-/- mice. The 
stimulation of different immune cell populations in the different infection routes 
could be a contributing factor for these discrepancies. For example, and due to the 
known role of DC in the spreading of the parasite trough the host38, the early 
encounter of activated DC in the MLN of mice i.g. infected as described in chapter 
3 could indicate that if the infection is established through the intestinal mucosa 
this population could be responsible for the trafficking and shielding of the parasite 
from the host immune response. This is a point certainly worth exploring in future 
studies. In addition, and taking into account the widespread use of i.p. infection for 
the evaluation of the host protective effect of nearly all immunization studies in 
murine neosporosis to date7,9, these results indicate that different infection routes 
could lead to different outcomes in terms of protection. As such, i.g. infection route 
more closely represents the route followed by the parasite in horizontally 
transmitted neosporosis. On the other hand, the host protective effect observed in 
i.p. infected immunized p40-/- mice did not allow to conclude that the mucosal 
barriers, such as intestinal IgA, are indeed responsible for the protection observed 
in i.g. infected immunized mice. In this regard, the use of mice deficient on IgA 
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production39 or its translocation to the intestinal mucosa40 could allow a more 
definitive conclusion on this matter in future studies. Nevertheless, and taking into 
consideration the initially stated objectives of this thesis, a novel mucosal 
immunization protocol capable of conferring long-lasting protection against i.g. 
established neosporosis was achieved and it could also be effective in mice 
presenting a compromised cell-mediated immunity.  
Lastly, in chapter 7 the final proposed objective was addressed and it was 
confirmed that the used i.n. immunization could elicit a parasite-specific humoral 
and cellular immune response in cattle. Although limited in scope, this initial 
analysis confirmed the feasibility and immunogenicity of this immunization strategy 
in the final target species, the bovine. Furthermore, for the first time a mucosal 
immunization protocol was used in cattle as a means to confer host protection 
against N. caninum, which opens new perspectives for future alternatives to 
achieve control of this parasitosis. The analysis of host protection in immunized 
cattle will be an essential point to be addressed in future studies, although the 
establishment of an oral based infection in cattle will be a challenging proposition. 
Altogether, the results presented in this thesis further expanded the 
knowledge on the host immune response in the intestinal mucosa of N. caninum 
infected mice. This knowledge may help in the rational development of novel 
strategies to control this parasitic disease. In addition, the developed mucosal 
immunization protocol presented here was capable of inducing mucosal and 
systemic parasite-specific immunity that could confer long-lasting protection 
against N. caninum infection. 
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Annex 1 
Mucosal and systemic T cell response in mice intragastrically infected with 
Neospora caninum tachyzoites 
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Annex 2 
Protective effect of intranasal immunization with Neospora caninum 
membrane antigens against murine neosporosis established through the 
gastrointestinal tract 
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